Science.gov

Sample records for ferrous bisglycinate chelate

  1. Treatment of mild non-chemotherapy-induced iron deficiency anemia in cancer patients: comparison between oral ferrous bisglycinate chelate and ferrous sulfate.

    PubMed

    Ferrari, Paola; Nicolini, Andrea; Manca, Maria Laura; Rossi, Giuseppe; Anselmi, Loretta; Conte, Massimo; Carpi, Angelo; Bonino, Ferruccio

    2012-09-01

    In cancer patients mild-moderate non-chemotherapy-induced iron deficiency anemia (IDA) is usually treated with oral iron salts, mostly ferrous sulfate. In this study, we compare efficacy and toxicity of oral ferrous bisglycinate chelate and ferrous sulfate in cancer patients with mild IDA. Twenty-four patients operated on for solid tumors (10 breast, 12 colorectal, 2 gastric), aged 61±10 years (range 45-75), with non-chemotherapy-induced hemoglobin (Hb) values between 10 and 12 g/dL and ferritin lower than 30 ng/mL were randomized to receive oral ferrous bisglycinate chelate, 28 mg per day for 20 days, and then 14 mg per day for 40 days (12 patients) (A group) or oral ferrous sulphate, 105 mg per day for 60 days (12 patients) (B group). Values of hemoglobin and ferritin obtained at diagnosis, 1 and 2 months from the beginning of treatment were compared. Adverse events (AEs) related to the two treatments were recorded. In the 12 patients treated with ferrous bisglycinate chelate, basal hemoglobin and ferritin values (mean±SD) were 11.6±0.8 g/dL and 16.1±8.0 ng/mL. After 2 months of treatment, they were 13.0±1.4 g/dL and 33.8±22.0 ng/mL, respectively (P=0.0003 and P=0.020). In the group treated with ferrous sulphate, hemoglobin and ferritin mean values were 11.3±0.6 g/dL and 19.0±6.4 ng/mL basally, and 12.7±0.70 g/dL and 40.8±28.1 ng/mL (P<0.0001 and P=0.017) after 2 months of treatment. AEs occurred in six cases. In all these six cases, two (17%) treated with ferrous bisglycinate chelate and four (33%) with ferrous sulphate, toxicity was grade 1. In conclusion, these data suggest that ferrous bisglycinate chelate has similar efficacy and likely lower GI toxicity than ferrous sulphate given at the conventional dose of 105 mg per day for the same time. PMID:22795809

  2. Effect of supplementation with ferrous sulfate or iron bis-glycinate chelate on ferritin concentration in Mexican schoolchildren: a randomized controlled trial

    PubMed Central

    2014-01-01

    Background Iron deficiency is one of the most common nutritional deficiencies worldwide. It is more prevalent when iron requirements are increased during pregnancy and during growth spurts of infancy and adolescence. The last stage in the process of iron depletion is characterized by a decrease in hemoglobin concentration, resulting in iron deficiency anemia. Iron deficiency, even before it is clinically identified as anemia, compromises the immune response, physical capacity for work, and intellectual functions such as attention level. Therefore, interventions addressing iron deficiency should be based on prevention rather than on treatment of anemia. The aim of this study was to compare short- and medium-term effects on ferritin concentration of daily supplementation with ferrous sulfate or iron bis-glycinate chelate in schoolchildren with iron deficiency but without anemia. Methods Two hundred schoolchildren from public boarding schools in Mexico City who had low iron stores as assessed by serum ferritin concentration but without anemia were randomly assigned to a daily supplement of 30 mg/day of elemental iron as ferrous sulfate or iron bis-glycinate chelate for 12 weeks. Iron status was evaluated at baseline, one week post-supplementation (short term), and 6 months (medium term) after supplementation. Results Ferritin concentration increased significantly between baseline and post-supplementation as well as between baseline and 6 months after supplementation. One week post-supplementation no difference was found in ferritin concentration between iron compounds, but 6 months after supplementation ferritin concentration was higher in the group that received bis-glycinate chelate iron. However, there is no difference in the odds for low iron storage between 6 months after supplementation versus the odds after supplementation; nor were these odds different by type of supplement. Hemoglobin concentration did not change significantly in either group after

  3. Absorption of nitric oxide into aqueous solutions of ferrous chelates accompanied by instantaneous reaction

    SciTech Connect

    Demmink, J.F.; Gils, I.C.F. van; Beenackers, A.A.C.M.

    1997-11-01

    The absorption of nitric oxide (NO) into aqueous solutions of ferrous chelates of nitrilotriacetic acid (NTA), ethylenediaminetetraacetic acid (EDTA), hydroxyethylenediaminetriacetic acid (HEDTA), and diethylenetriaminepentaacetic acid (DTPA) was studied in a stirred cell reactor. The absorption leads to stable ferrous NO chelates. Due to the high reaction rate, in combination with the relatively high P{sub NO} applied, the absorption rate is strongly affected by mass transfer limitation only. By applying penetration theory, the ratio of the diffusion coefficients of ferrous chelates and NO was determined. At elevated T, (D{sub Fe(II)chelate}/D{sub NO}){sup 1/2} decreases due to the unusual T-dependency of D{sub NO}. For ferrous NTA, the formation of the ferrous NO chelate is accompanied by pH effects that can be understood from iron chelate chemistry. In the case of ferrous NTA, pH < 5, or an excess of ligand, these effects lead to local pH gradients at the gas-liquid interface, that substantially affect the NO absorption rates. Kinetic data from the literature on the absorption of NO into ferrous chelates were evaluated using the mass transfer parameters determined. These kinetic data are often unreliable.

  4. Study of Anti-Fatigue Effect in Rats of Ferrous Chelates Including Hairtail Protein Hydrolysates

    PubMed Central

    Huang, Saibo; Lin, Huimin; Deng, Shang-gui

    2015-01-01

    The ability of ferrous chelates including hairtail protein hydrolysates to prevent and reduce fatigue was studied in rats. After hydrolysis of hairtail surimi with papain, the hairtail protein hydrolysates (HPH) were separated into three groups by range of relative molecular weight using ultrafiltration membrane separation. Hairtail proteins were then chelated with ferrous ions, and the antioxidant activity, the amino acid composition and chelation rate of the three kinds of ferrous chelates including hairtail protein hydrolysates (Fe-HPH) were determined. Among the three groups, the Fe-HPH chelate showing the best conditions was selected for the anti-fatigue animal experiment. For it, experimental rats were randomly divided into seven groups. Group A was designated as the negative control group given distilled water. Group B, the positive control group, was given glutathione. Groups C, D and E were designated as the Fe-HPH chelate treatment groups and given low, medium, and high doses, respectively. Group F was designated as HPH hydrolysate treatment group, and Group G was designated as FeCl2 treatment group. The different diets were orally administered to rats for 20 days. After that time, rats were subjected to forced swimming training after 1 h of gavage. Rats given Fe-FPH chelate had higher haemoglobin regeneration efficiency (HRE), longer exhaustive swimming time and higher SOD activity. Additionally, Fe-FPH chelate was found to significantly decrease the malondialdehyde content, visibly enhance the GSH-Px activity in liver and reduce blood lactic acid of rats. Fe-HPH chelate revealed an anti-fatigue effect, similar to or better than the positive control substance and superior to HPH or Fe when provided alone. PMID:26633476

  5. Degradation of toluene, ethylbenzene, and xylene using heat and chelated-ferrous iron activated persulfate oxidation

    NASA Astrophysics Data System (ADS)

    Mondal, P.; Sleep, B.

    2014-12-01

    Toluene, ethylbenze, and xylene (TEX) are common contaminants in the subsurface. Activated persulfate has shown promise for degrading a wide variety of organic compounds. However, studies of persulfate application for in situ degradation of TEX and effects on the subsequent bioremediation are limited. In this work, degradation studies of TEX in aqueous media and soil are being conducted using heat activated and chelated-ferrous iron activated persulfate oxidation in batch and flow-through column experiments. In the batch experiments, sodium persulfate is being used at different concentrations to provide an initial persulfate to TEX molar ratios between 10:1 and 100:1. Sodium persulfate solutions are being activated at 20, 37, 60, and 80 oC temperatures for the heat activated oxidation. For the chelated-ferrous iron activated oxidation, ferrous iron and citric acid, both are being used at concentration of 5 mM. In the experiments with soil slurry, a soil to water ratio of 1 to 5 is being used. Flow through water saturated column experiments are being conducted with glass columns (45 cm in length and 4 cm in diameter) uniformly packed with soils, and equilibrated with water containing TEX at the target concentrations. Both the heat activation and chelated-ferrous iron activation of persulfate are being employed in the column experiments. Future experiments are planned to determine the suitability of persulfate oxidation of TEX on the subsequent biodegradation using batch microcosms containing TEX degrading microbial cultures. In these experiments, the microbial biomass will be monitored using total phospholipids, and the microbial community will be determined using quantitative real-time polymerase chain reaction (qPCR) on the extracted DNA. This study is expected to provide suitable operating conditions for in situ chemical oxidation of TEX with activated persulfate followed by bioremediation.

  6. Preparation of ferrous chelate of hairtail (Trichiurus haumela) protein hydrolysate (Fe(II)-HPH) and its antibacterial activity

    NASA Astrophysics Data System (ADS)

    Lin, Huimin; Zhang, Bin; Yu, Tian; Deng, Shanggui

    The preparation of a ferrous chelate of hairtail (Trichiurus haumela) protein hydrolysate (Fe(II)-HPH) and its antibacterial activity were studied. The optimal conditions of hydrolysis by papain and ferrous chelation were obtained by single-factor experiments and orthogonal test, with the antibacterial activities as the index. In addition, the antibacterial activity of Fe(II)-HPH was evaluated using the Plackett-Burman design. The orthogonal test results showed that Fe(II)-HPH had an antibacterial activity of 98.3% under a temperature of 40 °C at pH 6.5 for an enzymolysis duration of eight hours in the presence of 20,000 U/g of enzyme. The Plackett-Burman design analysis showed that the three most significant factors (P < 0.05) influencing the antibacterial activity of Fe(II)-HPH were pH, the concentration (mg/mL), and presence of magnesium sulfate.

  7. Mössbauer Spectroscopy of Iron Containing Vitamins and Dietary Supplements

    NASA Astrophysics Data System (ADS)

    Oshtrakh, M. I.; Milder, O. B.; Semionkin, V. A.

    2004-12-01

    Mössbauer spectroscopy was used to study various industrial samples of vitamins containing ferrous fumarate and ferrous bisglycinate chelate (Ferrochel®) and dietary supplements containing ferrous sulfate. The presence of small quantities of various ferric impurities was found. Two vitamins contained major iron compounds that did not correspond to ferrous fumarate and ferrous bisglycinate chelate.

  8. Iron Chelation

    MedlinePlus

    ... iron overload and need treatment. What is iron overload? Iron chelation therapy is used when you have ... may want to perform: How quickly does iron overload happen? This is different for each person. It ...

  9. Study of Vitamins and Dietary Supplements Containing Ferrous Fumarate and Ferrous Sulfate Using Moessbauer Spectroscopy

    SciTech Connect

    Oshtrakh, M. I.; Novikov, E. G.; Semionkin, V. A.; Dubiel, S. M.

    2010-07-13

    A study of several samples of vitamins and dietary supplements containing ferrous fumarate and ferrous sulfate was carried out using Moessbauer spectroscopy with a high velocity resolution. A presence of ferrous and ferric impurities was revealed. Small variations of Moessbauer hyperfine parameters were found for both ferrous fumarates and ferrous sulfates in the investigated medicines.

  10. Hydroxypyridonate chelating agents

    DOEpatents

    Raymond, Kenneth N.; Scarrow, Robert C.; White, David L.

    1987-01-01

    Chelating agents having 1-hydroxy-2-pyridinone (HOPO) and related moieties incorporated within their structures, including polydentate HOPO-substituted polyamines such as spermidine and spermine, and HOPO-substituted desferrioxamine. The chelating agents are useful in selectively removing certain cations from solution, and are particularly useful as ferric ion and actinide chelators. Novel syntheses of the chelating agents are provided.

  11. Effect of iron chelators on placental uptake and transfer of iron in rat

    SciTech Connect

    Wong, C.T.; McArdle, H.J.; Morgan, E.H.

    1987-05-01

    The uptake of radiolabeled transferrin and iron by the rat placenta has been studied using two approaches. The first involved injection of a ferrous or ferric iron chelator followed by injection of label. Neither chelator decreased the amount of labelled transferrin in the placenta after 2-h incubation and only bipyridine, a ferrous iron chelator, inhibited iron transport to the fetus. Deferoxamine (DFO), a ferric iron chelator, had no effect on iron transport to the fetus but reduced iron uptake by the liver. Both bipyridine and DFO increased iron excretion into the gut and by the urinary tract to the same degree into the gut, but there was a 10-fold greater urinary excretion with bipyridine than with DFO. Injection of iron attached to the chelators showed that neither bipyridine nor DFO could donate iron to the fetus as efficiently as transferrin. The mechanism involved was further investigated by studying the effect of the chelators on uptake of transferrin-bound iron by placental cells in culture. DFO inhibited iron accumulation more effectively than bipyridine in the cultured cells. The effect was not due to a decrease in the cycling time of the receptor. The results can be explained if the iron is released from the transferrin in intracellular vesicles in the ferrous form, where it may be chelated by bipyridine and prevented from passing to the fetus or converted to the ferric form once it is inside the cell matrix.

  12. 21 CFR 184.1308 - Ferrous gluconate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ...-yellow powder or granules. It is prepared by reacting hot solutions of barium or calcium gluconate with ferrous sulfate or by heating freshly prepared ferrous carbonate with gluconic acid in aqueous...

  13. 21 CFR 184.1308 - Ferrous gluconate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ...-yellow powder or granules. It is prepared by reacting hot solutions of barium or calcium gluconate with ferrous sulfate or by heating freshly prepared ferrous carbonate with gluconic acid in aqueous...

  14. 21 CFR 582.5315 - Ferrous sulfate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or Dietary Supplements 1 § 582.5315 Ferrous sulfate. (a) Product. Ferrous sulfate. (b) Conditions of use. This...

  15. 21 CFR 582.5311 - Ferrous lactate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or Dietary Supplements 1 § 582.5311 Ferrous lactate. (a) Product. Ferrous lactate. (b) Conditions of use. This...

  16. 21 CFR 73.160 - Ferrous gluconate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... ferrous gluconate is the ferrous gluconate defined in the Food Chemicals Codex, 3d Ed. (1981), pp. 122-123... shall meet the specifications given in the Food Chemicals Codex, 3d Ed. (1981), which is incorporated...

  17. 21 CFR 73.160 - Ferrous gluconate.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... ferrous gluconate is the ferrous gluconate defined in the Food Chemicals Codex, 3d Ed. (1981), pp. 122-123... shall meet the specifications given in the Food Chemicals Codex, 3d Ed. (1981), which is incorporated...

  18. 21 CFR 73.160 - Ferrous gluconate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... ferrous gluconate is the ferrous gluconate defined in the Food Chemicals Codex, 3d Ed. (1981), pp. 122-123... shall meet the specifications given in the Food Chemicals Codex, 3d Ed. (1981), which is incorporated...

  19. 21 CFR 73.160 - Ferrous gluconate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... ferrous gluconate is the ferrous gluconate defined in the Food Chemicals Codex, 3d Ed. (1981), pp. 122-123... shall meet the specifications given in the Food Chemicals Codex, 3d Ed. (1981), which is incorporated...

  20. 21 CFR 73.160 - Ferrous gluconate.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... ferrous gluconate is the ferrous gluconate defined in the Food Chemicals Codex, 3d Ed. (1981), pp. 122-123... shall meet the specifications given in the Food Chemicals Codex, 3d Ed. (1981), which is incorporated...

  1. 21 CFR 184.1311 - Ferrous lactate.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... lactic acid with iron filings, reaction of ferrous chloride with sodium lactate, or reaction of ferrous...) and 1 CFR part 51. Copies are available from the National Academy Press, 2101 Constitution Ave....

  2. 21 CFR 184.1311 - Ferrous lactate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... lactic acid with iron filings, reaction of ferrous chloride with sodium lactate, or reaction of ferrous...) and 1 CFR part 51. Copies are available from the National Academy Press, 2101 Constitution Ave....

  3. 21 CFR 184.1311 - Ferrous lactate.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... lactic acid with iron filings, reaction of ferrous chloride with sodium lactate, or reaction of ferrous...) and 1 CFR part 51. Copies are available from the National Academy Press, 2101 Constitution Ave....

  4. 46 CFR 148.260 - Ferrous metal.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 46 Shipping 5 2011-10-01 2011-10-01 false Ferrous metal. 148.260 Section 148.260 Shipping COAST... THAT REQUIRE SPECIAL HANDLING Special Requirements for Certain Materials § 148.260 Ferrous metal. (a... waters of United States. (b) Ferrous metal may not be stowed or transported in bulk unless the...

  5. 46 CFR 148.260 - Ferrous metal.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 46 Shipping 5 2014-10-01 2014-10-01 false Ferrous metal. 148.260 Section 148.260 Shipping COAST... THAT REQUIRE SPECIAL HANDLING Special Requirements for Certain Materials § 148.260 Ferrous metal. (a... waters of United States. (b) Ferrous metal may not be stowed or transported in bulk unless the...

  6. 46 CFR 148.260 - Ferrous metal.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 46 Shipping 5 2013-10-01 2013-10-01 false Ferrous metal. 148.260 Section 148.260 Shipping COAST... THAT REQUIRE SPECIAL HANDLING Special Requirements for Certain Materials § 148.260 Ferrous metal. (a... waters of United States. (b) Ferrous metal may not be stowed or transported in bulk unless the...

  7. 46 CFR 148.260 - Ferrous metal.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 46 Shipping 5 2012-10-01 2012-10-01 false Ferrous metal. 148.260 Section 148.260 Shipping COAST... THAT REQUIRE SPECIAL HANDLING Special Requirements for Certain Materials § 148.260 Ferrous metal. (a... waters of United States. (b) Ferrous metal may not be stowed or transported in bulk unless the...

  8. Chelation in Metal Intoxication

    PubMed Central

    Flora, Swaran J.S.; Pachauri, Vidhu

    2010-01-01

    Chelation therapy is the preferred medical treatment for reducing the toxic effects of metals. Chelating agents are capable of binding to toxic metal ions to form complex structures which are easily excreted from the body removing them from intracellular or extracellular spaces. 2,3-Dimercaprol has long been the mainstay of chelation therapy for lead or arsenic poisoning, however its serious side effects have led researchers to develop less toxic analogues. Hydrophilic chelators like meso-2,3-dimercaptosuccinic acid effectively promote renal metal excretion, but their ability to access intracellular metals is weak. Newer strategies to address these drawbacks like combination therapy (use of structurally different chelating agents) or co-administration of antioxidants have been reported recently. In this review we provide an update of the existing chelating agents and the various strategies available for the treatment of heavy metals and metalloid intoxications. PMID:20717537

  9. Macrocyclic bifunctional chelating agents

    DOEpatents

    Meares, Claude F.; DeNardo, Sally J.; Cole, William C.; Mol, Min K.

    1987-01-01

    A copper chelate conjugate which is stable in human serum. The conjugate includes the copper chelate of a cyclic tetraaza di-, tri-, or tetra-acetic acid, a linker attached at one linker end to a ring carbon of the chelate, and a biomolecule joined at the other end of the linker. The conjugate, or the linker-copper chelate compound used in forming the conjugate, are designed for use in diagnostic and therapeutic applications which involve Cu(II) localization via the systemic route.

  10. Comment on the paper by R. Sankar, C.M. Ragahvan, R. Mohan Kumar, R. Jayavel, “Growth and characterization of bis-glycine sodium nitrate (BGSN), a novel semiorganic nonlinear optical crystal”, J. Crystal Growth 309 (2007) 30 36

    NASA Astrophysics Data System (ADS)

    Petrosyan, A. M.

    2008-08-01

    It is argued that the conclusion of the authors of the title paper on obtaining of a new crystal bis-glycine sodium nitrate is erroneous. From an aqueous solution containing 2 glycine+NaNO 3 the authors actually have obtained earlier known crystals: glycine (alpha form) and glycine sodium nitrate.

  11. The Chelate Effect Redefined.

    ERIC Educational Resources Information Center

    da Silva, J. J. R. Frausto

    1983-01-01

    Discusses ambiguities of the accepted definition of the chelate effect, suggesting that it be defined in terms of experimental observation rather than mathematical abstraction. Indicates that the effect depends on free energy change in reaction, ligand basicity, pH of medium, type of chelates formed, and concentration of ligands in solution. (JN)

  12. Study of Vitamins and Dietary Supplements Containing Ferrous Fumarate and Ferrous Sulfate Using Mössbauer Spectroscopy

    NASA Astrophysics Data System (ADS)

    Oshtrakh, M. I.; Novikov, E. G.; Dubiel, S. M.; Semionkin, V. A.

    2010-07-01

    A study of several samples of vitamins and dietary supplements containing ferrous fumarate and ferrous sulfate was carried out using Mössbauer spectroscopy with a high velocity resolution. A presence of ferrous and ferric impurities was revealed. Small variations of Mössbauer hyperfine parameters were found for both ferrous fumarates and ferrous sulfates in the investigated medicines.

  13. The Rules of Ferrous Metallurgy

    PubMed Central

    2010-01-01

    The ways in which the sciences have been delineated and categorized throughout history provide insights into the formation, stabilization, and establishment of scientific systems of knowledge. The Dresdener school’s approach for explaining and categorizing the genesis of the engineering disciplines is still valid, but needs to be complemented by further-reaching methodological and theoretical reflections. Pierre Bourdieu’s theory of social practice is applied to the question of how individual agents succeed in influencing decisively a discipline’s changing object orientation, institutionalisation and self-reproduction. Through the accumulation of social, cultural and economic capital, they succeed in realising their own organisational ideas and scientific programs. Key concepts for the analysis include the struggle for power and resources, monopolies of interpretation, and the degree of autonomy. A case study from the Aachener Technische Hochschule shows that the consolidation of ferrous metallurgy can be conceived as a symbolical struggle between Fritz Wüst, professor for ferrous metallurgy, and the German Iron and Steel Institute, leading to a construction of a system of differences in which scientists accepted being scientists rather than entrepreneurs, and entrepreneurs accepted becoming entrepreneurs and renounced science.

  14. 21 CFR 582.5308 - Ferrous gluconate.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 6 2013-04-01 2013-04-01 false Ferrous gluconate. 582.5308 Section 582.5308 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or Dietary Supplements 1 § 582.5308 Ferrous gluconate....

  15. 21 CFR 582.5308 - Ferrous gluconate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 6 2010-04-01 2010-04-01 false Ferrous gluconate. 582.5308 Section 582.5308 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or Dietary Supplements 1 § 582.5308 Ferrous gluconate....

  16. Ferrous iron transport in Streptococcus mutans

    SciTech Connect

    Evans, S.L.; Arcenaeux, J.E.L.; Byers, B.R.; Martin, M.E.; Aranha, H.

    1986-12-01

    Radioiron uptake from /sup 59/FeCl/sub 3/ by Streptococcus mutans OMZ176 was increased by anaerobiosis, sodium ascorbate, and phenazine methosulfate (PMS), although there was a 10-min lag before PMS stimulation was evident. The reductant ascorbate may have provided ferrous iron. The PMS was reduced by the cells, and the reduced PMS then may have generated ferrous iron for transport; reduced PMS also may have depleted dissolved oxygen. It was concluded that S. mutans transports only ferrous iron, utilizing reductants furnished by glucose metabolism to reduce iron prior to its uptake.

  17. 21 CFR 184.1311 - Ferrous lactate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... prepared by reacting calcium lactate or sodium lactate with ferrous sulfate, direct reaction of lactic acid.... (1996), pp. 154 to 155, which is incorporated by reference in accordance with 5 U.S.C. 552(a) and 1...

  18. 21 CFR 184.1311 - Ferrous lactate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... reacting calcium lactate or sodium lactate with ferrous sulfate, direct reaction of lactic acid with iron... to 155, which is incorporated by reference in accordance with 5 U.S.C. 552(a) and 1 CFR part...

  19. Liposome encapsulation of chelating agents

    DOEpatents

    Rahman, Yueh Erh

    1976-01-13

    A method for transferring a chelating agent across a cellular membrane by encapsulating the charged chelating agent within liposomes and carrying the liposome-encapsulated chelating agent to the cellular membrane where the liposomes containing the chelating agent will be taken up by the cells, thereby transferring the chelating agent across the cellular membrane. A chelating agent can be introduced into the interior of a cell of a living organism wherein the liposomes will be decomposed, releasing the chelating agent to the interior of the cell. The released chelating agent will complex intracellularly deposited toxic heavy metals, permitting the more soluble metal complex to transfer across the cellular membrane from the cell and subsequently be removed from the living organism.

  20. The antioxidant effect of fermented papaya preparation involves iron chelation.

    PubMed

    Prus, E; Fibach, E

    2012-01-01

    Iron-overload is a major clinical problem in various diseases. Under this condition, serum iron which surpasses the binding capacity of transferrin is present as non-transferrin bound iron and cellular unbound Labile Iron Pool (LIP) is increased. LIP participates in the generation of free radicals, including reactive oxygen species (ROS). Increased ROS, with concomitant decrease in anti-oxidants, results in oxidative stress and toxicity to the liver, heart and other tissues, causing serious morbidity and eventually mortality. Therapeutic iron chelation reduces the LIP and thereby ameliorates oxidative stress-mediated toxicity. Many food-derived antioxidants have the capacities to scavenge ROS and chelate iron. We have reported that fermented papaya preparation (FPP) has ROS scavenging effect on blood cells in vitro or in vivo (in thalassemic patients and experimental animals). We now investigated FPP's iron chelating effect - its ability to prevent (and revert) LIP accumulation. Liver- and heart-derived cells, and RBCs were exposed to non-transferrin bound iron in the form of ferrous ammonium sulfate and the effect of FPP on their LIP content and ROS generation was measured by flow-cytometry. The results indicate that FPP reduces LIP and ROS, and suggests that its antioxidant mechanism is related, at least in part, to iron chelation. PMID:22824747

  1. Rigid bifunctional chelating agents

    DOEpatents

    Sweet, Mark P.; Mease, Ronnie C.; Srivastava, Suresh C.

    1998-07-21

    Bicyclo›2.2.2! octane-2,3 diamine-N,N,N',N'-tetraacetic acids (BODTA) and bicyclo›2.2.1! heptane-2,3 diamine-N,N,N',N'-tetraacetic acid (BHDTA) are chelating agents useful in forming detectably labeled bioconjugate compounds for diagnostic and therapeutic purposes. New compounds and processes of forming BODTA and BHDTA are disclosed. Radioimmunoconjugates of the present invention show high and prolonged tumor uptake with low normal tissue uptakes.

  2. Rigid bifunctional chelating agents

    DOEpatents

    Sweet, Mark P.; Mease, Ronnie C.; Srivastava, Suresh C.

    2000-02-08

    Bicyclo[2.2.2]octane-2,3 diamine-N,N,N',N'-tetraacetic acids (BODTA) and bicyclo[2.2.1]heptane-2,3 diamine-N,N,N',N'-tetraacetic acid (BHDTA) are chelating agents useful in forming detectably labeled bioconjugate compounds for diagnostic and therapeutic purposes. New compounds and processes of forming BODTA and BHDTA are disclosed. Radioimmunoconjugates of the present invention show high and prolonged tumor uptake with low normal tissue uptakes.

  3. Rigid bifunctional chelating agents

    DOEpatents

    Sweet, M.P.; Mease, R.C.; Srivastava, S.C.

    1998-07-21

    Bicyclo[2.2.2] octane-2,3 diamine-N,N,N`,N`-tetraacetic acids (BODTA) and bicyclo[2.2.1] heptane-2,3 diamine-N,N,N`,N`-tetraacetic acid (BHDTA) are chelating agents useful in forming detectably labeled bioconjugate compounds for diagnostic and therapeutic purposes. New compounds and processes of forming BODTA and BHDTA are disclosed. Radioimmunoconjugates of the present invention show high and prolonged tumor uptake with low normal tissue uptakes.

  4. Metal Chelating Crosslinkers Form Nanogels with High Chelation Stability.

    PubMed

    Lux, Jacques; Chan, Minnie; Elst, Luce Vander; Schopf, Eric; Mahmoud, Enas; Laurent, Sophie; Almutairi, Adah

    2013-12-14

    We present a series of hydrogel nanoparticles (nanogels) incorporating either acyclic or cyclic metal chelates as crosslinkers. These crosslinkers are used to formulate polyacrylamide-based nanogels (diameter 50 to 85 nm) yielding contrast agents with enhanced relaxivities (up to 6-fold greater than Dotarem®), because this nanogel structure slows the chelator's tumbling frequency and allows fast water exchange. Importantly, these nanogels also stabilize Gd(3+) within the chelator thermodynamically and kinetically against metal displacement through transmetallation, which should reduce toxicity associated with release of free Gd(3+). This chelation stability suggests that the chelate crosslinker strategy may prove useful for other applications of metal-chelating nanoparticles in medicine, including other imaging modalities and radiotherapy. PMID:24505553

  5. Metal Chelating Crosslinkers Form Nanogels with High Chelation Stability

    PubMed Central

    Elst, Luce Vander; Schopf, Eric; Mahmoud, Enas; Laurent, Sophie; Almutairi, Adah

    2013-01-01

    We present a series of hydrogel nanoparticles (nanogels) incorporating either acyclic or cyclic metal chelates as crosslinkers. These crosslinkers are used to formulate polyacrylamide-based nanogels (diameter 50 to 85 nm) yielding contrast agents with enhanced relaxivities (up to 6-fold greater than Dotarem®), because this nanogel structure slows the chelator's tumbling frequency and allows fast water exchange. Importantly, these nanogels also stabilize Gd3+ within the chelator thermodynamically and kinetically against metal displacement through transmetallation, which should reduce toxicity associated with release of free Gd3+. This chelation stability suggests that the chelate crosslinker strategy may prove useful for other applications of metal-chelating nanoparticles in medicine, including other imaging modalities and radiotherapy. PMID:24505553

  6. 21 CFR 582.5308 - Ferrous gluconate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 6 2011-04-01 2011-04-01 false Ferrous gluconate. 582.5308 Section 582.5308 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or...

  7. 21 CFR 582.5311 - Ferrous lactate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 6 2010-04-01 2010-04-01 false Ferrous lactate. 582.5311 Section 582.5311 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or...

  8. 21 CFR 582.5311 - Ferrous lactate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 6 2014-04-01 2014-04-01 false Ferrous lactate. 582.5311 Section 582.5311 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or...

  9. 21 CFR 582.5308 - Ferrous gluconate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 6 2014-04-01 2014-04-01 false Ferrous gluconate. 582.5308 Section 582.5308 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or...

  10. 21 CFR 582.5315 - Ferrous sulfate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 6 2014-04-01 2014-04-01 false Ferrous sulfate. 582.5315 Section 582.5315 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or...

  11. 21 CFR 73.165 - Ferrous lactate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... is incorporated by reference in accordance with 5 U.S.C. 552(a) and 1 CFR part 51. Copies are... 21 Food and Drugs 1 2010-04-01 2010-04-01 false Ferrous lactate. 73.165 Section 73.165 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES GENERAL LISTING OF...

  12. 21 CFR 582.5315 - Ferrous sulfate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 6 2010-04-01 2010-04-01 false Ferrous sulfate. 582.5315 Section 582.5315 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or...

  13. 21 CFR 73.165 - Ferrous lactate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... is incorporated by reference in accordance with 5 U.S.C. 552(a) and 1 CFR part 51. Copies are... availability of this material at NARA, call 202-741-6030, or go to: http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html. (c) Uses and restrictions. Ferrous lactate may...

  14. 21 CFR 73.165 - Ferrous lactate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... is incorporated by reference in accordance with 5 U.S.C. 552(a) and 1 CFR part 51. Copies are... availability of this material at NARA, call 202-741-6030, or go to: http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html. (c) Uses and restrictions. Ferrous lactate may...

  15. 46 CFR 56.60-3 - Ferrous materials.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 46 Shipping 2 2012-10-01 2012-10-01 false Ferrous materials. 56.60-3 Section 56.60-3 Shipping COAST GUARD, DEPARTMENT OF HOMELAND SECURITY (CONTINUED) MARINE ENGINEERING PIPING SYSTEMS AND APPURTENANCES Materials § 56.60-3 Ferrous materials. (a) Ferrous pipe used for salt water service must...

  16. 46 CFR 56.60-3 - Ferrous materials.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 46 Shipping 2 2010-10-01 2010-10-01 false Ferrous materials. 56.60-3 Section 56.60-3 Shipping COAST GUARD, DEPARTMENT OF HOMELAND SECURITY (CONTINUED) MARINE ENGINEERING PIPING SYSTEMS AND APPURTENANCES Materials § 56.60-3 Ferrous materials. (a) Ferrous pipe used for salt water service must...

  17. 46 CFR 56.60-3 - Ferrous materials.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 46 Shipping 2 2011-10-01 2011-10-01 false Ferrous materials. 56.60-3 Section 56.60-3 Shipping COAST GUARD, DEPARTMENT OF HOMELAND SECURITY (CONTINUED) MARINE ENGINEERING PIPING SYSTEMS AND APPURTENANCES Materials § 56.60-3 Ferrous materials. (a) Ferrous pipe used for salt water service must...

  18. Nitrosylation of rabbit ferrous heme-hemopexin.

    PubMed

    Fasano, Mauro; Bocedi, Alessio; Mattu, Marco; Coletta, Massimo; Ascenzi, Paolo

    2004-10-01

    Hemopexin (HPX) serves as a trap for toxic plasma heme, ensuring its complete clearance by transportation to the liver. Moreover, HPX-heme has been postulated to play a key role in the homeostasis of nitric oxide (NO). Here, the thermodynamics for NO binding to rabbit ferrous HPX-heme as well as the EPR and optical absorption spectroscopic properties of rabbit ferrous nitrosylated HPX-heme (HPX-heme-NO) are reported. The value of the dissociation equilibrium constant for NO binding to rabbit ferrous HPX-heme (i.e., H) is (1.4+/-0.2)x10(-7) M, at pH 7.0 and 10.0 degrees C; the value of H is unaffected by sodium chloride. At pH 7.0, rabbit ferrous HPX-heme-NO is a six-coordinate heme-iron species, characterized by an X-band EPR spectrum with an axial geometry and by epsilon=146 mM(-1) cm(-1) at 419 nm. At pH 4.0, rabbit ferrous HPX-heme-NO is a five-coordinate heme-iron species, characterized by an X-band EPR spectrum with three-line splitting centered at 334 mT and by epsilon=74 mM(-1) cm(-1) at 387 nm. The p K(a) value of the reversible pH-induced six- to five-coordinate spectroscopic transition is 4.8+/-0.1 in the absence of sodium chloride and 4.3+/-0.1 in the presence of 1.5x10(-1) M sodium chloride. This result is in agreement with the effect of sodium chloride on rabbit HPX-heme stability. The present data have been analyzed in parallel with those of a related heme model compound and heme-protein systems. PMID:15378409

  19. Natural chelates for radionuclide decorporation

    DOEpatents

    Premuzic, E.T.

    1983-08-25

    This invention relates to the method and resulting chelates of desorbing a radionuclide selected from thorium, uranium, and plutonium containing cultures in a bioavailable form involving pseudomonas or other microorganisms. A preferred microorganism is Pseudomonas aeruginosa which forms multiple chelates with thorium in the range of molecular weight 1000 to 1000 and also forms chelates with uranium of molecular weight in the area of 100 to 1000 and 1000 to 2000.

  20. Recycling ferrous and nonferrous waste streams with FASTMET

    NASA Astrophysics Data System (ADS)

    McClelland, James M.; Metius, Gary E.

    2003-08-01

    In metals processing, residue streams are routinely generated containing recoverable metallic compounds. These metallics represent both valuable materials and potential disposal problems to the producer. Midrex, primarily involved in ferrous conversion for many years, has developed a variety of new processing techniques for ferrous and non-ferrous recovery. The processing technologies involve either shaft or rotary hearth furnaces, and can be both hydrocarbon or coal based. Recent developments have included conversion studies for ferrous and non-ferrous residual streams that are energy efficient and environmentally friendly. The technologies to be presented, predominantly coal based, include FASTMET®, FASTMELT®, and Itmk3®.

  1. Removal of copper from ferrous scrap

    DOEpatents

    Blander, M.; Sinha, S.N.

    1990-05-15

    A process for removing copper from ferrous or other metal scrap in which the scrap is contacted with a polyvalent metal sulfide slag in the presence of an excess of copper-sulfide forming additive to convert the copper to copper sulfide which is extracted into the slag to provide a ratio of copper in the slag to copper in the metal scrap of at least about 10.

  2. Removal of copper from ferrous scrap

    DOEpatents

    Blander, Milton; Sinha, Shome N.

    1990-01-01

    A process for removing copper from ferrous or other metal scrap in which the scrap is contacted with a polyvalent metal sulfide slag in the presence of an excess of copper-sulfide forming additive to convert the copper to copper sulfide which is extracted into the slag to provide a ratio of copper in the slag to copper in the metal scrap of at least about 10.

  3. Removal of copper from ferrous scrap

    DOEpatents

    Blander, M.; Sinha, S.N.

    1987-07-30

    A process for removing copper from ferrous or other metal scrap in which the scrap is contacted with a polyvalent metal sulfide slag in the presence of an excess of copper-sulfide forming additive to convert the copper to copper sulfide which is extracted into the slag to provide a ratio of copper in the slag to copper in the metal scrap of at least about 10.

  4. 21 CFR 184.1315 - Ferrous sulfate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ...) sulfate heptahydrate, FeSO4·7H2O, CAS Reg. No. 7782-63-0) is prepared by the action of sulfuric acid on... 21 Food and Drugs 3 2011-04-01 2011-04-01 false Ferrous sulfate. 184.1315 Section 184.1315 Food... nutrient supplements as defined in § 170.3(o)(20) of this chapter and as a processing aid as defined...

  5. 21 CFR 184.1315 - Ferrous sulfate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... heptahydrate, FeSO4·7H2O, CAS Reg. No. 7782-63-0) is prepared by the action of sulfuric acid on iron. It occurs... 21 Food and Drugs 3 2010-04-01 2009-04-01 true Ferrous sulfate. 184.1315 Section 184.1315 Food and... supplements as defined in § 170.3(o)(20) of this chapter and as a processing aid as defined in §...

  6. Polycatecholamide chelating agents

    DOEpatents

    Weitl, Frederick L.; Raymond, Kenneth N.

    1984-01-01

    Novel polybenzamide compounds useful for in vitro or in vivo chelation are described. The compounds have the formula ##STR1## Polyamines are reacted with 2,3-dimethoxy benzoyl chloride unsubstituted or substituted with SO.sub.3 H, SO.sub.3 M, NO.sub.2, CO.sub.2 H or CO.sub.2 M as desired is reacted with a polyamine in an inert solvent then demethylated with BBr.sub.3 or BCl.sub.3 in an inert solvent. Where compounds symmetrically substituted on the terminal N's are desired, the polyamine is first reductively alkylated by reaction with an aldehyde or ketone and the resulting Schiff base is hydrogenated.

  7. Novel polycatecholamide chelating agents

    DOEpatents

    Weitl, F.L.; Raymond, K.N.

    1981-08-24

    Novel polybenzamide compounds useful for in vitro or in vivo chelation are described. Formulas of the compounds are given. To prepare them polyamines are reacted with 2,3-dimethoxy benzoyl chloride unsubstituted or substituted with SO/sub 3/H, SO/sub 3/M, NO/sub 2/, CO/sub 2/H or CO/sub 2/M as desired is reacted with a polyamine in an inert solvent then demethylated with BBr/sub 3/ or BCl/sub 3/ in an inert solvent. Where compounds symmetrically substituted on the terminal N's are desired, the polyamine is first reductively alkylated by reaction with an aldehyde or ketone and the resulting Schiff base is hydrogenated.

  8. Polycatecholamide chelating agents

    DOEpatents

    Weitl, F.L.; Raymond, K.N.

    1984-04-10

    Novel polybenzamide compounds useful for in vitro or in vivo chelation are described. The compounds have the formula given in patent. Polyamines are reacted with 2,3-dimethoxy benzoyl chloride unsubstituted or substituted with SO[sub 3]H, SO[sub 3]M, NO[sub 2], CO[sub 2]H or CO[sub 2]M as desired is reacted with a polyamine in an inert solvent then demethylated with BBr[sub 3] or BCl[sub 3] in an inert solvent. Where compounds symmetrically substituted on the terminal N's are desired, the polyamine is first reductively alkylated by reaction with an aldehyde or ketone and the resulting Schiff base is hydrogenated. No Drawings

  9. Rapid and selective chelatometric titration of zinc in non-ferrous alloys.

    PubMed

    Nan, Z; Zhi-Ren, L; Yuan-Xiang, G

    1983-11-01

    A rapid titrimetric method for the determination of Zn (5%) in zinc, aluminium and copper alloys is proposed. It is based on the chelation of Zn(II) with HEDTA as titrant in an ethanolic aqueous medium. The end-point is detected with hydrazidazol, a new indicator developed in China. Up to at least 6% Mn in the alloy does not interfere. Direct determination of Zn(II) is rendered possible by using a combination of masking agents. A separation is needed only if nickel is also present. A decided advantage of this method is its high selectivity. The standard deviation was found to be 0.07 mg and the coefficient of variation to vary from 0.2 to 0.5%. The method has been successfully used to determine Zn in different kinds of non-ferrous alloys, especially those containing Mn. PMID:18963480

  10. METHOD OF REDUCING PLUTONIUM WITH FERROUS IONS

    DOEpatents

    Dreher, J.L.; Koshland, D.E.; Thompson, S.G.; Willard, J.E.

    1959-10-01

    A process is presented for separating hexavalent plutonium from fission product values. To a nitric acid solution containing the values, ferrous ions are added and the solution is heated and held at elevated temperature to convert the plutonium to the tetravalent state via the trivalent state and the plutonium is then selectively precipitated on a BiPO/sub 4/ or LaF/sub 3/ carrier. The tetravalent plutonium formed is optionally complexed with fluoride, oxalate, or phosphate anion prior to carrier precipitation.

  11. Hydroxypyridonate chelating agents and synthesis thereof

    DOEpatents

    Raymond, K.N.; Scarrow, R.C.; White, D.L.

    1985-11-12

    Chelating agents having 1-hydroxy-2-pyridinone (HOPO) and related moieties incorporated within their structures, including polydentate HOPO-substituted polyamines such as spermidine and spermine, and HOPO-substituted desferrioxamine. The chelating agents are useful in selectively removing certain cations from solution, and are particularly useful as ferric ion and actinide chelators. Novel syntheses of the chelating agents are provided. 4 tabs.

  12. Thermodynamic fundamentals of ferrous cake sulfitization

    NASA Astrophysics Data System (ADS)

    Tyurin, A. G.; Vasekha, M. V.; Biryukov, A. I.

    2016-03-01

    The Pourbaix diagrams of the systems SO 4 2- -SO 3 2- -H2O and iron hydroxide (oxide)-H2O are refined. The E(pH) dependence of the sulfitization of iron(III) hydroxide is refined with allowance for the regions of predominant phase constituents of the systems. The potential E-pH electrochemical equilibrium diagrams of the systems Fe(OH)3-H2SO4-SO 3 2- -H2O, FeOOH-H2SO4-SO 3 2- -H2O, and Fe2O3-H2SO4-SO 3 2- -H2O are plotted. These diagrams can be considered as a thermodynamic basis for the sulfite conversion of the ferrous cake of copper-nickel production.

  13. Removal of cyanides by complexation with ferrous compounds

    SciTech Connect

    Varuntanya, C.P.; Zabban, W.

    1995-12-31

    Alkaline chlorination, an oxidation process with chlorine (Cl{sub 2}) or hypochlorite (ClO{sup {minus}}), is the most widely accepted method of cyanide treatment. However, removal of cyanide from wastewater to the extent required by the effluent limits imposed by Federal and State regulatory authorities is practically impossible, especially when the majority of the cyanide is present as an iron-cyanide complex. One potential treatment method being further investigated uses ferrous (Fe{sup 2+}) compounds to react with free and complex cyanide ions and produce insoluble iron-cyanide complexes. However, sludges generated by this treatment method contain cyanide wastes which may be considered a hazardous waste by the US Environmental Protection Agency (US EPA). The studies reported in this paper demonstrate that ferrous (Fe{sup 2+}) precipitation can remove cyanide ions (both free and complex) to a concentration within the range of 1 to 2 mg/L. The wastewaters utilized in these tests were collected from a coke plant facility. Synthetic cyanide solutions were used in the studied as well. Ferrous compounds used in the studies included commercial-grade ferrous sulfate, commercial-grade ferrous chloride, and spent pickle liquor (containing ferrous ion). The desired effluent quality was successfully attained in the treatment of the above-mentioned wastewaters by using ferrous compounds as well as spent pickle liquor.

  14. The removal of hexavalent chromium from water by ferrous sulfate

    SciTech Connect

    Lin, C.J.J.; Vesilind, P.A.

    1995-12-31

    The redox reaction of hexavalent chromium and ferrous sulfate is investigated in his study. Hexavalent chromium, a highly toxic and mobile anion, could exist in raw water used as a public water supply due to the industrial chromium contamination of natural water or due to natural oxidation of trivalent chromium. Ferrous sulfate is one of the widely used coagulants in water treatment plants and has good reducing ability. Because of its reducing capacity, ferrous sulfate can be applied to remove hexavalent chromium from water. The required contact time to reach equilibrium, the effectiveness of Cr(VI) reduction at different initial pH, and the required ferrous sulfate dosage for complete reduction are investigated. The redox reaction can be completed within 10 minutes, allowing 30 mg/L of hexavalent chromium to react with stoichiometric dosage of ferrous sulfate in deionized water, regardless of the initial pH. The pH of the solution is depressed during the progress of the reaction due to the hydrolysis of the produced Fe(III) and Cr(III) ions from the reaction. Dissolved oxygen in water is found to interfere with the redox reaction by consuming ferrous ions when the initial pH of solutions is high. In deionized water, complete Cr(VI) reduction can be achieved by applying excess ferrous sulfate under the condition of this study. It is also achievable when the raw water from Durham Water Treatment Plant is used as the reaction medium, without additional dosage of ferrous sulfate. Based on the results, simultaneous removal of hexavalent chromium in water treatment by applying ferrous sulfate as the coagulant is theoretically feasible.

  15. METHOD OF FORMING A PROTECTIVE COATING ON FERROUS METAL SURFACES

    DOEpatents

    Schweitzer, D.G.; Weeks, J.R.; Kammerer, O.F.; Gurinsky, D.H.

    1960-02-23

    A method is described of protecting ferrous metal surfaces from corrosive attack by liquid metals, such as liquid bismuth or lead-bismuth alloys. The nitrogen content of the ferrous metal surface is first reduced by reacting the metal surface with a metal which forms a stable nitride. Thereafter, the surface is contacted with liquid metal containing at least 2 ppm zirconium at a temperature in the range of 550 to 1100 deg C to form an adherent zirconium carbide layer on the ferrous surface.

  16. Questions and Answers on Unapproved Chelation Products

    MedlinePlus

    ... OTC) to prevent or treat diseases. Companies are marketing unapproved OTC chelation therapy products to patients with ... 4. Why did FDA take this action? Companies marketing unapproved OTC chelation products with unsubstantiated treatment claims ...

  17. Hydroxypyridonate and hydroxypyrimidinone chelating agents

    SciTech Connect

    Raymond, Kenneth N.; Doble, Daniel M.; Sunderland, Christopher J.; Thompson, Marlon

    2005-01-25

    The present invention provides hydroxypyridinone and hydroxypyrimidone chelating agents. Also provides are Gd(III) complexes of these agents, which are useful as contrast enhancing agents for magnetic resonance imaging. The invention also provides methods of preparing the compounds of the invention, as well as methods of using the compounds in magnetic resonance imaging applications.

  18. Natural chelating agents for radionuclide decorporation

    DOEpatents

    Premuzic, Eugene T.

    1988-01-01

    This invention relates to the preparation of new, naturally produced chelating agents as well as to the method and resulting chelates of desorbing cultures in a bioavailable form involving Pseudomonas species or other microorganisms. A preferred microorganism is Pseudomonas aeruginosa which forms multiple chelates with thorium in the range of molecular weight 100-1,000 and also forms chelates with uranium of molecular weight in the area of 100-1,000 and 1,000-2,000.

  19. Metallic Recovery and Ferrous Melting Processes

    SciTech Connect

    Luis Trueba

    2004-05-30

    The effects of melting atmosphere and charge material type on the metallic and alloy recovery of ferrous charge materials were investigated in two sets of experiments (Tasks 1 and 2). In addition, thermodynamic studies were performed (Task 3) to determine the suitability of ladle treatment for the production of ductile iron using scrap charge materials high in manganese and sulfur. Task 1--In the first set of experiments, the charge materials investigated were thin steel scrap, thick steel scrap, cast iron scrap, and pig iron in the rusty and clean states. Melting atmospheres in this set of experiments were varied by melting with and without a furnace cover. In this study, it was found that neither covered melting nor melting clean (non-rusty) ferrous charge materials improved the metallic recovery over the recovery experienced with uncovered melting or rusty charge materials. However, the silicon and manganese recoveries were greater with covered melting and clean materials. Silicon and manganese in the molten iron react with oxygen dissolved in the iron from uncovered melting and oxidized iron (surface rust). Silica and manganese silicates are formed which float to the slag decreasing recoveries of silicon and manganese. Cast iron and pig iron had higher metallic recoveries than steel scrap. Carbon recovery was affected by the carbon content of the charge materials, and not by the melting conditions. Irons with higher silicon contents had higher silicon recovery than irons with lower silicon contents. Task 2--In the second set of experiments, briquetted turnings and borings were used to evaluate the effects of briquette cleanliness, carbon additions, and melting atmosphere on metallic and alloy recovery. The melting atmosphere in this set of experiments was varied by melting in air and with an argon atmosphere using the SPAL process. In this set of experiments, carbon additions to the briquettes were found to have the greatest effect on metallic and alloy

  20. Pulsed laser surface hardening of ferrous alloys.

    SciTech Connect

    Xu, Z.; Reed, C. B.; Leong, K. H.; Hunter, B. V.

    1999-09-30

    A high power pulsed Nd:YAG laser and special optics were used to produce surface hardening on 1045 steel and gray cast iron by varying the process parameters. Unlike CO{sub 2} lasers, where absorptive coatings are required, the higher absorptivity of ferrous alloys at the Nd:YAG laser wavelength eliminates the necessity of applying a coating before processing. Metallurgical analysis of the treated tracks showed that very fine and hard martensitic microstructure (1045 steel) or inhomogeneous martensite (gray cast iron) were obtained without surface melting, giving maximum hardness of HRC 61 and HRC 40 for 1045 steel and gray cast iron respectively. The corresponding maximum case depths for both alloys at the above hardness are 0.6 mm. Gray cast iron was more difficult to harden without surface melting because of its lower melting temperature and a significantly longer time-at-temperature required to diffuse carbon atoms from the graphite flakes into the austenite matrix during laser heating. The thermal distortion was characterized in term of flatness changes after surface hardening.

  1. Ferrous iron partitioning in the lower mantle

    NASA Astrophysics Data System (ADS)

    Muir, Joshua M. R.; Brodholt, John P.

    2016-08-01

    We used density functional theory (DFT) to examine the partitioning of ferrous iron between periclase and bridgmanite under lower mantle conditions. To study the effects of the three major variables - pressure, temperature and concentration - these have been varied from 0 to 150 GPa, from 1000 to 4000 K and from 0 to 100% total iron content. We find that increasing temperature increases KD, increasing iron concentration decreases KD, while pressure can both increase and decrease KD. We find that KD decreases slowly from about 0.32 to 0.06 with depth under lower mantle conditions. We also find that KD increases sharply to 0.15 in the very lowermost mantle due to the strong temperature increases near the CMB. Spin transitions have a large effect on the activity of ferropericlase which causes KD to vary with pressure in a peak-like fashion. Despite the apparently large changes in KD through the mantle, this actually results in relatively small changes in total iron content in the two phases, with XFefp ranging from about 0.20 to 0.35, before decreasing again to about 0.28 at the CMB, and XFebd has a pretty constant value of about 0.04-0.07 throughout the lower mantle. For the very high Fe concentrations suggested for ULVZs, Fe partitions very strongly into ferropericlase.

  2. Preparation and Characterization of Cast Ferrous Metal Matrix Composites

    NASA Astrophysics Data System (ADS)

    Dash, R. R.; Chakrabarti, A. K.; Mukherjee, P. S.

    2012-02-01

    TiC/SiC reinforced cast ferrous composites have been prepared by smelting red mud—30 pct charcoal briquettes in a 20-kg basic lined, single-phase direct arc furnace. Elements like silicon, aluminum, zirconium, and so on are also reduced from their respective oxides in the red mud and dissolved in the ferrous matrix. TiC/SiC particulates in the composite grow in a typical spiraling fashion.

  3. Enhanced NO{sub x} removal in wet scrubbers using metal chelates. Final report, Volume 1

    SciTech Connect

    Smith, K.; Lani, B.; Berisko, D.; Schultz, C.; Carlson, W.; Benson, L.B.

    1992-12-01

    Successful pilot plant tests of simultaneous removal of S0{sub 2} and NO{sub x} in a wet lime flue gas desulfurization system were concluded in December. The tests, at up to 1.5 MW(e) capacity, were conducted by the Cincinnati Gas and Electric Company and Dravo Lime Company for the US Department of Energy at a pilot facility at the Miami Fort station of CG&E near Cincinnati, Ohio. The pilot plant scrubbed a slipstream of flue gas from Unit 7, a 530 MW coal-fired electric generating unit. Tests were conducted in three phases between April and December. The technology tested was wet scrubbing with Thiosorbic{reg_sign} magnesium-enhanced lime for S0{sub 2} removal and simultaneous NO scrubbing with ferrous EDTA, a metal chelate. Magnesium-enhanced lime-based wet scrubbing is used at 20 full-scale high-sulfur coal-fired electric generating units with a combined capacity of 8500 NW. Ferrous EDTA reacts with nitric oxide, NO, which comprises about 95% of NO{sub x} from coal-fired boilers. In this report, although not precise, NO and NO{sub x} are used interchangably. A major objective of the tests was to combine NO{sub x} removal using ferrous EDTA, a developing technology, with SO{sub 2} removal using wet lime FGD, already in wide commercial use. If successful, this could allow wide application of this NO{sub x} removal technology.

  4. Luminescent lanthanide chelates and methods of use

    DOEpatents

    Selvin, Paul R.; Hearst, John

    1997-01-01

    The invention provides lanthanide chelates capable of intense luminescence. The celates comprise a lanthanide chelator covalently joined to a coumarin-like or quinolone-like sensitizer. Exemplary sensitzers include 2- or 4-quinolones, 2- or 4-coumarins, or derivatives thereof e.g. carbostyril 124 (7-amino-4-methyl-2-quinolone), coumarin 120 (7-amino-4-methyl-2-coumarin), coumarin 124 (7-amino-4-(trifluoromethyl)-2-coumarin), aminomethyltrimethylpsoralen, etc. The chelates form high affinity complexes with lanthanides, such as terbium or europium, through chelator groups, such as DTPA. The chelates may be coupled to a wide variety of compounds to create specific labels, probes, diagnostic and/or therapeutic reagents, etc. The chelates find particular use in resonance energy transfer between chelate-lanthanide complexes and another luminescent agent, often a fluorescent non-metal based resonance energy acceptor. The methods provide useful information about the structure, conformation, relative location and/or interactions of macromolecules.

  5. Some Linguistic Detail on Chelation

    NASA Astrophysics Data System (ADS)

    Haworth, Daniel T.

    1998-01-01

    The term chelate was first applied by Morgan and Drew in 1920 to describe the heterocyclic rings formed from bidentate ligands bonding to a central atom. The history of the word ch_l_ is traced from its original Greek meaning through the Latin language to its anglicized form, chela. This word has a very rich history and has been cited by both Greek (Aristotle) and Latin (Cicero, Vergil) philosophers and poets.

  6. Ferrous iron sorption by hydrous metal oxides.

    PubMed

    Nano, Genevieve Villaseñor; Strathmann, Timothy J

    2006-05-15

    Ferrous iron is critical to a number of biogeochemical processes that occur in heterogeneous aquatic environments, including the abiotic reductive transformation of subsurface contaminants. The sorption of Fe(II) to ubiquitous soil minerals, particularly iron-free mineral phases, is not well understood. Colloidal TiO2, gamma-AlOOH, and gamma-Al2O2 were used as model hydrous oxides to investigate Fe(II) sorption to iron-free mineral surfaces. Rapid Fe(II) sorption during the first few hours is followed by a much slower uptake process that continues for extended periods (at least 30 days). For equivalent solution conditions, the extent of Fe(II) sorption decreases in the order TiO2 >gamma-Al2O3 >gamma-AlOOH. Short-term equilibrium sorption data measured over a wide range of conditions (pH, ionic strength, Fe(II)-to-sorbent ratio) are well described by the diffuse double layer model. Fe(II) sorption to TiO2 is best described by a single-site model that considers formation of two surface complexes, SOFe+ and SOFeOH0. For gamma-AlOOH and gamma-Al2O3, sorption data are best described by a two-site model that considers formation of SOFe+ complexes at weak- and strong-binding surface sites. Accurate description of sorption data for higher Fe(II) concentrations at alkaline pH conditions requires the inclusion of a Fe(II) surface precipitation reaction in the model formulation. The presence of common groundwater constituents (calcium, sulfate, bicarbonate, or fulvic acid) had no significant effect on Fe(II) sorption. These results demonstrate that iron-free soil minerals can exert a significant influence on Fe(II) sorption and speciation in heterogeneous aquatic systems. PMID:16337955

  7. Ferrous iron content of intravenous iron formulations.

    PubMed

    Gupta, Ajay; Pratt, Raymond D; Crumbliss, Alvin L

    2016-06-01

    The observed biological differences in safety and efficacy of intravenous (IV) iron formulations are attributable to physicochemical differences. In addition to differences in carbohydrate shell, polarographic signatures due to ferric iron [Fe(III)] and ferrous iron [Fe(II)] differ among IV iron formulations. Intravenous iron contains Fe(II) and releases labile iron in the circulation. Fe(II) generates toxic free radicals and reactive oxygen species and binds to bacterial siderophores and other in vivo sequestering agents. To evaluate whether differences in Fe(II) content may account for some observed biological differences between IV iron formulations, samples from multiple lots of various IV iron formulations were dissolved in 12 M concentrated HCl to dissociate and release all iron and then diluted with water to achieve 0.1 M HCl concentration. Fe(II) was then directly measured using ferrozine reagent and ultraviolet spectroscopy at 562 nm. Total iron content was measured by adding an excess of ascorbic acid to reduce Fe(III) to Fe(II), and Fe(II) was then measured by ferrozine assay. The Fe(II) concentration as a proportion of total iron content [Fe(III) + Fe(II)] in different lots of IV iron formulations was as follows: iron gluconate, 1.4 and 1.8 %; ferumoxytol, 0.26 %; ferric carboxymaltose, 1.4 %; iron dextran, 0.8 %; and iron sucrose, 10.2, 15.5, and 11.0 % (average, 12.2 %). The average Fe(II) content in iron sucrose was, therefore, ≥7.5-fold higher than in the other IV iron formulations. Further studies are needed to investigate the relationship between Fe(II) content and increased risk of oxidative stress and infections with iron sucrose. PMID:26956439

  8. Chelating agents and cadmium intoxication

    SciTech Connect

    Shinobu, L.A.

    1985-01-01

    A wide range of conventional chelating agents have been screened for (a) antidotal activity in acute cadmium poisoning and (b) ability to reduce aged liver and kidney deposits of cadmium. Chelating agents belonging to the dithiocarbamate class have been synthesized and tested in both the acute and chronic modes of cadmium intoxication. Several dithiocarbamates, not only provide antidotal rescue, but also substantially decrease the intracellular deposits of cadmium associated with chronic cadmium intoxication. Fractionating the cytosol from the livers and kidneys of control and treated animals by Sephadex G-25 gel filtration clearly demonstrates that the dithiocarbamates are reducing the level of metallothionein-bound cadmium. However, the results of cell culture (Ehrlich ascites) studies designed to investigate the removal of cadmium from metallothionein and subsequent transport of the resultant cadmium complex across the cell membrane were inconclusive. In other in vitro investigations, the interaction between isolated native Cd, Zn-metallothionein and several chelating agents was explored. Ultracentrifugation, equilibrium dialysis, and Sephadex G-25 gel filtration studies have been carried out in an attempt to determine the rate of removal of cadmium from metallothionein by these small molecules. Chemical shifts for the relevant cadmium-dithiocarbamate complexes have been determined using natural abundance Cd-NMR.

  9. The origin of ferrous zoning in Allende chondrule olivines

    NASA Astrophysics Data System (ADS)

    Peck, J. A.; Wood, J. A.

    1987-06-01

    Very similar major and minor element compositions are noted in the ferrous olivine occurring in chondrules at olivine grain boundaries, along cracks in olivine grains, interleaved with enstatite, and in the inner portions of exposed olivine grain surface rims; simultaneous formation by a single process is therefore suggested. The ferrous chondrule olivine probably formed by the reaction of chondrules with very hot nebular vapors over a period of several hours, followed by the condensation of residual metal vapors onto those olivine surfaces that were in direct contact with the gas as the system cooled. The ferrous chondrule olivine that occurs interleaved with enstatite in Allende does not have a composition identical to, and is not the precursor of, matrix olivine.

  10. Beliefs about chelation among thalassemia patients

    PubMed Central

    2012-01-01

    Background Understanding patients’ views about medication is crucial to maximize adherence. Thalassemia is a congenital blood disorder requiring chronic blood transfusions and daily iron chelation therapy. Methods The Beliefs in Medicine Questionnaire (BMQ) was used to assess beliefs in chelation in thalassemia patients from North America and London in the Thalassemia Longitudinal Cohort (TLC) of the Thalassemia Clinical Research Network (TCRN). Chelation adherence was based on patient report of doses administered out of those prescribed in the last four weeks. Results Of 371 patients (ages 5-58y, mean 24y), 93% were transfused and 92% receiving chelation (26% deferoxamine (DFO; a slow subcutaneous infusion via portable pump), 63% oral, 11% combination). Patients expressed high “necessity” for transfusion (96%), DFO chelation (92%) and oral chelation (89%), with lower “concern” about treatment (48%, 39%, 19% respectively). Concern about oral chelation was significantly lower than that of DFO (p<0.001). Self-reported adherence to chelation was not associated with views about necessity or concerns, but negatively correlated with perceived sensitivity to DFO (Sensitive Soma scale; r=−0.23, p=0.01) and side effects of oral chelation (r=−0.14, p=0.04). High ferritin iron levels, potentially indicating lower adherence, were found in 41% of patients reporting low necessity of oral chelation compared to 24% reporting high necessity (p=0.048). Concerns about treatment were associated with lower quality of life and more symptoms of anxiety and depression. Conclusions Despite their requirement for multimodal therapy, thalassemia patients have positive views about medicine, more so than in other disease populations. Patients may benefit from education about the tolerability of chelation and strategies to effectively cope with side effects, both of which might be beneficial in lowering body iron burden. Clinicaltrials.gov identifier NCT00661804 PMID:23216870

  11. 21 CFR 184.1307c - Ferrous citrate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 3 2010-04-01 2009-04-01 true Ferrous citrate. 184.1307c Section 184.1307c Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) FOOD FOR HUMAN CONSUMPTION (CONTINUED) DIRECT FOOD SUBSTANCES AFFIRMED AS GENERALLY RECOGNIZED AS SAFE Listing of Specific Substances Affirmed as GRAS...

  12. LIMESTONE AND LIME NEUTRALIZATION OF FERROUS IRON ACID MINE DRAINAGE

    EPA Science Inventory

    The U.S. Environmental Protection Agency conducted a 2-yr study on hydrated lime and rock-dust limestone neutralization of acid mine drainage containing ferrous iron at the EPA Crown Mine Drainage Control Field Site near Rivesville, West Virginia. The study investigated optimizat...

  13. Cu(II) - Catalyzed Hydrazine Reduction of Ferrous Nitrate

    SciTech Connect

    Karraker, D.G.

    2001-10-15

    This report discusses the results of a study of catalyzed hydrazine reduction of ferrous nitrate. It is apparent that there is a substantial reaction between hydrazine and nitrate ion (or nitric acid) to produce HN3 during both the reduction of Fe(III) and during storage at room temperature.

  14. Method for the preparation of ferrous low carbon porous material

    DOEpatents

    Miller, Curtis Jack

    2014-05-27

    A method for preparing a porous metal article using a powder metallurgy forming process is provided which eliminates the conventional steps associated with removing residual carbon. The method uses a feedstock that includes a ferrous metal powder and a polycarbonate binder. The polycarbonate binder can be removed by thermal decomposition after the metal article is formed without leaving a carbon residue.

  15. 21 CFR 184.1307d - Ferrous fumarate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... Codex, 3d Ed. (1981), pp. 120-122, which is incorporated by reference. Copies are available from the... 21 Food and Drugs 3 2010-04-01 2009-04-01 true Ferrous fumarate. 184.1307d Section 184.1307d Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) FOOD...

  16. Metal ions, Alzheimer's disease and chelation therapy.

    PubMed

    Budimir, Ana

    2011-03-01

    In the last few years, various studies have been providing evidence that metal ions are critically involved in the pathogenesis of major neurological diseases (Alzheimer, Parkinson). Metal ion chelators have been suggested as potential therapies for diseases involving metal ion imbalance. Neurodegeneration is an excellent target for exploiting the metal chelator approach to therapeutics. In contrast to the direct chelation approach in metal ion overload disorders, in neurodegeneration the goal seems to be a better and subtle modulation of metal ion homeostasis, aimed at restoring ionic balance. Thus, moderate chelators able to coordinate deleterious metals without disturbing metal homeostasis are needed. To date, several chelating agents have been investigated for their potential to treat neurodegeneration, and a series of 8-hydroxyquinoline analogues showed the greatest potential for the treatment of neurodegenerative diseases. PMID:21406339

  17. DETERMINATION OF THE RATES AND PRODUCTS OF FERROUS IRON OXIDATION IN ARSENIC-CONTAMINATED POND WATER.

    EPA Science Inventory

    Dissolved ferrous iron and arsenic in the presence of insufficient oxygenated ground water is released into a pond. When the mixing of ferrous iron and oxygenated water within the pond occurs, the ferrous iron is oxidized and precipitated as an iron oxide. Groups of experiments...

  18. Orange but not apple juice enhances ferrous fumarate absorption in small children

    Technology Transfer Automated Retrieval System (TEKTRAN)

    Ferrous fumarate is a common, inexpensive iron form increasingly used instead of ferrous sulfate as a food iron supplement. However, few data exist as to whether juices enhance iron absorption from ferrous fumarate. We studied 21 children, ages 4.0 to 7.9 years using a randomized crossover design. S...

  19. Absorption of iron from ferritin is independent of heme iron and ferrous salts in women and rat intestinal segments.

    PubMed

    Theil, Elizabeth C; Chen, Huijun; Miranda, Constanza; Janser, Heinz; Elsenhans, Bernd; Núñez, Marco T; Pizarro, Fernando; Schümann, Klaus

    2012-03-01

    Ferritin iron from food is readily bioavailable to humans and has the potential for treating iron deficiency. Whether ferritin iron absorption is mechanistically different from iron absorption from small iron complexes/salts remains controversial. Here, we studied iron absorption (RBC (59)Fe) from radiolabeled ferritin iron (0.5 mg) in healthy women with or without non-ferritin iron competitors, ferrous sulfate, or hemoglobin. A 9-fold excess of non-ferritin iron competitor had no significant effect on ferritin iron absorption. Larger amounts of iron (50 mg and a 99-fold excess of either competitor) inhibited iron absorption. To measure transport rates of iron that was absorbed inside ferritin, rat intestinal segments ex vivo were perfused with radiolabeled ferritin and compared to perfusion with ferric nitrilotriacetic (Fe-NTA), a well-studied form of chelated iron. Intestinal transport of iron absorbed inside exogenous ferritin was 14.8% of the rate measured for iron absorbed from chelated iron. In the steady state, endogenous enterocyte ferritin contained >90% of the iron absorbed from Fe-NTA or ferritin. We found that ferritin is a slow release source of iron, readily available to humans or animals, based on RBC iron incorporation. Ferritin iron is absorbed by a different mechanism than iron salts/chelates or heme iron. Recognition of a second, nonheme iron absorption process, ferritin endocytosis, emphasizes the need for more mechanistic studies on ferritin iron absorption and highlights the potential of ferritin present in foods such as legumes to contribute to solutions for global iron deficiency. PMID:22259191

  20. Natural chelating agents for radionuclide decorporation

    DOEpatents

    Premuzic, E.T.

    1985-06-11

    This invention relates to the production of metal-binding compounds useful for the therapy of heavy metal poisoning, for biological mining and for decorporation of radionuclides. The present invention deals with an orderly and effective method of producing new therapeutically effective chelating agents. This method uses challenge biosynthesis for the production of chelating agents that are specific for a particular metal. In this approach, the desired chelating agents are prepared from microorganisms challenged by the metal that the chelating agent is designed to detoxify. This challenge induces the formation of specific or highly selective chelating agents. The present invention involves the use of the challenge biosynthetic method to produce new complexing/chelating agents that are therapeutically useful to detoxify uranium, plutonium, thorium and other toxic metals. The Pseudomonas aeruginosa family of organisms is the referred family of microorganisms to be used in the present invention to produce the new chelating agent because this family is known to elaborate strains resistant to toxic metals.

  1. Effect of Fe-chelating complexes on a novel M2FC performance with ferric chloride and ferricyanide catholytes.

    PubMed

    Chung, Kyungmi; Lee, Ilgyu; Han, Jong-In

    2012-01-01

    As an effort to better utilize the microbial fuel cell (MFC) technology, we previously proposed an innovative MFC system named M2FC consisting of ferric-based MFC part and ferrous-based fuel cell (FC) part. In this reactor, ferric ion, the catholyte in the MFC part, was efficiently regenerated by the FC part with the generation of additional electricity. When both units were operated separately, the ferric-based MFC part produced approximately 1360 mW m(-2) of power density with FeCl(3) as catholyte and Fe-citrate as anolyte. The ferrous-based FC part with FeCl(3) as catholyte and Fe-EDTA as anolyte displayed the highest power density (1500 mW m(-2)), while that with ferricyanide as catholyte and Fe-noligand as anolyte had the lowest power density (380 mW m(-2)). The types of catholytes and chelating complexes as anolyte were found to play important roles in the reduction of ferric ions and oxidation of ferrous ion. Linear sweep voltammetry results supported that the cathode electrolytes were electrically active and these agreed well with the M2FC reactor performance. These results clearly showed that ligands played critical role in the efficiency and rate for recycling iron ion and thus the M2FC performance. PMID:22018860

  2. Enhanced NO{sub x} removal in wet scrubbers using metal chelates. Final report, Volume 2

    SciTech Connect

    1992-12-01

    Successful pilot plant tests of simultaneous removal of SO{sub 2} and NO{sub x} in a wet lime flue gas desulfurization system were concluded in December. The test, at up to 1.5 MW(e) capacity, were conducted by the Cincinnati Gas and Electric Company and Dravo Lime Company for the US Department of Energy at a pilot plant facility at the Miami Fort station of CG&E near Cincinnati, Ohio. The pilot plant scrubbed a slipstream of flue gas from Unit 7 a 530 MW coal-fired electric generating unit. Tests were conducted in three phases between April and December. The technology tested was wet scrubbing with Thiosorbic{reg_sign} magnesium-enhanced lime for SO{sub 2} removal and simultaneous NO scrubbing with ferrous EDTA, a metal chelate. Magnesium-enhanced lime-based wet scrubbing is used at 20 full-scale high-sulfur coal-fired electric generating units with a combined capacity of 8500 MW. Ferrous EDTA reacts with nitric oxide, NO, which comprises about 96% of NO{sub x} from coal-fired boilers. In this report, although not precise, NO and NO{sub x} are used interchangeably. A major objective of the tests was to combine NO{sub x} removal using ferrous EDTA, a developing technology, with SO{sub 2} removal using wet lime FGD, already in wide commercial use. If successful, this could allow wide application of this NO{sub x} removal technology. Volume 2 covers: description and results of NO{sub x} removal tests; and description and results of waste characterization studies.

  3. Clickable bifunctional radiometal chelates for peptide labeling†

    PubMed Central

    Lebedev, Artem Y.; Holland, Jason P.; Lewis, Jason S.

    2016-01-01

    Novel synthetic methods for producing an array of chelates for use in “click”-radiolabeling of peptides are described, and their reactivity with regards to subsequent conjugation and radiolabeling is discussed. PMID:20177623

  4. Microbial Reduction of Ferrous Arsenate: Biogeochemical Implications for Arsenic Mobilization

    SciTech Connect

    Babechuk, M.; Weisener, C.G.; Fryer, B.; Paktunc, D.; Maunders, C.

    2010-11-12

    In reduced aqueous environments, the presence of As in solution is a function of both biotic and abiotic mechanisms. Recent studies have demonstrated a significant release of As(III) through the microbial reduction of dissolved and mineral-bound As(V), which raises health concerns when the greater comparative mobility and toxicity of As(III) is considered. These release mechanisms do not operate in isolation but occur in concert with a number of removal processes, including secondary mineralization and sorption to other natural substrates. Thermodynamic and applied experimental studies have shown that ferrous arsenates, such as symplesite [Fe(II){sub 3}(As(V)O{sub 4}){sub 2} {center_dot} 8H{sub 2}O], may provide a significant sink for Fe(II) and As(V). In this study, the stability of a representative ferrous arsenate phase in the presence of the arsenate-reducing bacterium Shewanella sp. strain ANA-3 is examined. The reduction of ferrous arsenate by ANA-3 results in the release of aqueous As(III) and, subsequently, the progressive nucleation of a biogenic ferrous arsenite phase proximal to the microbial cells. The valence states of secondary solid-phase products were verified using X-ray absorption spectroscopy (XAS). Electron microscopy reveals that nucleation occurs on cellular exudates which may imply a role of extracellular reduction through c-type cytochromes as investigated in recent literature. These observations provide new insights into the reduction mechanisms of ANA-3 and the biogeochemical cycling of As(III) in natural systems.

  5. Anaerobic ferrous oxidation by heterotrophic denitrifying enriched culture.

    PubMed

    Wang, Ru; Zheng, Ping; Xing, Ya-Juan; Zhang, Meng; Ghulam, Abbas; Zhao, Zhi-Qing; Li, Wei; Wang, Lan

    2014-05-01

    Heterotrophic denitrifying enriched culture (DEC) from a lab-scale high-rate denitrifying reactor was discovered to perform nitrate-dependent anaerobic ferrous oxidation (NAFO). The DEC was systematically investigated to reveal their denitrification activity, their NAFO activity, and the predominant microbial population. The DEC was capable of heterotrophic denitrification with methanol as the electron donor, and autotrophic denitrification with ferrous salt as the electron donor named NAFO. The conversion ratios of ferrous-Fe and nitrate-N were 87.41 and 98.74 %, and the consumption Fe/N ratio was 2.3:1 (mol/mol). The maximum reaction velocity and half saturation constant of Fe were 412.54 mg/(l h) and 8,276.44 mg/l, and the counterparts of N were 20.87 mg/(l h) and 322.58 mg/l, respectively. The predominant bacteria were Hyphomicrobium, Thauera, and Flavobacterium, and the predominant archaea were Methanomethylovorans, Methanohalophilus, and Methanolobus. The discovery of NAFO by heterotrophic DEC is significant for the development of wastewater treatment and the biogeochemical iron cycle and nitrogen cycle. PMID:24619339

  6. Iron-chelating activity of chickpea protein hydrolysate peptides.

    PubMed

    Torres-Fuentes, Cristina; Alaiz, Manuel; Vioque, Javier

    2012-10-01

    Chickpea-chelating peptides were purified and analysed for their iron-chelating activity. These peptides were purified after affinity and gel filtration chromatography from a chickpea protein hydrolysate produced with pepsin and pancreatin. Iron-chelating activity was higher in purified peptide fractions than in the original hydrolysate. Histidine contents were positively correlated with the iron-chelating activity. Hence fractions with histidine contents above 20% showed the highest chelating activity. These results show that iron-chelating peptides are generated after chickpea protein hydrolysis with pepsin plus pancreatin. These peptides, through metal chelation, may increase iron solubility and bioavailability and improve iron absorption. PMID:25005984

  7. Fluid extraction using carbon dioxide and organophosphorus chelating agents

    DOEpatents

    Smart, N.G.; Wai, C.M.; Lin, Y.; Kwang, Y.H.

    1998-11-24

    Methods for extracting metalloid and metal species from a solid or liquid material by exposing the material to a fluid solvent, particularly supercritical CO{sub 2}, and a chelating agent are described. The chelating agent forms a chelate with the species, the chelate being soluble in the fluid to allow removal of the species from the material. In preferred embodiments the extraction solvent is supercritical CO{sub 2} and the chelating agent comprises an organophosphorous chelating agent, particularly sulfur-containing organophosphorous chelating agents, including mixtures of chelating agents. Examples of chelating agents include monothiophosphinic acid, di-thiophosphinic acid, phosphine sulfite, phosphorothioic acid, and mixtures thereof. The method provides an environmentally benign process for removing metal and metalloids from industrial waste solutions, particularly acidic solutions. Both the chelate and the supercritical fluid can be regenerated and the contaminant species recovered to provide an economic, efficient process. 1 fig.

  8. Fluid extraction using carbon dioxide and organophosphorus chelating agents

    DOEpatents

    Smart, Neil G.; Wai, Chien M.; Lin, Yuehe; Kwang, Yak Hwa

    1998-01-01

    Methods for extracting metalloid and metal species from a solid or liquid material by exposing the material to a fluid solvent, particularly supercritical CO.sub.2, and a chelating agent are described. The chelating agent forms a chelate with the species, the chelate being soluble in the fluid to allow removal of the species from the material. In preferred embodiments the extraction solvent is supercritical CO.sub.2 and the chelating agent comprises an organophosphorous chelating agent, particularly sulfur-containing organophosphorous chelating agents, including mixtures of chelating agents. Examples of chelating agents include monothiophosphinic acid, di-thiophosphinic acid, phosphine sulfite, phosphorothioic acid, and mixtures thereof. The method provides an environmentally benign process for removing metal and metalloids from industrial waste solutions, particularly acidic solutions. Both the chelate and the supercritical fluid can be regenerated and the contaminant species recovered to provide an economic, efficient process.

  9. Protective Effects of Quercetin on Selected Oxidative Biomarkers in Bovine Spermatozoa Subjected to Ferrous Ascorbate.

    PubMed

    Tvrdá, E; Tušimová, E; Kováčik, A; Paál, D; Libová, Ľ; Lukáč, N

    2016-08-01

    Quercetin (QUE) is a natural flavonol-type flavonoid with antibacterial, anti-inflammatory and anti-aggregatory properties. It is also a powerful reactive oxygen species (ROS) scavenger and chelating agent. The aim of this study was to assess the effectiveness of QUE to reverse ROS-mediated alterations to the motility, viability and intracellular antioxidant profile of bovine spermatozoa. Spermatozoa were washed out of fresh bovine semen, suspended in 2.9% sodium citrate and subjected to QUE treatment (7.5, 25, 50 and 100 μmol/l) in the presence or absence of a pro-oxidant, that is ferrous ascorbate (FeAA; 150 μmol/l FeSO4 and 750 μmol/l ascorbic acid) during a 6-h in vitro culture. Spermatozoa motion characteristics were assessed using the SpermVision computer-aided sperm analysis (CASA) system. Cell viability was examined with the metabolic activity (MTT) assay, ROS generation was quantified via luminometry, and the nitroblue tetrazolium (NBT) test was applied to quantify the intracellular superoxide formation. Cell lysates were prepared at the end of the in vitro culture to investigate the intracellular activity of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) as well as the concentrations of glutathione (GSH) and malondialdehyde (MDA). FeAA treatment led to a reduced sperm motility (p < 0.001), viability (p < 0.001) and decreased the antioxidant parameters of the sperm samples (p < 0.001) but increased the ROS generation (p < 0.001), superoxide production (p < 0.001) and lipid peroxidation (p < 0.001). QUE administration resulted in a preservation of the spermatozoa vitality and antioxidant characteristics (p < 0.01 with respect to the enzymatic antioxidants, p < 0.001 in relation to GSH) with a concentration range of 50-100 μmol/l QUE revealing to be the most effective. Our results suggest that QUE exhibits significant ROS-scavenging and metal-chelating properties which may prevent spermatozoa alterations

  10. Copper Chelation in Alzheimer's Disease Protein

    NASA Astrophysics Data System (ADS)

    Rose, Frisco; Hodak, Miroslav; Bernholc, Jerry

    2013-03-01

    Alzheimer's disease (AD) is a neurodegenerative disorder affecting millions of people in the U.S. AD is primarily characterized at the cellular level by densely tangled fibrils of amyloid- β protein. These protein clusters have been found in association with elevated levels of multiple transition metals, with copper being the most egregious. Interestingly, metal chelation has shown promise in attenuating the symptoms of AD in recent clinical studies. We investigate this process by constructing an atomistic model of the amyloid- β-copper complex and profile the energetic viability in each of its subsequent disassociation stages. Our results indicate that five energetic barriers must be overcome for full metal chelation. The energy barriers are biologically viable in the presence water mediated bond and proton transfer between the metal and the protein. We model the chelation reaction using a consecutive path nudged elastic band method implemented in our ab initio real-space multi-grid code to obtain a viable sequence. This reaction model details a physically consistent explanation of the chelation process that could lead to the discovery of more effective chelation agents in the treatment of AD.

  11. Iron (FeII) Chelation, Ferric Reducing Antioxidant Power, and Immune Modulating Potential of Arisaema jacquemontii (Himalayan Cobra Lily)

    PubMed Central

    Sudan, Rasleen; Bhagat, Madhulika; Singh, Jasvinder; Koul, Anupurna

    2014-01-01

    This study explored the antioxidant and immunomodulatory potential of ethnomedicinally valuable species, namely, Arisaema jacquemontii of north-western Himalayan region. The tubers, leaves, and fruits of this plant were subjected to extraction using different solvents. In vitro antioxidant studies were performed in terms of chelation power on ferrous ions and FRAP assay. The crude methanol extract of leaves was found to harbour better chelating capacity (58% at 100 μg/mL) and reducing power (FRAP value 1085.4 ± 0.11 μMFe3+/g dry wt.) than all the other extracts. The crude methanol extract was thus further partitioned with solvents to yield five fractions. Antioxidant study of fractions suggested that the methanol fraction possessed significant chelation capacity (49.7% at 100 μg/mL) and reducing power with FRAP value of 1435.4 μM/g dry wt. The fractions were also studied for immune modulating potential where it was observed that hexane fraction had significant suppressive effect on mitogen induced T-cell and B-cell proliferation and remarkable stimulating effect on humoral response by 141% and on DTH response by 168% in immune suppressed mice as compared to the controls. Therefore, it can be concluded that A. jacquemontii leaves hold considerable antioxidant and immunomodulating potential and they can be explored further for the identification of their chemical composition for a better understanding of their biological activities. PMID:24895548

  12. Mercury emission and behavior in primary ferrous metal production

    NASA Astrophysics Data System (ADS)

    Fukuda, Naomichi; Takaoka, Masaki; Doumoto, Shingo; Oshita, Kazuyuki; Morisawa, Shinsuke; Mizuno, Tadao

    2011-07-01

    Ferrous metal production is thought to be a major mercury emission source because it uses large amounts of coal and iron ore, which contain trace amounts of mercury impurities. However, there is limited information about mercury emissions during the production process. In this study, we focused on the coke-oven process, sintering furnace process, and blast furnace process. We measured the mercury concentration in the raw materials, products, and byproducts to estimate the amount of mercury emitted and to investigate the behavior of mercury during the processes. Average mercury concentrations were 30.8 μg kg -1 in 54 samples of iron ore and 59.9 μg kg -1 in 33 samples of coal. The total mercury used for ferrous metal production in Japan was estimated to be 8.45 tons in 2005, with 4.07 tons from iron ore, 3.76 tons from coal, and 0.478 tons from limestone. Emissions from the sintering process accounted for more than 90% of the total emissions, and mercury in the exhaust gas was reduced using an activated coke tower and desulfurization equipment installed downstream of an electrostatic precipitator. When byproduct gas generated from coke-oven and blast furnace processes were included, mercury emissions estimates based on actual measurements were 4.08 tons y -1 (in 2005). Thus, about 50% of the mercury input in ferrous metal production was emitted to the atmosphere. The emission factor was calculated as 0.0488 g Hg ton -1 for crude steel production. The introduction of activated coke tower or desulfurization equipment in sintering furnace facilities would reduce mercury emissions.

  13. Overview of Lightweight Ferrous Materials: Strategies and Promises

    NASA Astrophysics Data System (ADS)

    Rana, Radhakanta; Lahaye, Chris; Ray, Ranjit Kumar

    2014-09-01

    Reducing the density of steels is a novel approach for weight reduction of automobiles to improve fuel efficiency. In this overview article, strategies for the development of lightweight steels are presented with a focus on bulk ferrous alloys. The metallurgical principles of these steels and their mechanical properties of relevance to automotive applications are discussed. Some of the engineering aspects highlighting the possible problems related to mass production of these steels are also considered. Application prospects of these steels vis-à-vis standard automotive steels are shown.

  14. Overview of Lightweight Ferrous Materials: Strategies and Promises

    NASA Astrophysics Data System (ADS)

    Rana, Radhakanta; Lahaye, Chris; Ray, Ranjit Kumar

    2014-08-01

    Reducing the density of steels is a novel approach for weight reduction of automobiles to improve fuel efficiency. In this overview article, strategies for the development of lightweight steels are presented with a focus on bulk ferrous alloys. The metallurgical principles of these steels and their mechanical properties of relevance to automotive applications are discussed. Some of the engineering aspects highlighting the possible problems related to mass production of these steels are also considered. Application prospects of these steels vis-à-vis standard automotive steels are shown.

  15. Bifunctional Gallium-68 Chelators: Past, Present, and Future.

    PubMed

    Spang, Philipp; Herrmann, Christian; Roesch, Frank

    2016-09-01

    This article reviews the development of bifunctional chelates for synthesising (68)Ga radiopharmaceuticals. It structures the chelates into groups of macrocycles, nonmacrocycles, and chimeric derivatives. The most relevant bifunctional chelates are discussed in chelate structure, parameters of (68)Ga-labeling, and stability of the (68)Ga-chelate complexes. Furthermore those derivatives are included, where (67)Ga was applied instead of (68)Ga. A particular feature discussed is the ability of certain bifunctional chelate structures to function in kit-type preparation of the (68)Ga radiopharmaceuticals. Currently, nonmacrocyclic and chimeric derivates attract particular attention such as THP-derivates and DATA-derivates. PMID:27553464

  16. Method and apparatus for back-extracting metal chelates

    DOEpatents

    Wai, Chien M.; Smart, Neil G.; Lin, Yuehe

    1998-01-01

    A method of extracting metal and metalloid species from a solid or liquid substrate using a supercritical fluid solvent containing one or more chelating agents followed by back-extracting the metal and metalloid species from the metal and metalloid chelates formed thereby. The back-extraction acidic solution is performed utilizing an acidic solution. Upon sufficient exposure of the metal and metalloid chelates to the acidic solution, the metal and metalloid species are released from the chelates into the acid solution, while the chelating agent remains in the supercritical fluid solvent. The chelating agent is thereby regenerated and the metal and metalloid species recovered.

  17. Method and apparatus for back-extracting metal chelates

    DOEpatents

    Wai, C.M.; Smart, N.G.; Lin, Y.

    1998-08-11

    A method is described for extracting metal and metalloid species from a solid or liquid substrate using a supercritical fluid solvent containing one or more chelating agents followed by back-extracting the metal and metalloid species from the metal and metalloid chelates formed thereby. The back-extraction acidic solution is performed utilizing an acidic solution. Upon sufficient exposure of the metal and metalloid chelates to the acidic solution, the metal and metalloid species are released from the chelates into the acid solution, while the chelating agent remains in the supercritical fluid solvent. The chelating agent is thereby regenerated and the metal and metalloid species recovered. 3 figs.

  18. Method of encapsulating polyaminopolycarboxylic acid chelating agents in liposomes

    DOEpatents

    Rahman, Yueh Erh

    1977-11-10

    A method is provided for transferring a polyaminopolycarboxylic acid chelating agent across a cellular membrane by encapsulating the charged chelating agent within liposomes, which liposomes will be taken up by the cells, thereby transferring the chelating agent across the cellular membrane. The chelating agent is encapsulated within liposomes by drying a lipid mixture to form a thin film and wetting the lipid film with a solution containing the chelating agent. Mixing then results in the formation of a suspension of liposomes encapsulating the chelating agent, which liposomes can then be separated.

  19. Trypanotoxic activity of thiosemicarbazone iron chelators.

    PubMed

    Ellis, Samuel; Sexton, Darren W; Steverding, Dietmar

    2015-03-01

    Only a few drugs are available for treating sleeping sickness and nagana disease; parasitic infections caused by protozoans of the genus Trypanosoma in sub-Saharan Africa. There is an urgent need for the development of new medicines for chemotherapy of these devastating diseases. In this study, three newly designed thiosemicarbazone iron chelators, TSC24, Dp44mT and 3-AP, were tested for in vitro activity against bloodstream forms of Trypanosoma brucei and human leukaemia HL-60 cells. In addition to their iron chelating properties, TSC24 and Dp44mT inhibit topoisomerase IIα while 3-AP inactivates ribonucleotide reductase. All three compounds exhibited anti-trypanosomal activity, with minimum inhibitory concentration (MIC) values ranging between 1 and 100 µM and 50% growth inhibition (GI50) values of around 250 nM. Although the compounds did not kill HL-60 cells (MIC values >100 µM), TSC24 and Dp44mT displayed considerable cytotoxicity based on their GI50 values. Iron supplementation partly reversed the trypanotoxic and cytotoxic activity of TSC24 and Dp44mT but not of 3-AP. This finding suggests possible synergy between the iron chelating and topoisomerase IIα inhibiting activity of the compounds. However, further investigation using separate agents, the iron chelator deferoxamine and the topoisomerase II inhibitor epirubicin, did not support any synergy for the interaction of iron chelation and topoisomerase II inhibition. Furthermore, TSC24 was shown to induce DNA degradation in bloodstream forms of T. brucei indicating that the mechanism of trypanotoxic activity of the compound is topoisomerase II independent. In conclusion, the data support further investigation of thiosemicarbazone iron chelators with dual activity as lead compounds for anti-trypanosomal drug development. PMID:25595343

  20. Combined SO{sub 2}/NO{sub x} control using ferrous{center_dot}EDTA and a secondary additive in a lime-based aqueous scrubber system

    SciTech Connect

    Mendelsohn, M.H.; Livengood, C.D.; Harkness, J.B.L.

    1991-12-01

    Integration of NO{sub x} control into existing flue-gas desulfurization (FGD) systems addresses site-specific control requirements while minimizing retrofit difficulties. Argonne has studied the use of the metal-chelate additives, such as ferrous{center_dot}EDTA in various wet FGD chemistries, to promote combined SO{sub 2}/NO{sub x} scrubbing. A major process problem is oxidation of the iron to the ferric species, leading to a significant decrease in NO{sub x}-removal capability. Argonne discovered a class of organic compounds that, when used with ferrous{center_dot}EDTA in a sodium carbonate chemistry, could maintain high levels of NO{sub x} removal. However, those antioxidant/reducing agents are not effective in a lime-based chemistry, and a broader investigation of antioxidants was initiated. This paper discusses results of that investigation, which found a practical antioxidant/reducing agent capable of maintaining NO{sub x} removals of about 50% (compared with about 15% without the agent) in a lime-based FGD chemistry with FE(II){center_dot}EDTA. 5 refs., 10 figs.

  1. Lung cancer in ferrous foundry workers: a review.

    PubMed

    Palmer, W G; Scott, W D

    1981-05-01

    Epidemiologic studies indicate that an increased incidence of lung cancer may be associated with specific work areas in ferrous foundries. With the exception of crane operators, who were found to have an elevated lung cancer rate in one foundry, the excess lung cancer incidence is generally confined to molders, casters, and cleaning room operators whose lung cancer risk is two- to threefold higher than that of standard populations. These studies reflect conditions that existed in the foundries several decades ago. The lung cancer risk today may differ as a result of the introduction of new foundry practices and the use of new molding materials. Benzo(a)pyrene and certain other polycyclic aromatic hydrocarbons have been found in many locations in the foundries. It is not known if tumor promoters, co-carcinogens, or other classes of chemical carcinogens are present. The contribution of tobacco smoke to the lung cancer risk of ferrous foundry workers is also unknown. Current studies are examining the composition and long-term health effects of emissions from molds composed of modern synthetic chemical molding materials as well as those from the more traditional green sand molds. PMID:7013460

  2. Tryptophan-to-heme electron transfer in ferrous myoglobins

    PubMed Central

    Monni, Roberto; Al Haddad, André; van Mourik, Frank; Auböck, Gerald; Chergui, Majed

    2015-01-01

    It was recently demonstrated that in ferric myoglobins (Mb) the fluorescence quenching of the photoexcited tryptophan 14 (*Trp14) residue is in part due to an electron transfer to the heme porphyrin (porph), turning it to the ferrous state. However, the invariance of *Trp decay times in ferric and ferrous Mbs raises the question as to whether electron transfer may also be operative in the latter. Using UV pump/visible probe transient absorption, we show that this is indeed the case for deoxy-Mb. We observe that the reduction generates (with a yield of about 30%) a low-valence Fe–porphyrin π [FeII(porph●−)] -anion radical, which we observe for the first time to our knowledge under physiological conditions. We suggest that the pathway for the electron transfer proceeds via the leucine 69 (Leu69) and valine 68 (Val68) residues. The results on ferric Mbs and the present ones highlight the generality of Trp–porphyrin electron transfer in heme proteins. PMID:25902517

  3. Analyzing the International Exergy Flow Network of Ferrous Metal Ores

    PubMed Central

    Qi, Hai; An, Haizhong; Hao, Xiaoqing; Zhong, Weiqiong; Zhang, Yanbing

    2014-01-01

    This paper employs an un-weighted and weighted exergy network to study the properties of ferrous metal ores in countries worldwide and their evolution from 2002 to 2012. We find that there are few countries controlling most of the ferrous metal ore exports in terms of exergy and that the entire exergy flow network is becoming more heterogeneous though the addition of new nodes. The increasing of the average clustering coefficient indicates that the formation of an international exergy flow system and regional integration is improving. When we contrast the average out strength of exergy and the average out strength of currency, we find both similarities and differences. Prices are affected largely by human factors; thus, the growth rate of the average out strength of currency has fluctuated acutely in the eleven years from 2002 to 2012. Exergy is defined as the maximum work that can be extracted from a system and can reflect the true cost in the world, and this parameter fluctuates much less. Performing an analysis based on the two aspects of exergy and currency, we find that the network is becoming uneven. PMID:25188407

  4. Development of an upconverting chelate assay

    NASA Astrophysics Data System (ADS)

    Xiao, Xudong; Haushalter, Jeanne P.; Kotz, Kenneth T.; Faris, Gregory W.

    2005-04-01

    We report progress on performing a cell-based assay for the detection of EGFR on cell surfaces by using upconverting chelates. An upconversion microscope has been developed for performing assays and testing optical response. A431 cells are labeled with europium DOTA and imaged using this upconverting microscope.

  5. Thermal Stability of Chelated Indium Activable Tracers

    SciTech Connect

    Chrysikopoulos, Costas; Kruger, Paul

    1986-01-21

    The thermal stability of indium tracer chelated with organic ligands ethylenediaminetetraacetic acid (EDTA) and nitrilotriacetic acid (NTA) was measured for reservoir temperatures of 150, 200, and 240 C. Measurements of the soluble indium concentration was made as a function of time by neutron activation analysis. From the data, approximate thermal decomposition rates were estimated. At 150 C, both chelated tracers were stable over the experimental period of 20 days. At 200 C, the InEDTA concentration remained constant for 16 days, after which the thermal decomposition occurred at a measured rate constant of k = 0.09 d{sup -1}. The thermal decomposition of InNTA at 200 C showed a first order reaction with a measured rate constant of k = 0.16 d{sup -1}. At 240 C, both indium chelated tracers showed rapid decomposition with rate constants greater than 1.8 d{sup -1}. The data indicate that for geothermal reservoir with temperatures up to about 200 C, indium chelated tracers can be used effectively for transit times of at least 20 days. These experiments were run without reservoir rock media, and do not account for concomitant loss of indium tracer by adsorption processes.

  6. Determination of equilibrium constants of alkaline earth metal ion chelates with Dowex A-1 chelating resin.

    PubMed

    Harju, L; Krook, T

    1995-03-01

    A complexation chemistry model is applied to chelating ion-exchange systems and a method is presented for the determination of equilibrium constants for metal ion chelates with these resins. Protonation constants for the iminodiacetic based chelating resin Dowex A-1 were determined from potentiometric pH-data. Equilibrium constants were determined for 1:1 beryllium, magnesium, calcium, strontium and barium chelates with the resin in a wide pH range by measuring the concentrations of respective metal ions in the aqueous phase with direct current plasma atomic emission spectrometry (DCP-AES). A batch technique was used for the equilibrium experiments. At pH below 7 protonated 1:1 species were also found to be formed with the resin. From the obtained equilibrium constants, theoretical distribution coefficients were calculated as function of pH for respective metal ion resin system. PMID:18966248

  7. Clean ferrous casting technology research. Final technical report, September 29, 1993--December 31, 1995

    SciTech Connect

    Piwonka, T.S.

    1996-01-01

    This report details results of a 30-month program to develop methods of making clean ferrous castings, i.e., castings free of inclusions and surface defects. The program was divided into 3 tasks: techniques for producing clean steel castings, electromagnetic removal of inclusions from ferrous melts, and study of causes of metal penetration in sand molds in cast iron.

  8. Bacterial oxidation of ferrous iron at low temperatures.

    PubMed

    Kupka, Daniel; Rzhepishevska, Olena I; Dopson, Mark; Lindström, E Börje; Karnachuk, Olia V; Tuovinen, Olli H

    2007-08-15

    This study comprises the first report of ferrous iron oxidation by psychrotolerant, acidophilic iron-oxidizing bacteria capable of growing at 5 degrees C. Samples of mine drainage-impacted surface soils and sediments from the Norilsk mining region (Taimyr, Siberia) and Kristineberg (Skellefte district, Sweden) were inoculated into acidic ferrous sulfate media and incubated at 5 degrees C. Iron oxidation was preceded by an approximately 3-month lag period that was reduced in subsequent cultures. Three enrichment cultures were chosen for further work and one culture designated as isolate SS3 was purified by colony isolation from a Norilsk enrichment culture for determining the kinetics of iron oxidation. The 16S rRNA based phylogeny of SS3 and two other psychrotolerant cultures, SS5 from Norilsk and SK5 from Northern Sweden, was determined. Comparative analysis of amplified 16S rRNA gene sequences showed that the psychrotolerant cultures aligned within Acidithiobacillus ferrooxidans. The rate constant of iron oxidation by growing cultures of SS3 was in the range of 0.0162-0.0104 h(-1) depending on the initial pH. The oxidation kinetics followed an exponential pattern, consistent with a first order rate expression. Parallel iron oxidation by a mesophilic reference culture of Acidithiobacillus ferrooxidans was extremely slow and linear. Precipitates harvested from the 5 degrees C culture were identified by X-ray diffraction as mixtures of schwertmannite (ideal formula Fe(8)O(8)(OH)(6)SO(4)) and jarosite (KFe(3)(SO(4))(2)(OH)(6)). Jarosite was much more dominant in precipitates produced at 30 degrees C. PMID:17304566

  9. Relationship among Chelator Adherence, Change in Chelators, and Quality of Life in Thalassemia

    PubMed Central

    Trachtenberg, Felicia L.; Gerstenberger, Eric; Xu, Yan; Mednick, Lauren; Sobota, Amy; Ware, Hannah; Thompson, Alexis A.; Neufeld, Ellis J.; Yamashita, Robert

    2015-01-01

    Purpose Thalassemia, a chronic blood disease, necessitates life-long adherence to blood transfusions and chelation therapy to reduce iron overload. We examine stability of Health-Related Quality of Life (HRQOL) in thalassemia and adherence to chelation therapy over time, especially after changes in chelator choice. Methods Thalassemia Longitudinal Cohort participants in the US, UK, and Canada completed the SF-36v2 (ages 14+), and the PF-28 CHQ (parents of children<14 years). Chelation adherence was defined as self-reported percent of doses administered in the last 4 weeks. Results 258 adults/adolescents (mean 29.7 years) and 133 children (mean 8.5 years) completed a mean of 2.8 years follow-up. Children made few chelator changes, whereas a mean of 2.2 changes was observed among the 37% of adults/adolescents who made chelator changes, mainly, due to patient preference or medical necessity. Physical HRQOL improved among those with lower iron burden (better health status) at baseline who made a single change in chelator, but declined among participants with multiple changes and/or high iron burden (worse health status). Mental health improved among participants with lower iron burden, but iron overload was negatively associated with social functioning. Adherence did not significantly change over follow-up except for an increase after a change from DFO infusion to oral deferasirox (p=0.03). Predictors of lower adherence for adults/adolescents at follow-up included side effects, smoking, younger age, problems preparing DFO, increased number of days per week DFO prescribed, and lower physical QOL. Conclusions Strategies to balance medical needs with family, work, and personal life may assist in adherence. PMID:24682717

  10. Single-molecule magnets of ferrous cubes: structurally controlled magnetic anisotropy.

    PubMed

    Oshio, Hiroki; Hoshino, Norihisa; Ito, Tasuku; Nakano, Motohiro

    2004-07-21

    Tetranuclear Fe(II) cubic complexes were synthesized with Schiff base ligands bridging the Fe(II) centers. X-ray structural analyses of six ferrous cubes, [Fe4(sap)4(MeOH)4].2H2O (1), [Fe4(5-Br-sap)4(MeOH)4] (2), [Fe4(3-MeO-sap)4(MeOH)4].2MeOH (3), [Fe4(sae)4(MeOH)4] (4), [Fe4(5-Br-sae)4(MeOH)4].MeOH (5), and [Fe4(3,5-Cl2-sae)4(MeOH)4] (6) (R-sap and R-sae were prepared by condensation of salicylaldehyde derivatives with aminopropyl alcohol and aminoethyl alcohol, respectively) were performed, and their magnetic properties were studied. In 1-6, the alkoxo groups of the Schiff base ligands bridge four Fe(II) ions in a mu3-mode forming [Fe4O4] cubic cores. The Fe(II) ions in the cubes have tetragonally elongated octahedral coordination geometries, and the equatorial coordination bond lengths in 4-6 are shorter than those in 1-3. Dc magnetic susceptibility measurements for 1-6 revealed that intramolecular ferromagnetic interactions are operative to lead an S = 8 spin ground state. Analyses of the magnetization data at 1.8 K gave the axial zero-field splitting parameters (D) of +0.81, +0.80, +1.15, -0.64, -0.66, and -0.67 cm(-1) for 1-6, respectively. Ac magnetic susceptibility measurements for 4-6 showed both frequency dependent in- and out-of-phase signals, while 1-3 did not show out-of-phase signals down to 1.8 K, meaning 4-6 are single-molecule magnets (SMMs). The energy barriers to flip the spin between up- and down-spin were estimated to 28.4, 30.5, and 26.2 K, respectively, for 4-6. The bridging ligands R-sap2- in 1-3 and R-sae2- in 4-6 form six- and five-membered chelate rings, respectively, which cause different steric strain and Jahn-Teller distortions at Fe(II) centers. The sign of the D value was discussed by using angular overlap model (AOM) calculations for irons with different coordination geometry. PMID:15250734

  11. Resveratrol offers protection to oxidative stress induced by ferrous ascorbate in bovine spermatozoa.

    PubMed

    Tvrdá, Eva; Kováčik, Anton; Tušimová, Eva; Massányi, Peter; Lukáč, Norbert

    2015-01-01

    Resveratrol (RES) is a natural polyphenol and phytoestrogen exhibiting cardioprotective, anticancer, antibacterial and vasorelaxing properties. It is also a powerful reactive oxygen species (ROS) scavenger and chelating agent. This study was designed to determine the efficiency of RES to reverse the ROS-mediated impairment of the motility, viability and intracellular antioxidant profile of bovine spermatozoa. Spermatozoa were washed out of fresh bovine semen, suspended in 2.9% sodium citrate and subjected to RES treatment (5, 10, 25 and 50 μmol L(-1)) in the presence or absence of a pro-oxidant, i.e., ferrous ascorbate (FeAA; 150 μmol L(-1) FeSO4 and 750 μmol L(-1) ascorbic acid) during a 6-h in vitro culture. Spermatozoa motion parameters were assessed using the SpermVision computer-aided sperm analysis (CASA) system. Cell viability was examined with the metabolic activity (MTT) assay, and the nitroblue-tetrazolium (NBT) test was applied to quantify the intracellular superoxide formation. Cell lysates were prepared at the end of the in vitro experiments in order to investigate the intracellular activity of superoxide dismutase (SOD), catalase (CAT), as well as the concentrations of glutathione (GSH) and malondialdehyde (MDA). FeAA treatment led to a reduced sperm motility (P < 0.001) and viability (P < 0.001), decreased the antioxidant parameters of the samples (P < 0.001 in case of SOD; P < 0.01 with respect to CAT; P < 0.05 in relation to GSH) but increased the superoxide production (P < 0.001) and lipid peroxidation (P < 0.001). RES supplementation resulted in a preservation of the spermatozoa vitality and antioxidant characteristics (P < 0.001 in case of SOD; P < 0.01 with respect to 25-50 μmol L(-1) RES and P < 0.05 in relation to 10 μmol L(-1) RES; P < 0.05 in case of GSH), with 50 μmol L(-1) RES proving to be the most effective RES concentration. Our results suggest that RES possesses significant antioxidant properties that may prevent the deleterious

  12. Silybin, a new iron-chelating agent.

    PubMed

    Borsari, M; Gabbi, C; Ghelfi, F; Grandi, R; Saladini, M; Severi, S; Borella, F

    2001-06-01

    Silybin, a natural occurring flavolignan isolated from the fruits of Silibum marianum, has been reported to exert antioxidant and free radical scavenging abilities. It was suggested to act also as an iron chelator. The complexation and protonation equilibria of the ferric complex of this compound have been studied by potentiometric, spectrophotometric and electrochemical techniques. The formation of the complex silybin-Ga(III) in anhydrous DMSO-d6 has been studied by 1H NMR spectroscopy. Mass spectrometry and infrared spectroscopy on silybin-Fe(III) complex confirm all data obtained by 1H NMR spectroscopy. The experimental results show that silybin binds Fe(III) even at acidic pH. Different ternary complexes were observed at increasing methoxide ion concentration and their stability constants have been calculated. The results show the possible role of silybin in relation to the chelation therapy of chronic iron overload, as occurs in the treatment of Cooley's anemia. PMID:11410232

  13. Paramagnetic lanthanide chelates for multicontrast MRI.

    PubMed

    Cakić, Nevenka; Savić, Tanja; Stricker-Shaver, Janice; Truffault, Vincent; Platas-Iglesias, Carlos; Mirkes, Christian; Pohmann, Rolf; Scheffler, Klaus; Angelovski, Goran

    2016-07-28

    The preparation of a paramagnetic chelator that serves as a platform for multicontrast MRI, and can be utilized either as a T1-weighted, paraCEST or (19)F MRI contrast agent is reported. Its europium(iii) complex exhibits an extremely slow water exchange rate which is optimal for the use in CEST MRI. The potential of this platform was demonstrated through a series of MRI studies on tube phantoms and animals. PMID:27291157

  14. Iron Chelation Therapy in Thalassemia Syndromes

    PubMed Central

    Cianciulli, Paolo

    2009-01-01

    Transfusional hemosiderosis is a frequent complication in patients with transfusion dependent chronic diseases such as thalassemias and severe type of sickle cell diseases. As there are no physiological mechanisms to excrete the iron contained in transfused red cells (1 unit of blood contains approximately 200 mg of iron) the excess of iron is stored in various organs. Cardiomyopathy is the most severe complication covering more than 70% of the causes of death of thalassemic patients. Although the current reference standard iron chelator deferoxamine (DFO) has been used clinically for over four decades, its effectiveness is limited by a demanding therapeutic regimen that leads to poor compliance. Despite poor compliance, because of the inconvenience of subcutaneous infusion, DFO improved considerably the survival and quality of life of patients with thalassemia. Deferiprone since 1998 and Deferasirox since 2005 were licensed for clinical use. The oral chelators have a better compliance because of oral use, a comparable efficacy to DFO in iron excretion and probably a better penetration to myocardial cells. Considerable increase in iron excretion was documented with combination therapy of DFO and Deferiprone. The proper use of the three chelators will improve the prevention and treatment of iron overload, it will reduce complications, and improve survival and quality of life of transfused patients. PMID:21415999

  15. Metal chelate catalysts for fuel cells

    NASA Astrophysics Data System (ADS)

    Darby, R.; White, R.; Yamana, M.; Tsutsue, M.

    1981-07-01

    A variety of metal chelates were synthesized and evaluated for their activity as oxygen cathode electrocatalysts in strong acidic electrolytes. It was found that Cobalt tetraazaanulene (CoTAA) and iron phthalocyanine (FePc) exhibit the best activity of all the metal chelates synthesized, but have very limited stability. The proposed solution to this problem is the synthesis of polymeric forms of these chelates, with comparable active and considerably greater stability than the monomers. Three methods for stability testing were developed: (1) Potentiostatic, with periodic measurement of the current potential characteristic; (2) potentiostatic, with continuous monitoring of the current, and; (3) galvanostatic, with continuous monitoring of potential. Each method provides a good evaluation of activity versus time, and the method to be used depends upon the objective of the test. A polymeric form of Co(TAA) was synthesized by means of an acetylene terminated monomer, which in turn was made via a Co(TAA)Br2 intermediate. The activity of the polymer was found to be comparable to that of Co(TAA) monomer, and significantly greater than that of either the stacked or sheet polymeric forms of Cobalt tetraphenylporphrine (CoTPP) previously synthesized and tested.

  16. Ferrous iron oxidation by Thiobacillus ferrooxidans: inhibition with benzoic acid, sorbic acid, and sodium lauryl sulfate

    SciTech Connect

    Onysko, S.J.; Kleinmann, R.L.P.; Erickson, P.M.

    1984-07-01

    Thiobacillus ferrooxidans promote indirect oxidation of pyrite through the catalysis of the oxidation of ferrous iron to ferric iron, which is an effective oxidant of pyrite. These bacteria also may catalyze direct oxidation of pyrite by oxygen. A number of organic compounds, under laboratory conditions, can apparently inhibit both the oxidation of ferrous iron to ferric iron by T. ferrooxidans and the weathering of pyritic material by mixed cultures of acid mine drainage microorganisms. In this study, benzoic acid, sorbic acid, and sodium lauryl sulfate at low concentrations (5 to 10 mg/liter) each effectively inhibited bacterial oxidation of ferrous iron in batch cultures of Thiobacillus ferrooxidans. The rate of chemical oxidation of ferrous iron in low-pH, sterile batch reactors was not substantially affected at the tested concentrations (5 to 50 mg/liter) of any of the compounds.

  17. Insight into the formation of magnetite mesocrystals from ferrous precursors in ethylene glycol.

    PubMed

    Wan, Jiaqi; Tang, Jing; Zhang, Chongyu; Yuan, Ruiting; Chen, Kezheng

    2015-11-14

    Uniform magnetite mesocrystals were fabricated by solvothermal treatment of ferrous chloride in ethylene glycol in the presence of sodium hydroxide. The formation mechanism of magnetite mesocrystals in ethylene glycol was deduced by a time-dependent experiment. PMID:26255597

  18. Ferrous iron oxidation by Thiobacillus ferrooxidans: inhibition with benzoic acid, sorbic acid and sodium lauryl sulfate

    SciTech Connect

    Onysko, S.J.

    1984-07-01

    Acid mine drainage is formed by the weathering or oxidation of pyritic material exposed during coal mining. The rate of pyritic material oxidation can be greatly accelerated by certain acidophilic bacteria such as Thiobacillus ferrooxidans which catalyse the oxidation of ferrous to ferric iron. A number of organic compounds, under laboratory conditions, can apparently inhibit both the oxidation of ferrous to ferric iron by T. ferrooxidans and the weathering of pyritic material by mixed cultures of acid mine drainage micro-organisms. Sodium lauryl sulphate (SLS), an anionic surfactant has proved effective in this respect. Benzoic acid, sorbic acid and SLS at low concentrations, each effectively inhibited bacterial oxidation of ferrous iron in batch cultures of T. ferrooxidans. The rate of chemical oxidation of ferrous iron in low pH, sterile, batch reactors was not substantially affected at the tested concentrations of any of the compounds.

  19. Ferrous Minerals and Impactite Mineralization at Missouri's Crooked Creek and Decaturville Impact Craters

    NASA Astrophysics Data System (ADS)

    Beauford, R. E.

    2012-03-01

    Epigenetic hydrothermal mineralization, subsequent to the Crooked Creek and Decaturville impacts, accompanied Paleozoic dolomitization of carbonates at a regional scale in the Ozarks and produced quantities of ferrous minerals at both locations.

  20. Chelators whose affinity for calcium is decreased by illumination

    NASA Technical Reports Server (NTRS)

    Tsien, Roger Y. (Inventor); Grynkiewicz, Grzegorz (Inventor); Minta, Akwasi (Inventor)

    1987-01-01

    The present invention discloses a group of calcium chelating compounds which have a descreased affinity for calcium following illumination. These new compounds contain a photolabile nitrobenzyl derivative coupled to a tetracarboxylate Ca.sup.2+ chelating parent compound having the octacoordinate chelating groups characteristic of EGTA or BAPTA. In a first form, the new compounds are comprised of a BAPTA-like chelator coupled to a single 2-nitrobenzyl derivative, which in turn is a photochemical precursor of a 2-nitrosobenzophenone. In a second form, the new compounds are comprised of a BAPTA-like chelator coupled to two 2-nitrobenzyl derivatives, themselves photochemical prcursors of the related 2-nitrosobenzophenones. The present invention also discloses a novel method for preparing 1-hydroxy- or 1-alkoxy-1-(2-nitroaryl)-1-aryl methanes. Methanes of this type are critical to the preparation of, or actually constitute, the photolabile Ca.sup.2+ chelating compounds disclosed and claimed herein.

  1. Development of cast ferrous alloys for Stirling engine application

    NASA Technical Reports Server (NTRS)

    Lemkey, F. D.

    1982-01-01

    Low cost cast ferrous base alloys that can be used for cylinder and regenerator housing components of the Stirling engine were investigated. The alloys must meet the requirements of high strength and thermal fatigue resistance to approximately 1500 F, compatibility and low permeability with hydrogen, good elevated temperature oxidation/corrosion resistance, and contain a minimum of strategic elements. The phase constituents of over twenty alloy iterations were examined by X-ray diffraction. These alloy candidates were further screened for their tensile and stress rupture strength and surface stability in air at 1450 and 1600 F, respectively. Two alloys, NASAUT 1G (Fe-10Mn-20Cr-1.5C-1.0Si) and NASAUT 4G (Fe-15Mn-12Cr-3Mo-1.5C-1.0Si-1.0Nb), were chosen for more extensive elevated temperature testing. These alloys were found to exhibit nearly equivalent elevated temperature creep strength and oxidation resistance. Silicon present in these alloys at the 1 w/o level permitted the achievement of oxide scale adherence to 1600 F without loss of strength (or ductility) as was noted for equivalent additions of aluminum.

  2. Friction and wear of some ferrous-base metallic glasses

    NASA Technical Reports Server (NTRS)

    Miyoshi, K.; Buckley, D. H.

    1984-01-01

    Sliding friction experiments, X-ray photoelectron spectroscopy (XPS) analysis, and electron microscopy and diffraction studies were conducted with ferrous base metallic glasses (amorphous alloys) in contact with aluminium oxide at temperatures to 750 C in a vacuum. Sliding friction experiments were also conducted in argon and air atmospheres. The results of the investigation indicate that the coefficient of friction increases with increasing temperature to 350 C in vacuum. The increase in friction is due to an increase in adhesion resulting from surface segregation of boric oxide and/or silicon oxide to the surface of the foil. Above 500 C the coefficient of friction decreased rapidly. The decrease correlates with the segregation of boron nitride to the surface. Contaminants can come from the bulk of the material to the surface upon heating and impart boric oxide and/or silicon oxide at 350 C and boron nitride above 500 C. The segregation of contaminants is responsible for the friction behavior. The amorphous alloys have superior wear resistance to crystalline 304 stainless steel. The relative concentrations of the various constituents at the surfaces of the amorphous alloys are very different from the nominal bulk compositions.

  3. Friction and wear of some ferrous-base metallic glasses

    NASA Technical Reports Server (NTRS)

    Miyoshi, K.; Buckley, D. H.

    1983-01-01

    Sliding friction experiments, X-ray photoelectron spectroscopy (XPS) analysis, and electron microscopy and diffraction studies were conducted with ferrous base metallic glasses (amorphous alloys) in contact with aluminum oxide at temperatures to 750 C in a vacuum. Sliding friction experiments were also conducted in argon and air atmospheres. The results of the investigation indicate that the coefficient of friction increases with increasing temperature to 350 C in vacuum. The increase in friction is due to an increase in adhesion resulting from surface segregation of boric oxide and/or silicon oxide to the surface of the foil. Above 500 C the coefficient of friction decreased rapidly. The decrease correlates with the segregation of boron nitride to the surface. Contaminants can come from the bulk of the material to the surface upon heating and impart boric oxide and/or silicon oxide at 350 C and boron nitride above 500 C. The segregation of contaminants is responsible for the friction behavior. The amorphous alloys have superior wear resistance to crystalline 304 stainless steel. The relative concentrations of the various constituents at the surfaces of the amorphous alloys are very different from the nominal bulk compositions.

  4. [Hypothyroidism as the result of drug interaction between ferrous sulfate and levothyroxine].

    PubMed

    Fiaux, E; Kadri, K; Levasseur, C; Le Guillou, C; Chassagne, P

    2010-10-01

    We report a case of drug-drug interaction between ferrous sulfate and l-thyroxin. A 95-year-old woman treated successfully with l-thyroxin for many years received ferrous sulfate for anemia. This association led rapidly to recurrence of hypothyroidism with elevated serum than TSH level which completely resolved after withdrawal of iron therapy. Interaction was confirmed after both drugs were daily administrated separately without recurrence of hypothyroidism. PMID:20554088

  5. An enzymatic approach to bifunctional chelating agents.

    PubMed

    Minazzi, Paolo; Lattuada, Luciano; Menegotto, Ivan G; Giovenzana, Giovanni B

    2014-09-21

    Bifunctional chelating agents (BFCAs) combine the complexing properties of a multidentate ligand with the presence of a free reactive functional group, mainly devoted to conjugation purposes. Indeed, products obtained by conjugation of a BFCA to a biomolecule and coordination of a suitable metal ion are widely applied in medicine nowadays as diagnostic and therapeutic agents. BFCAs are generally prepared through multi-step syntheses and with extensive application of protection-deprotection strategies, due to the large number of functional groups involved. Hydrolytic enzymes, with their unique chemoselectivity, provided the best results in the preparation of three different BFCAs based on very useful and well known ligand platforms. PMID:25060174

  6. Effect of ferrous metal presence on lead leaching in municipal waste incineration bottom ashes.

    PubMed

    Oehmig, Wesley N; Roessler, Justin G; Zhang, Jianye; Townsend, Timothy G

    2015-01-01

    The recovery of ferrous and non-ferrous metals from waste to energy (WTE) ash continues to advance as the sale of removed metals improves the economics of waste combustion. Published literature suggests that Fe and Fe oxides play a role in suppressing Pb leaching in the Toxicity Characteristic Leaching Procedure (TCLP); further removal of ferrous metals from WTE ashes may facilitate higher Pb leaching under the TCLP. Eight WTE bottom ash size-fractions, from three facilities, were evaluated to assess the effect of metallic Fe addition and ferrous metal removal on TCLP leaching. Metallic Fe addition was demonstrated to reduce Pb leaching; the removal of ferrous metals by magnet resulted in a decrease in total available Pb (mg/kg) in most ash samples, yet Pb leachability increased in 5 of 6 ash samples. The research points to two chemical mechanisms to explain these results: redox interactions between Pb and Fe and the sorption of soluble Pb onto Fe oxide surfaces, as well as the effect of the leachate pH before and after metals recovery. The findings presented here indicate that generators, processors, and regulators of ash should be aware of the impact ferrous metal removal may have on Pb leaching, as a substantial increase in leaching may have significant implications regarding the management of WTE ashes. PMID:25464288

  7. Mechanism of Ferrous Iron Binding and Oxidation by Ferritin from a Pennate Diatom*

    PubMed Central

    Pfaffen, Stephanie; Abdulqadir, Raz; Le Brun, Nick E.; Murphy, Michael E. P.

    2013-01-01

    A novel ferritin was recently found in Pseudo-nitzschia multiseries (PmFTN), a marine pennate diatom that plays a major role in global primary production and carbon sequestration into the deep ocean. Crystals of recombinant PmFTN were soaked in iron and zinc solutions, and the structures were solved to 1.65–2.2-Å resolution. Three distinct iron binding sites were identified as determined from anomalous dispersion data from aerobically grown ferrous soaked crystals. Sites A and B comprise the conserved ferroxidase active site, and site C forms a pathway leading toward the central cavity where iron storage occurs. In contrast, crystal structures derived from anaerobically grown and ferrous soaked crystals revealed only one ferrous iron in the active site occupying site A. In the presence of dioxygen, zinc is observed bound to all three sites. Iron oxidation experiments using stopped-flow absorbance spectroscopy revealed an extremely rapid phase corresponding to Fe(II) oxidation at the ferroxidase site, which is saturated after adding 48 ferrous iron to apo-PmFTN (two ferrous iron per subunit), and a much slower phase due to iron core formation. These results suggest an ordered stepwise binding of ferrous iron and dioxygen to the ferroxidase site in preparation for catalysis and a partial mobilization of iron from the site following oxidation. PMID:23548912

  8. Free radical scavenging and metal chelation by Tinospora cordifolia, a possible role in radioprotection.

    PubMed

    Goel, H C; Prem Kumar, I; Rana, S V S

    2002-06-01

    Aqueous extract of T. cordifolia inhibited Fenton (FeSO4) reaction and radiation mediated 2-deoxyribose degradation in a dose dependent fashion with an IC50 value of 700 microg/ml for both Fenton and radiation mediated 2-DR degradation. Similarly, it showed a moderate but dose dependent inhibition of chemically generated superoxide anion at 500 microg/ml concentration and above with an IC50 value of 2000 microg/ml. Aqueous extract inhibited the formation of Fe2+-bipiridyl complex and formation of comet tail by chelating Fe2+ ions in a dose dependent manner with an IC50 value of 150 microg/ml for Fe2+-bipirydyl formation and maximally 200 microg/ml for comet tail formation, respectively. The extract inhibited ferrous sulphate mediated lipid peroxidation in a dose-dependent manner with an IC50 value of 1300 microg/ml and maximally (70%) at 2000 microg/ml. The results reveal that the direct and indirect antioxidant actions of T. cordifolia probably act in corroboration to manifest the overall radioprotective effects. PMID:12587720

  9. Neuroprotective effects of ginkgetin against neuroinjury in Parkinson's disease model induced by MPTP via chelating iron.

    PubMed

    Wang, Y-Q; Wang, M-Y; Fu, X-R; Peng-Yu; Gao, G-F; Fan, Y-M; Duan, X-L; Zhao, B-L; Chang, Y-Z; Shi, Z-H

    2015-01-01

    Disruption of neuronal iron homeostasis and oxidative stress are closely related to the pathogenesis of Parkinson's disease (PD). Ginkgetin, a natural biflavonoid isolated from leaves of Ginkgo biloba L, has many known effects, including anti-inflammatory, anti-influenza virus, and anti-fungal activities, but its underlying mechanism of the neuroprotective effects in PD remains unclear. The present study utilized PD models induced by 1-methyl-4-phenylpyridinium (MPP(+)) and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) to explore the neuroprotective ability of ginkgetin in vivo and in vitro. Our results showed that ginkgetin could provide significant protection from MPP(+)-induced cell damage in vitro by decreasing the levels of intracellular reactive oxygen species and maintaining mitochondrial membrane potential. Meanwhile, ginkgetin dramatically inhibited cell apoptosis induced by MPP+ through the caspase-3 and Bcl2/Bax pathway. Moreover, ginkgetin significantly improved sensorimotor coordination in a mouse PD model induced by MPTP by dramatically inhibiting the decrease of tyrosine hydroxylase expression in the substantia nigra and superoxide dismutase activity in the striatum. Interestingly, ginkgetin could strongly chelate ferrous ion and thereby inhibit the increase of the intracellular labile iron pool through downregulating L-ferritin and upregulating transferrin receptor 1. These results indicate that the neuroprotective mechanism of ginkgetin against neurological injury induced by MPTP occurs via regulating iron homeostasis. Therefore, ginkgetin may provide neuroprotective therapy for PD and iron metabolism disorder related diseases. PMID:25968939

  10. Metal regeneration of iron chelates in nitric oxide scrubbing

    DOEpatents

    Chang, Shih-Ger; Littlejohn, David; Shi, Yao

    1997-08-19

    The present invention relates to a process of using metal particles to reduce NO to NH.sub.3. More specifically, the invention concerns an improved process to regenerate iron (II) (CHELATE) by reduction of iron (II) (CHELATE) (NO) complex, which process comprises: a) contacting an aqueous solution containing iron (II) (CHELATE) (NO) with metal particles at between about 20.degree. and 90.degree. C. to reduce NO present, produce ammonia or an ammonium ion, and produce free iron (II) (CHELATE) at a pH of between about 3 and 8. The process is useful to remove NO from flue gas and reduce pollution.

  11. Metal regeneration of iron chelates in nitric oxide scrubbing

    DOEpatents

    Chang, S.G.; Littlejohn, D.; Shi, Y.

    1997-08-19

    The present invention relates to a process of using metal particles to reduce NO to NH{sub 3}. More specifically, the invention concerns an improved process to regenerate iron (II) (CHELATE) by reduction of iron (II) (CHELATE) (NO) complex, which process comprises: (a) contacting an aqueous solution containing iron (II) (CHELATE) (NO) with metal particles at between about 20 and 90 C to reduce NO present, produce ammonia or an ammonium ion, and produce free iron (II) (CHELATE) at a pH of between about 3 and 8. The process is useful to remove NO from flue gas and reduce pollution. 34 figs.

  12. A novel mechanism for the pyruvate protection against zinc-induced cytotoxicity: mediation by the chelating effect of citrate and isocitrate.

    PubMed

    Sul, Jee-Won; Kim, Tae-Youn; Yoo, Hyun Ju; Kim, Jean; Suh, Young-Ah; Hwang, Jung Jin; Koh, Jae-Young

    2016-08-01

    Intracellular accumulation of free zinc contributes to neuronal death in brain injuries such as ischemia and epilepsy. Pyruvate, a glucose metabolite, has been shown to block zinc neurotoxicity. However, it is largely unknown how pyruvate shows such a selective and remarkable protective effect. In this study, we sought to find a plausible mechanism of pyruvate protection against zinc toxicity. Pyruvate almost completely blocked cortical neuronal death induced by zinc, yet showed no protective effects against death induced by calcium (ionomycin, NMDA) or ferrous iron. Of the TCA cycle intermediates, citrate, isocitrate, and to a lesser extent oxaloacetate, protected against zinc toxicity. We then noted with LC-MS/MS assay that exposure to pyruvate, and to a lesser degree oxaloacetate, increased levels of citrate and isocitrate, which are known zinc chelators. While pyruvate added only during zinc exposure did not reduce zinc toxicity, citrate and isocitrate added only during zinc exposure, as did extracellular zinc chelator CaEDTA, completely blocked it. Furthermore, addition of pyruvate after zinc exposure substantially reduced intracellular zinc levels. Our results suggest that the remarkable protective effect of pyruvate against zinc cytotoxicity may be mediated indirectly by the accumulation of intracellular citrate and isocitrate, which act as intracellular zinc chelators. PMID:27515054

  13. Chemical treatment of chelated metal finishing wastes.

    PubMed

    McFarland, Michael J; Glarborg, Christen; Ross, Mark A

    2012-12-01

    This study evaluated two chemical approaches for treatment of commingled cadmium-cyanide (Cd-CN) and zinc-nickel (Zn-Ni) wastewaters. The first approach, which involved application of sodium hypochlorite (NaOCl), focused on elimination of chelating substances. The second approach evaluated the use of sodium dimethyldithiocarbamate (DMDTC) to specifically target and precipitate regulated heavy metals. Results demonstrated that by maintaining a pH of 10.0 and an oxidation-reduction potential (ORP) value of +600 mV, NaOCl treatment was effective in eliminating all chelating substances. Cadmium, chromium, nickel, and zinc solution concentrations were reduced from 0.27, 4.44, 0.06, and 0.10 ppm to 0.16, 0.17, 0.03, and 0.06 ppm, respectively. Similarly, a 1% DMDTC solution reduced these same metal concentrations in commingled wastewater to 0.009, 1.142, 0.036, and 0.320 ppm. Increasing the DMDTC concentration to 2% improved the removal of all regulated heavy metals except zinc, the removal of which at high pH values is limited by its amphotericity. PMID:23342939

  14. Degradation of ciprofloxacin and sulfamethoxazole by ferrous-activated persulfate: implications for remediation of groundwater contaminated by antibiotics.

    PubMed

    Ji, Yuefei; Ferronato, Corinne; Salvador, Arnaud; Yang, Xi; Chovelon, Jean-Marc

    2014-02-15

    The wide occurrence of antibiotics in groundwater raised great scientific interest as well as public awareness in recent years due to their potential ability to spread antibiotic resistant gene and pose risk to humans. The present study investigated the ferrous ion (Fe(II)) activated decomposition of persulfate (S2O8(2-)), as a potential in situ chemical oxidation (ISCO) approach, for remediation of groundwater contaminated by antibiotics. Fe(II)-persulfate mediated ciprofloxacin (CIP) degradation was found to be more efficient than sulfamethoxazole (SMX) at near neutral pH (pH6.0), probably due to the higher electric density in CIP molecule and its ability to form complex with Fe(II) as a ligand. Hydroxyl (HO) and sulfate radical (SO4(-)) were determined to be responsible for the degradation of CIP and SMX in Fe(II)-persulfate system by molecular probes. No enhancement in the degradation of CIP was observed when citrate (CA), ethylenediaminetetraacetate (EDTA) and (S,S)-ethylenediamine-N,N'-disuccinate (EDDS) were used as Fe(II) chelating agents in Fe(II)-persulfate system. For SMX, CA and EDTA accelerated the degradation by Fe(II)-persulfate. Degradation of antibiotics in river water matrix was nearly the same as that in Milli-Q water, implying the possibility of using Fe(II)-persulfate for antibiotics depletion under environmentally relevant condition. A comparison of the degradation efficiency of SMX with other sulfonamides and sulfanilic acid indicated that the heterocyclic ring has a large impact on the degradation of sulfonamides. Transformation products of CIP and SMX by Fe(II)-persulfate were analyzed by solid phase extraction-liquid chromatography-mass spectrometry (SPE-LC-MS) technique. Based on the intermediate products, Fe(II)-persulfate mediated CIP degradation pathways were tentatively proposed. PMID:24342085

  15. Precise determination of ferrous iron in silicate rocks

    NASA Astrophysics Data System (ADS)

    Yokoyama, Tetsuya; Nakamura, Eizo

    2002-03-01

    We have developed a highly precise method for the determination of ferrous iron (Fe 2+) in silicate rocks. Our new method is based on Wilson's procedure (1955) in which surplus V 5+ is used to oxidize Fe 2+ into Fe 3+ while equivalently reducing V 5+ into V 4+. Because V 4+ is more resistant to atmospheric oxidation than Fe 2+, Fe 2+ in the sample can be determined by measuring unreacted V 5+ by adding excess Fe 2+ after sample decomposition and then titrating the unreacted Fe 2+ with Cr 6+. With our method, which involves conditioning the sample solution with 5 M H 2SO 4 in a relatively small beaker (7 mL), the oxidation of Fe 2+ or V 4+ that leads to erroneous results can be completely avoided, even in 100-h sample decompositions at 100°C. We have measured the concentration of FeO in 15 standard silicate rock powders provided by the Geological Survey of Japan (GSJ). Analytical reproducibility was better than 0.5% (1σ) for all but those samples that had small amounts of Fe 2+ (<1.5 wt.% of FeO). Fourteen of these samples gave FeO contents significantly higher than the GSJ reference values. This likely indicates that the GSJ reference values, obtained by compiling previously published data, contain a large number of poor-quality data obtained by methods with lower recovery of Fe 2+ caused by oxidation or insufficient sample decomposition during analyses. To achieve accurate determinations of Fe 2+ in our method, several factors besides the oxidation must be considered, including: (1) long-term variations in the concentration of Fe 2+ solution must be corrected; (2) excess use of the indicator must be avoided; and (3) the formation of inert FeF + complex must be avoided during titration when using boric acid as a masking agent.

  16. Ultrafine Particulate Ferrous Iron and Anthracene Associations with Mitochondrial Dysfunction

    SciTech Connect

    Faiola, Celia; Johansen, Anne M.; Rybka, Sara; Nieber, Annika; Thomas-Bradley, Carin; Bryner, Stephanie; Johnston, Justin M.; Engelhard, Mark H.; Nachimuthu, Ponnusamy; Owens, Kalyn S.

    2011-04-20

    The ultrafine size fraction of ambient particles (ultrafine particles, UFP, diameter < 100 nm) has been identified as being far more potent in their adverse health effects than their larger counterparts, yet, the detailed mechanisms for why UFP display such distinctive toxicity are not well understood. In the present study, ambient UFP were exposed to mitochondria while monitoring electron transport chain (ETC) activity as a model system for biochemical toxicity. UFP samples were collected in rural (Ellensburg, WA) and urban environments (Seattle, WA) and chemically characterized for total trace metals, ferrous (Fe(II)) and easily reducible ferric (Fe(III)) iron, polycyclic aromatic hydrocarbons, and surface constituents with X-ray photoelectron spectroscopy (XPS). Low doses of UFP (8 µg mL-1) caused a decrease in mitochondrial ETC function compared to controls in 94% of the samples after The 20 min of exposure. Significant correlations exist between initial %ETC inhibition (0-10 min) and Fe(II) (R=0.55, P=0.03, N=15), anthracene (R=0.74, P<0.01, N=13), and %C-O surface bonds (R=0.56, P=0.03, N=15), whereby anthracene and %C-O correlate as well (R=0.58, P=0.03, N=14). No significant associations were identified with total Fe and other trace metals. Results from this study indicate that the redox active fraction of Fe as well as the abundance of anthracene-related, C-O containing, surface structures may contribute to the initial detrimental behavior of UFP, thus supporting the idea that the Fe(II)/Fe(III) and certain efficient hydroquinone/quinone redox pairs may play an important role likely due to their potential to produce reactive oxygen species (ROS).

  17. Hydrocarbon microseepage detection based on normalized ferric and ferrous indices of Landsat imagery

    NASA Astrophysics Data System (ADS)

    Zhu, M.; Xie, H.; Liu, D.; Zhang, Y.

    2006-05-01

    Ferric index (TM 3/1) (Fe3), ferrous index (TM 5/4) (Fe2), and clay and/or carbonate index (TM 5/7) have been successfully applied in mapping hydrothermal-alteration minerals, soil types, organics abundance, and mine waste. However, the ferric/ferrous indices do not work well when they are applied to detect relative oxidation/reduction area in hydrocarbon microseepage regions where the total iron and iron ion types are different in background rocks or soils. For example, there is relative high ferrous in organic-rich sediments and basic igneous rock, such as in coal-bearing beds. Clearly, the high ferrous concentration is not resulted from exotic reduction. Usually, under a homogeneous exotic reduced condition, the higher the total iron in rock or soil, the more the transferred ferrous iron produced. In order to remove the effects of total iron difference in rocks and soils on hydrocarbon microseepage detection, a new method, referred to as normalized ferric and ferrous index, is developed in this study, i.e. the normalized ferric index (NFe3) = Fe3 / (Fe3 + Fe2) and the normalized ferrous index (NFe2) = Fe2 / (Fe3 + Fe2). The NFe3 and NFe2 are successfully applied and tested in two sites for hydrocarbon microseepage detection in oil/gas-bearing Ordos Basin and Eren Basin, China. The NFe3 and NFe2 index images can preserve not only the major information of the ratio 3/1 and 5/4 images, but also remove the effects of total iron in background. Comparing to the mineral composite image (TM 3/1, 5/4, and 5/7 in RGB), the normalized indices color composite image (NFe3, NFe2, and TM5/7 in RGB) shows hydrocarbon microseepage areas clearly in green color. In addition, the composite images of normalized index also remove the vegetation effect to some degree in the test sites.

  18. Chelation Treatment for Autism Spectrum Disorders: A Systematic Review

    ERIC Educational Resources Information Center

    Davis, Tonya N.; O'Reilly, Mark; Kang, Soyeon; Lang, Russell; Rispoli, Mandy; Sigafoos, Jeff; Lancioni, Giulio; Copeland, Daelynn; Attai, Shanna; Mulloy, Austin

    2013-01-01

    Chelation treatment is used to eliminate specific metals from the body, such as mercury. It has been hypothesized that mercury poisoning may be a factor in autism and data suggest that perhaps 7% of individuals with autism spectrum disorder (ASD) have received chelation treatment. It would therefore seem timely to review studies investigating the…

  19. Reusable chelating resins concentrate metal ions from highly dilute solutions

    NASA Technical Reports Server (NTRS)

    Bauman, A. J.; Weetal, H. H.; Weliky, N.

    1966-01-01

    Column chromatographic method uses new metal chelating resins for recovering heavy-metal ions from highly dilute solutions. The absorbed heavy-metal cations may be removed from the chelating resins by acid or base washes. The resins are reusable after the washes are completed.

  20. Chelating Agents and the Regulation of Metal Ions

    PubMed Central

    Bulman, Robert A.

    1994-01-01

    Up to about the early 1980s it was perhaps still possible to summarize in a review of a moderate length the development of the medicinal applications of chelation chemistry and the exploitation of such chemistry in regulating the metal ion concentrations in the body. However, in the last few years there has a great surge in the development of chelation chemistry and its usage in medicine and related areas of life sciences research. It is no longer the case that such a review primarily concentrates upon the use of chelating agents in removing toxic metals from the body but it must now cover the use of chelating agents in the imaging procedures nuclear medicine and magnetic resonance imaging (MRI), the use of chelating agents in unravelling the biochemistry of reactive oxidative species (ROS) and the control and measurement of intracellular calcium ions. It is in the recent applications that there have been the greatest developments over the last ten years. PMID:18476223

  1. Clawing Back: Broadening the Notion of Metal Chelators in Medicine

    PubMed Central

    Franz, Katherine J.

    2013-01-01

    The traditional notion of chelation therapy is the administration of a chemical agent to remove metals from the body. But formation of a metal-chelate can have biological ramifications that are much broader than metal elimination. Exploring these other possibilities could lead to pharmacological interventions that alter the concentration, distribution, or reactivity of metals in targeted ways for therapeutic benefit. This review highlights recent examples that showcase four general strategies of using principles of metal chelation in medicinal contexts beyond the traditional notion of chelation therapy. These strategies include altering metal biodistribution, inhibiting specific metalloenzymes associated with disease, enhancing the reactivity of a metal complex to promote cytotoxicity, and conversely, passivating the reactivity of metals by site-activated chelation to prevent cytotoxicity. PMID:23332666

  2. Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals†

    PubMed Central

    Cai, Zhengxin; Anderson, Carolyn J.

    2014-01-01

    The development of chelating agents for copper radionuclides in positron emission tomography radiopharmaceuticals has been a highly active and important area of study in recent years. The rapid evolution of chelators has resulted in highly specific copper chelators that can be readily conjugated to biomolecules and efficiently radiolabeled to form stable complexes in vivo. Chelators are not only designed for conjugation to monovalent biomolecules but also for incorporation into multivalent targeting ligands such as theranostic nanoparticles. These advancements have strengthened the role of copper radionuclides in the fields of nuclear medicine and molecular imaging. This review emphasizes developments of new copper chelators that have most greatly advanced the field of copper-based radiopharmaceuticals over the past 5 years. PMID:24347474

  3. Chelation in metal intoxication XXI: chelation in lead intoxication during vitamin B complex deficiency

    SciTech Connect

    Not Available

    1986-09-01

    The vitamin B-complex deficiency increases the vulnerability to neuro- and systemic toxicity of Pb in young rats. Thus, the nutritional status of vitamins like that of protein or minerals seems to influence the etiology of Pb toxicity and may be expected to affect the response toward Pb chelators. 2,3 dimercaptosuccinic acid (DMSA) and N-(2-hydroxyethyl) ethylene-diamine triacetic acid (HEDTA) have been found to be effective antidotes to Pb intoxication. In the present study, these selective metal chelating agents were compared for their ability to reduce the body burden of Pb and restore the altered biochemical parameters in young developing Pb intoxicated rats maintained on normal or vitamin B-complex deficient diet. The investigation was aimed to suggest suitable prophylaxis of Pb poisoning prevalent among children who may also be suffering from vitamin deficiency in developing and poor countries.

  4. Chelating ionic liquids for reversible zinc electrochemistry.

    PubMed

    Kar, Mega; Winther-Jensen, Bjorn; Forsyth, Maria; MacFarlane, Douglas R

    2013-05-21

    Advanced, high energy-density, metal-air rechargeable batteries, such as zinc-air, are of intense international interest due to their important role in energy storage applications such as electric and hybrid vehicles, and to their ability to deal with the intermittency of renewable energy sources such as solar and wind. Ionic liquids offer a number of ideal thermal and physical properties as potential electrolytes in such large-scale energy storage applications. We describe here the synthesis and characterisation of a family of novel "chelating" ILs designed to chelate and solubilize the zinc ions to create electrolytes for this type of battery. These are based on quaternary alkoxy alkyl ammonium cations of varying oligo-ether side chains and anions such as p-toluene sulfonate, bis(trifluoromethylsulfonyl)amide and dicyanoamides. This work shows that increasing the ether chain length in the cation from two to four oxygens can increase the ionic conductivity and reduce the melting point from 67 °C to 15 °C for the tosylate system. Changing the anion also plays a significant role in the nature of the zinc deposition electrochemistry. We show that zinc can be reversibly deposited from [N(222(20201))][NTf2] and [N(222(202020201))][NTf2] beginning at -1.4 V and -1.7 V vs. SHE, respectively, but not in the case of tosylate based ILs. This indicates that the [NTf2] is a weaker coordinating anion with the zinc cation, compared to the tosylate anion, allowing the coordination of the ether chain to dominate the behavior of the deposition and stripping of zinc ions. PMID:23558696

  5. Fixation kinetics of chelated and non-chelated zinc in semi-arid alkaline soils: application to zinc management

    NASA Astrophysics Data System (ADS)

    Udeigwe, Theophilus K.; Eichmann, Madeleine; Menkiti, Matthew C.

    2016-07-01

    This study was designed to examine the fixation pattern and kinetics of zinc (Zn) in chelated (ethylenediaminetetraacetic acid, EDTA) and non-chelated mixed micronutrient systems of semi-arid alkaline soils from the Southern High Plains, USA. Soils were characterized for a suite of chemical and physical properties and data obtained from extraction experiments fitted to various kinetic models. About 30 % more plant-available Zn was fixed in the non-chelated system within the first 14 days with only about 18 % difference observed between the two systems by day 90, suggesting that the effectiveness of the chelated compounds tended to decrease over time. The strengths of the relationships of change in available Zn with respect to other micronutrients (copper, iron, and manganese) were higher and more significant in the non-chelated system (average R2 of 0.83), compared to the chelated (average R2 of 0.42). Fixation of plant-available Zn was best described by the power-function model (R2 = 0.94, SE = 0.076) in the non-chelated system, and was poorly described by all the models examined in the chelated system. Reaction rate constants and relationships generated from this study can serve as important tools for micronutrient management and for future micronutrient modeling studies on these soils and other semi-arid regions of the world.

  6. Liposomal Cu-64 labeling method using bifunctional chelators: polyethylene glycol spacer and chelator effects

    PubMed Central

    Seo, Jai Woong; Mahakian, Lisa M.; Kheirolomoom, Azadeh; Zhang, Hua; Meares, Claude F.; Ferdani, Riccardo; Anderson, Carolyn J.; Ferrara, Katherine W.

    2010-01-01

    Two bifunctional Cu-64 chelators (BFCs), (6-(6-(3-(2-pyridyldithio)propionamido)hexanamido)benzyl)-1,4,8,11-tetraazacyclotetradecane- 1,4,8,11-tetraacetic acid (TETA-PDP) and 4-(2-(2-pyridyldithioethyl)ethanamido)-11-carboxymethyl-1,4,8,11-tetraazabicyclo(6.6.2)hexadecane (CB-TE2A-PDEA), were synthesized and conjugated to long circulating liposomes (LCLs) via attachment to a maleimide lipid. An in vitro stability assay of 64Cu-TETA, 64Cu-TETA-PEG2k, and 64Cu-CB-TE2A-PEG2k liposomes showed that more than 86% of the radioactivity remains associated with the liposomal fraction after 48 hours of incubation with mouse serum. The in vivo time activity curves (TAC) for the three liposomal formulations showed that ~50% of the radioactivity cleared from the blood pool in 16 - 18 hours. As expected, the in vivo biodistribution and TAC data obtained at 48 hours demonstrate that the clearance of radioactivity from the liver slows with the incorporation of a polyethylene glycol-2k (PEG2k) brush. Our data suggest that 64Cu-TETA and 64Cu-CB-TE2A are similarly stable in the blood pool and accumulation of radioactivity in the liver and spleen is not related to the stability of Cu-64 chelator complex; however clearance of Cu-64 from the liver and spleen are faster when injected as 64Cu-TETA-chelated liposomes rather than 64Cu-CB-TE2A-chelated liposomes. PMID:20568726

  7. Cyanide binding to ferrous and ferric microperoxidase-11.

    PubMed

    Ascenzi, Paolo; Sbardella, Diego; Santucci, Roberto; Coletta, Massimo

    2016-07-01

    Microperoxidase-11 (MP11) is an undecapeptide derived from horse heart cytochrome c (cytc). MP11 is characterized by a covalently linked solvent-exposed heme group, the heme-Fe atom being axially coordinated by a histidyl residue. Here, the reactions of ferrous and ferric MP11 (MP11-Fe(II) and MP11-Fe(III), respectively) with cyanide have been investigated from the kinetic and thermodynamic viewpoints, at pH 7.0 and 20.0 °C. Values of the second-order rate constant for cyanide binding to MP11-Fe(II) and MP11-Fe(III) are 4.5 M(-1) s(-1) and 8.9 × 10(3) M(-1) s(-1), respectively. Values of the first-order rate constant for cyanide dissociation from ligated MP11-Fe(II) and MP11-Fe(III) are 1.8 × 10(-1) s(-1) and 1.5 × 10(-3) s(-1), respectively. Values of the dissociation equilibrium constant for cyanide binding to MP11-Fe(II) and MP11-Fe(III) are 3.7 × 10(-2) and 1.7 × 10(-7) M, respectively, matching very well with those calculated from kinetic parameters so that no intermediate species seem to be involved in the ligand-binding process. The pH-dependence of cyanide binding to MP11-Fe(III) indicates that CN(-) is the only binding species. Present results have been analyzed in parallel with those of several heme-proteins, suggesting that (1) the ligand accessibility to the metal center and cyanide ionization may modulate the formation of heme-Fe-cyanide complexes, and (2) the general polarity of the heme pocket and/or hydrogen bonding of the heme-bound ligand may affect cyanide exit from the protein matrix. Microperoxidase-11 (MP11) is an undecapeptide derived from horse heart cytochrome c. Penta-coordinated MP11 displays a very high reactivity towards cyanide, whereas the reactivity of hexa-coordinated horse heart cytochrome c is very low. PMID:27229515

  8. Potential for microbial oxidation of ferrous iron in basaltic glass.

    PubMed

    Xiong, Mai Yia; Shelobolina, Evgenya S; Roden, Eric E

    2015-05-01

    Basaltic glass (BG) is an amorphous ferrous iron [Fe(II)]-containing material present in basaltic rocks, which are abundant on rocky planets such as Earth and Mars. Previous research has suggested that Fe(II) in BG can serve as an energy source for chemolithotrophic microbial metabolism, which has important ramifications for potential past and present microbial life on Mars. However, to date there has been no direct demonstration of microbially catalyzed oxidation of Fe(II) in BG. In this study, three different culture systems were used to investigate the potential for microbial oxidation of Fe(II) in BG, including (1) the chemolithoautotrophic Fe(II)-oxidizing, nitrate-reducing "Straub culture"; (2) the mixotrophic Fe(II)-oxidizing, nitrate-reducing organism Desulfitobacterium frappieri strain G2; and (3) indigenous microorganisms from a streambed Fe seep in Wisconsin. The BG employed consisted of clay and silt-sized particles of freshly quenched lava from the TEB flow in Kilauea, Hawaii. Soluble Fe(II) or chemically reduced NAu-2 smectite (RS) were employed as positive controls to verify Fe(II) oxidation activity in the culture systems. All three systems demonstrated oxidation of soluble Fe(II) and/or structural Fe(II) in RS, whereas no oxidation of Fe(II) in BG material was observed. The inability of the Straub culture to oxidize Fe(II) in BG was particularly surprising, as this culture can oxidize other insoluble Fe(II)-bearing minerals such as biotite, magnetite, and siderite. Although the reason for the resistance of the BG toward enzymatic oxidation remains unknown, it seems possible that the absence of distinct crystal faces or edge sites in the amorphous glass renders the material resistant to such attack. These findings have implications with regard to the idea that Fe(II)-Si-rich phases in basalt rocks could provide a basis for chemolithotrophic microbial life on Mars, specifically in neutral-pH environments where acid-promoted mineral dissolution and

  9. Melting of low-level radioactive non-ferrous metal for release

    SciTech Connect

    Quade, Ulrich; Kluth, Thomas; Kreh, Rainer

    2007-07-01

    Siempelkamp Nukleartechnik GmbH has gained lots of experience from melting ferrous metals for recycling in the nuclear cycle as well as for release to general reuse. Due to the fact that the world market prices for non-ferrous metals like copper, aluminium or lead raised up in the past and will remain on a high level, recycling of low-level contaminated or activated metallic residues from nuclear decommissioning becomes more important. Based on the established technology for melting of ferrous metals in a medium frequency induction furnace, different melt treatment procedures for each kind of non-ferrous metals were developed and successfully commercially converted. Beside different procedures also different melting techniques such as crucibles, gas burners, ladles etc. are used. Approximately 340 Mg of aluminium, a large part of it with a uranium contamination, have been molten successfully and have met the release criteria of the German Radiation Protection Ordinance. The experience in copper and brass melting is based on a total mass of 200 Mg. Lead melting in a special ladle by using a gas heater results in a total of 420 Mg which could be released. The main goal of melting of non-ferrous metals is release for industrial reuse after treatment. Especially for lead, a cooperation with a German lead manufacturer also for recycling of non releasable lead is being planned. (authors)

  10. Evaluation of ferric and ferrous iron therapies in women with iron deficiency anaemia.

    PubMed

    Berber, Ilhami; Diri, Halit; Erkurt, Mehmet Ali; Aydogdu, Ismet; Kaya, Emin; Kuku, Irfan

    2014-01-01

    Introduction. Different ferric and ferrous iron preparations can be used as oral iron supplements. Our aim was to compare the effects of oral ferric and ferrous iron therapies in women with iron deficiency anaemia. Methods. The present study included 104 women diagnosed with iron deficiency anaemia after evaluation. In the evaluations performed to detect the aetiology underlying the iron deficiency anaemia, it was found and treated. After the detection of the iron deficiency anaemia aetiology and treatment of the underlying aetiology, the ferric group consisted of 30 patients treated with oral ferric protein succinylate tablets (2 × 40 mg elemental iron/day), and the second group consisted of 34 patients treated with oral ferrous glycine sulphate tablets (2 × 40 mg elemental iron/day) for three months. In all patients, the following laboratory evaluations were performed before beginning treatment and after treatment. Results. The mean haemoglobin and haematocrit increases were 0.95 g/dL and 2.62% in the ferric group, while they were 2.25 g/dL and 5.91% in the ferrous group, respectively. A significant difference was found between the groups regarding the increase in haemoglobin and haematocrit values (P < 0.05). Conclusion. Data are submitted on the good tolerability, higher efficacy, and lower cost of the ferrous preparation used in our study. PMID:25006339

  11. Active Insolubilized Antibiotics Based on Cellulose-Metal Chelates1

    PubMed Central

    Kennedy, J. F.; Barker, S. A.; Zamir, A.

    1974-01-01

    Cellulose was converted into a more reactive form by chelation with the transition metals titaniumIII, ironIII, tinIV, vanadiumIII, and zirconiumIV. The remaining unsubstituted ligands of the transition metal ions were found to be amenable to replacement by electron-donating groups of antibiotic molecules. Ampicillin, gentamicin, kanamycin, neomycin, paromomycin, polymyxin B, and streptomycin were used as antibacterial antibiotics, and amphotericin B and natamycin were used as antifungal antibiotics. Antibacterial activity of the products was tested against two gram-positive and two gram-negative bacteria, and antifungal activity was tested against four fungi. That the antibacterial antibiotics had complexed with the cellulose-metal chelates was demonstrated in that the product cellulose-metal-antibiotic chelates exhibited antibiotic activities whereas the metal chelates of cellulose themselves were inactive. Of 140 tests conducted, cellulose-metal-antibiotic chelates were active in 102 cases. Since the antibiotic derivatives were water insoluble and in fact retain some of the antibacterial activities of the parent compounds, the chelation method provides a facile way of rendering cellulose surfaces, etc., resistant to microbial attack over and above that degree of protection afforded by noncovalent adsorption of the antibiotic to cellulose itself. The underlying principles of the chelation reactions involved are discussed in detail. PMID:4451349

  12. Chelation therapy for metal intoxication: comments from a thermodynamic viewpoint.

    PubMed

    Nurchi, Valeria Marina; Alonso, Miriam Crespo; Toso, Leonardo; Lachowicz, Joanna Izabela; Crisponi, Guido

    2013-10-01

    Chelation therapy plays a prominent role in the clinical treatment of metal intoxication. In this paper the principal causes of metal toxicity are exposed, and the chemical and biomedical requisites of a chelating agent are sketched. The chelating agents currently in use for scavenging toxic metal ions from humans belong to few categories: those characterized by coordinating mercapto groups, by oxygen groups, poliaminocarboxylic acids, and dithiocarbamates. Considering that the complex formation equilibria have been studied for less than 50% of chelators in use, some reflections on the utility of stability constants are presented, together with an evaluation of ligands under the stability profile. The competition between endogenous and toxic target metal ions for the same chelating agent is furthermore examined. A thorough examination of stability constant databases has allowed to select, for each toxic metal, the ligands distinguished by the best pMe values. Even though this selection does not consider the biomedical requisites of a chelating agent, it gives a clear picture both of the pMe values that can be attained, and of the most appropriate chelators for each metal ion. PMID:23895193

  13. Nanoparticle and Iron Chelators as a Potential Novel Alzheimer Therapy

    PubMed Central

    Liu, Gang; Men, Ping; Perry, George; Smith, Mark A.

    2010-01-01

    Current therapies for Alzheimer disease (AD) such as the acetylcholinesterase inhibitors and the latest NMDA receptor inhibitor, Namenda, provide moderate symptomatic delay at various stages of the disease, but do not arrest the disease progression or bring in meaningful remission. New approaches to the disease management are urgently needed. Although the etiology of AD is largely unknown, oxidative damage mediated by metals is likely a significant contributor since metals such as iron, aluminum, zinc, and copper are dysregulated and/or increased in AD brain tissue and create a pro-oxidative environment. This role of metal ion-induced free radical formation in AD makes chelation therapy an attractive means of dampening the oxidative stress burden in neurons. The chelator desferrioxamine, FDA approved for iron overload, has shown some benefit in AD, but like many chelators, it has a host of adverse effects and substantial obstacles for tissue-specific targeting. Other chelators are under development and have shown various strengths and weaknesses. Here, we propose a novel system of chelation therapy through the use of nanoparticles. Nanoparticles conjugated to chelators show unique ability to cross the blood–brain barrier (BBB), chelate metals, and exit through the BBB with their corresponding complexed metal ions. This method may provide a safer and more effective means of reducing the metal load in neural tissue, thus attenuating the harmful effects of oxidative damage and its sequelae. Experimental procedures are presented in this chapter. PMID:20013176

  14. Chelation: Harnessing and Enhancing Heavy Metal Detoxification—A Review

    PubMed Central

    Sears, Margaret E.

    2013-01-01

    Toxic metals such as arsenic, cadmium, lead, and mercury are ubiquitous, have no beneficial role in human homeostasis, and contribute to noncommunicable chronic diseases. While novel drug targets for chronic disease are eagerly sought, potentially helpful agents that aid in detoxification of toxic elements, chelators, have largely been restricted to overt acute poisoning. Chelation, that is multiple coordination bonds between organic molecules and metals, is very common in the body and at the heart of enzymes with a metal cofactor such as copper or zinc. Peptides glutathione and metallothionein chelate both essential and toxic elements as they are sequestered, transported, and excreted. Enhancing natural chelation detoxification pathways, as well as use of pharmaceutical chelators against heavy metals are reviewed. Historical adverse outcomes with chelators, lessons learned in the art of using them, and successes using chelation to ameliorate renal, cardiovascular, and neurological conditions highlight the need for renewed attention to simple, safe, inexpensive interventions that offer potential to stem the tide of debilitating, expensive chronic disease. PMID:23690738

  15. Synthetic and natural iron chelators: therapeutic potential and clinical use

    PubMed Central

    Hatcher, Heather C; Singh, Ravi N; Torti, Frank M; Torti, Suzy V

    2013-01-01

    Iron-chelation therapy has its origins in the treatment of iron-overload syndromes. For many years, the standard for this purpose has been deferoxamine. Recently, considerable progress has been made in identifying synthetic chelators with improved pharmacologic properties relative to deferoxamine. Most notable are deferasirox (Exjade®) and deferiprone (Ferriprox®), which are now available clinically. In addition to treatment of iron overload, there is an emerging role for iron chelators in the treatment of diseases characterized by oxidative stress, including cardiovascular disease, atherosclerosis, neurodegenerative diseases and cancer. While iron is not regarded as the underlying cause of these diseases, it does play an important role in disease progression, either through promotion of cellular growth and proliferation or through participation in redox reactions that catalyze the formation of reactive oxygen species and increase oxidative stress. Thus, iron chelators may be of therapeutic benefit in many of these conditions. Phytochemicals, many of which bind iron, may also owe some of their beneficial properties to iron chelation. This review will focus on the advances in iron-chelation therapy for the treatment of iron-overload disease and cancer, as well as neurodegenerative and chronic inflammatory diseases. Established and novel iron chelators will be discussed, as well as the emerging role of dietary plant polyphenols that effectively modulate iron biochemistry. PMID:21425984

  16. Chelating agents and their use in radiopharmaceutical sciences.

    PubMed

    Wängler, B; Schirrmacher, R; Bartenstein, P; Wängler, C

    2011-10-01

    Radiometal nuclides can serve as diagnostic markers in molecular imaging or can be used in therapeutic settings for a rising number of human afflictions. For the targeted delivery of these medically interesting ions, appropriate chelating agents forming stable complexes are of fundamental importance. For different metal ions exhibiting different physical and chemical properties, resulting in different coordination chemistries and therefore differing requirements on the chelator used, a broad variety of chelating agents has been developed over the years. Not only the chemical properties of the metal ion determine the choice of the chelator, but also the desired in vivo behavior of the resulting molecular imaging or therapeutic compound influences the choice of the complexation agent. Furthermore, the conjugation chemistry for the introduction of the chelator into the biologically active compound and the complexation reaction of the metal ion can affect the choice of the appropriate chelator. This review outlines chelating agents used in medicinal chemistry, their radiometal complexation behavior and their potential influence on the properties of the resulting drugs. PMID:21762096

  17. The Pitsch-Petch orientation relationship in ferrous pearlite at small undercooling

    SciTech Connect

    Mangan, M.A.; Shiflet, G.J.

    1999-11-01

    The factors behind the occurrence of the Pitsch-Petch pearlitic orientation relationship (OR) in ferrous systems are investigated using a combination of crystallographic information obtained through electron-backscatter diffraction (EBSD) and knowledge of the three-dimensional (3-D) morphology of pearlite from serial sectioning. Both hypereutectoid and hypoeutectoid ferrous systems of various compositions providing a variety of morphologies are examined to consider the relationship between pearlite nucleation sites and ferrite-cementite interlamellar ORs. It is shown that the Pitsch-Petch OR occurs when a colony is cementite nucleated and this conclusion is valid for both sides of the eutectoid composition.

  18. Changes of ferrous iron and its transporters after intracerebral hemorrhage in rats

    PubMed Central

    Wang, Gaiqing; Shao, Anwen; Hu, Weimin; Xue, Fang; Zhao, Hongping; Jin, Xiaojie; Li, Guanglai; Sun, Zhitang; Wang, Li

    2015-01-01

    Objective: Ferrous iron is a major source inducing oxidative stress after intracerebral hemorrhage (ICH). Divalent metal transporter1 (DMT1) is the important and well-known plasma membrane transport protein which was proved to be involved in the transport of free ferrous iron in mammals. Ferroportin 1 (FPN1) is the unique exporter of ferrous iron from mammalian cells. The role of DMT1 and FPN1 in brain after ICH is still not elucidated. Therefore, we measure the expression of DMT1 and FPN1, to explore the correlations between ferrous iron and its specific transporters after ICH. Methods: Ninety-six Sprague-Dawley rats received intra-striatal infusions of 0.5 U type IV collagenase to establish ICH model. Ferrous iron content in brain was determined using Turnbull’s method. DMT1 and FPN1 expression were examined by immunohistochemical staining and Real-Time quantitative polymerase chain reaction (RT-PCR). With the use of confocal laser microscopy, we determined the colocalization of DMT1 and FPN1 at 1, 3, 7 and 14 days after ICH. Results: Ferrous iron deposition was shown in the perihematomal zone as early as 1 day after ICH; it reached a peak after 7 days and was not elevated within 14 days following ICH. The expression of the DMT1 upregulated and reached to peak at day 7 after ICH. FPN1 reached a plateau at 3 days post-ICH. Expression levels of DMT1 and FPN1 were in parallel with ferrous iron deposition. There was a positive correlation between FPN1 and DMT1. DMT1 mainly localized in the cytoplasm of glias and neurons. FPN1 were mostly distributed on the membrane of endothelial cells and glias. Confocal microscope showed that DMT1 colocalized with FPN1. Conclusions: DMT1 and FPN1 are positively influenced by ferrous iron status in brain after ICH. DMT1 and FPN1 attenuate iron overload after ICH via increasing transmembrane iron export. PMID:26617777

  19. Development of an intelligent control system for ferrous iron oxidation by Thiobacillus ferrooxidans

    SciTech Connect

    Light, M.D.; Torma, A.E.; Cordes, G.A.

    1991-01-01

    An intelligent control system (ICS) is being developed for ferrous iron oxidation by Thiobacillus ferroxidans. The ICS provides compterized data acquisition and control of process variables (temperature, Eh, pH, dissolved oxygen and carbon dioxide concentrations, and dilution rate) to maintain the ferrous iron oxidation at the highest possible rate. The ICS uses fuzzy logic for analysis of data inputs and implementation of control strategies. This paper provides preliminary information on the development of the ICS and its operation. 17 refs., 3 figs.

  20. Polyphosphate-enhanced production of reactive oxidants by nanoparticulate zero-valent iron and ferrous ion in the presence of oxygen: Yield and nature of oxidants.

    PubMed

    Kim, Hak-Hyeon; Lee, Hongshin; Kim, Hyung-Eun; Seo, Jiwon; Hong, Seok Won; Lee, Jeong-Yong; Lee, Changha

    2015-12-01

    The production of reactive oxidants from nanoparticulate zero-valent iron (nZVI) and ferrous ion (Fe(II)) in the presence of oxygen was greatly enhanced by the addition of tetrapolyphosphate (TPP) as an iron-chelating agent. Compared to other ligands, TPP exhibited superior activity in improving the oxidant yields. The nZVI/TPP/O2 and the Fe(II)/TPP/O2 systems showed similar oxidant yields with respect to the iron consumed, indicating that nZVI only serves as a source of Fe(II). The degradation efficacies of selected organic compounds were also similar in the two systems. It appeared that both hydroxyl radical (OH) and ferryl ion (Fe(IV)) are produced, and OH dominates at acidic pH. However, at pH > 6, little occurrence of hydroxylated oxidation products suggests that Fe(IV) is a dominant oxidant. The degradation rates of selected organic compounds by the Fe(II)/TPP/O2 system had two optimum points at pH 6 and 9, and these pH-dependent trends are likely attributed to the speciation of Fe(IV) with different reactivities. PMID:26093796

  1. Aminothiol multidentate chelators against Chagas disease.

    PubMed

    Deharo, E; Loyevsky, M; John, C; Balanza, E; Ruiz, G; Muñoz, V; Gordeuk, V R

    2000-03-01

    Three compounds of an aminothiol family of iron chelators were examined for activity against trypomastigote (human) and epimastigote (vector) forms of Trypanosoma cruzi: tetraethyl and tetramethyl derivatives of ethane-1,2-bis (N-1-amino-3-ethyl butyl-3-thiol) (BAT-TE and BAT-TM) and N',N',N'-tris-(2-methyl-2-mercaptopriopyl)- 1,4,7-triazacyclonane (TAT). BAT-TE at 270 microM completely arrested the growth of trypomastigote forms in mouse blood stored at 4 degrees C for 24 h (IC(50) 67.7+/-7 microM), while BAT-TM arrested growth at 630 microM (IC(50) 158+/-17 microM) and TAT at concentrations >800 microM (IC(50) 415+/-55 microM). In T. cruzi-infected mice, BAT-TE and BAT-TM had no anti-trypanosomal activity in doses up to 200 mg/kg, whether the route of administration was intraperitoneal or oral, and TAT was not tested due to insufficient quantity. TAT had an IC(50) of 52+/-7 microM against the epimastigote forms while BAT-TM and BAT-TE were inhibitory only at concentrations >250 microM. The trypanocidal activity of BAT derivatives in blood stored at 4 degrees C makes these compounds potential candidates for the purpose of clearing donated blood of trypomastigotes. PMID:10831386

  2. Chelating ligands for nanocrystals' surface functionalization.

    PubMed

    Querner, Claudia; Reiss, Peter; Bleuse, Joël; Pron, Adam

    2004-09-22

    A new family of ligands for the surface functionalization of CdSe nanocrystals is proposed, namely alkyl or aryl derivatives of carbodithioic acids (R-C(S)SH). The main advantages of these new ligands are as follows: they nearly quantitatively exchange the initial surface ligands (TOPO) in very mild conditions; they significantly improve the resistance of nanocrystals against photooxidation because of their ability of strong chelate-type binding to metal atoms; their relatively simple preparation via Grignard intermediates facilitates the development of new bifunctional ligands containing, in addition to the anchoring carbodithioate group, a second function, which enables the grafting of molecules or macromolecules of interest on the nanocrystal surface. To give an example of this approach, we report, for the first time, the grafting of an electroactive oligomer from the polyaniline family-aniline tetramer-on CdSe nanocrystals after their functionalization with 4-formyldithiobenzoic acid. The grafting proceeds via a condensation reaction between the aldehyde group of the ligand and the terminal primary amine group of the tetramer. The resulting organic/inorganic hybrid exhibits complete extinction of the fluorescence of its constituents, indicating efficient charge or energy transfer between the organic and the inorganic semiconductors. PMID:15366904

  3. Chelation in metal intoxication XVI. Influence of chelating agents on chromate poisoned rats

    SciTech Connect

    Tandon, S.K.; Srivastava, L.

    1985-01-01

    The ability of selective polyaminocarboxylic acids and common drugs to reduce the body burden of chromium and restore Cr induced biochemical alterations in chromate intoxicated rats was investigated. 1,2 Cychlohexylene dinitrilotetraacetic acid (CDTA) and triethylenetetramine hexacetic acid (TTHA) were more effective than p-aminosalicylic acid (PAS) and isoniazid (INH) in enhancing urinary excretion of Cr, lowering hepatic and blood levels of Cr and restoring inhibited activity of hepatic aldolase. The chromate antidotal property of chelators seem to be related to the combination of nitrogen and oxygen as the electron donating centres.

  4. Metal chelate process to remove pollutants from fluids

    DOEpatents

    Chang, S.G.T.

    1994-12-06

    The present invention relates to improved methods using an organic iron chelate to remove pollutants from fluids, such as flue gas. Specifically, the present invention relates to a process to remove NO[sub x] and optionally SO[sub 2] from a fluid using a metal ion (Fe[sup 2+]) chelate wherein the ligand is a dimercapto compound wherein the --SH groups are attached to adjacent carbon atoms (HS--C--C--SH) or (SH--C--CCSH) and contain a polar functional group so that the ligand of DMC chelate is water soluble. Alternatively, the DMC is covalently attached to a water insoluble substrate such as a polymer or resin, e.g., polystyrene. The chelate is regenerated using electroreduction or a chemical additive. The dimercapto compound bonded to a water insoluble substrate is also useful to lower the concentration or remove hazardous metal ions from an aqueous solution. 26 figures.

  5. Metal chelate process to remove pollutants from fluids

    DOEpatents

    Chang, Shih-Ger T.

    1994-01-01

    The present invention relates to improved methods using an organic iron chelate to remove pollutants from fluids, such as flue gas. Specifically, the present invention relates to a process to remove NO.sub.x and optionally SO.sub.2 from a fluid using a metal ion (Fe.sup.2+) chelate wherein the ligand is a dimercapto compound wherein the --SH groups are attached to adjacent carbon atoms (HS--C--C--SH) or (SH--C--CCSH) and contain a polar functional group so that the ligand of DMC chelate is water soluble. Alternatively, the DMC' is covalently attached to a water insoluble substrate such as a polymer or resin, e.g., polystyrene. The chelate is regenerated using electroreduction or a chemical additive. The dimercapto compound bonded to a water insoluble substrate is also useful to lower the concentration or remove hazardous metal ions from an aqueous solution.

  6. An efficient chelator for complexation of thorium-227.

    PubMed

    Ramdahl, Thomas; Bonge-Hansen, Hanne T; Ryan, Olav B; Larsen, Smund; Herstad, Gunnar; Sandberg, Marcel; Bjerke, Roger M; Grant, Derek; Brevik, Ellen M; Cuthbertson, Alan S

    2016-09-01

    We present the synthesis and characterization of a highly efficient thorium chelator, derived from the octadentate hydroxypyridinone class of compounds. The chelator forms extremely stable complexes with fast formation rates in the presence of Th-227 (ambient temperature, 20min). In addition, mouse biodistribution data are provided which indicate rapid hepatobiliary excretion route of the chelator which, together with low bone uptake, supports the stability of the complex in vivo. The carboxylic acid group may be readily activated for conjugation through the ɛ-amino groups of lysine residues in biomolecules such as antibodies. This chelator is a critical component of a new class of Targeted Thorium Conjugates (TTCs) currently under development in the field of oncology. PMID:27476138

  7. 3-hydroxy-2(1H)-pyridinone chelating agents

    DOEpatents

    Raymond, K.; Xu, J.

    1999-04-06

    Disclosed is a series of improved chelating agents and the chelates formed from these agents, which are highly effective upon both injection and oral administration. Several of the most effective are of low toxicity. These chelating agents incorporate within their structure 3-hydroxy-2-pyridinone (3,2-HOPO) moieties with a substituted carbamoyl group ortho to the hydroxy group of the hydroxypyridinone ring. The electron-withdrawing carbamoyl group increases the acidity, as well as the chemical stability towards oxidation and reduction, of the hydroxypyridinones. In the metal complexes of the chelating agents, the amide protons form very strong hydrogen bonds with the adjacent HOPO oxygen donor, making these complexes very stable at physiological conditions. The terminal N-substituents provide a certain degree of lipophilicity to the 3,2-HOPO, increasing oral activity. 2 figs.

  8. 3-hydroxy-2(1H)-pyridinone chelating agents

    DOEpatents

    Raymond, Kenneth; Xu, Jide

    1999-01-01

    Disclosed is a series of improved chelating agents and the chelates formed from these agents, which are highly effective upon both injection and oral administration. Several of the most effective are of low toxicity. These chelating agents incorporate within their structure 3-hydroxy-2-pyridinone (3,2-HOPO) moieties with a substituted carbamoyl group ortho to the hydroxy group of the hydroxypyridinone ring. The electron-withdrawing carbamoyl group increases the acidity, as well as the chemical stability towards oxidation and reduction, of the hydroxypyridinones. In the metal complexes of the chelating agents, the amide protons form very strong hydrogen bonds with the adjacent HOPO oxygen donor, making these complexes very stable at physiological conditions. The terminal N-substituents provide a certain degree of lipophilicity to the 3,2-HOPO, increasing oral activity.

  9. Comparing potential copper chelation mechanisms in Parkinson's disease protein

    NASA Astrophysics Data System (ADS)

    Rose, Frisco; Hodak, Miroslav; Bernholc, Jerry

    2011-03-01

    We have implemented the nudged elastic band (NEB) as a guided dynamics framework for our real-space multigrid method of DFT-based quantum simulations. This highly parallel approach resolves a minimum energy pathway (MEP) on the energy hypersurface by relaxing intermediates in a chain-of-states. As an initial application we present an investigation of chelating agents acting on copper ion bound to α -synuclein, whose misfolding is implicated in Parkinson's disease (PD). Copper ions are known to act as highly effective misfolding agents in a-synuclein and are thus an important target in understanding PD. Furthermore, chelation therapy has shown promise in the treatment of Alzheimer's and other neuro-degenerative diseases with similar metal-correlated pathologies. At present, our candidate chelating agents include nicotine, curcumin and clioquinol. We examine their MEP activation barriers in the context of a PD onset mechanism to assess the viability of various chelators for PD remediation.

  10. Strategies for the preparation of bifunctional gadolinium(III) chelators

    PubMed Central

    Frullano, Luca; Caravan, Peter

    2012-01-01

    The development of gadolinium chelators that can be easily and readily linked to various substrates is of primary importance for the development high relaxation efficiency and/or targeted magnetic resonance imaging (MRI) contrast agents. Over the last 25 years a large number of bifunctional chelators have been prepared. For the most part, these compounds are based on ligands that are already used in clinically approved contrast agents. More recently, new bifunctional chelators have been reported based on complexes that show a more potent relaxation effect, faster complexation kinetics and in some cases simpler synthetic procedures. This review provides an overview of the synthetic strategies used for the preparation of bifunctional chelators for MRI applications. PMID:22375102

  11. An Evaluation of the Chelating Agent EDDS for Marigold Production

    Technology Transfer Automated Retrieval System (TEKTRAN)

    Aminopolycarboxylic acid (APCA) ligands (chelating agents) like ethylenediaminetetraacetic acid (EDTA) and diethylenetriaminepentaacetic acid (DTPA) are commonly used in soluble fertilizers to supply copper (Cu), iron (Fe), manganese (Mn), and/or zinc (Zn) to plants. The offsite runoff and contamina...

  12. Cell assay using a two-photon-excited europium chelate

    PubMed Central

    Xiao, Xudong; Haushalter, Jeanne P.; Kotz, Kenneth T.; Faris, Gregory W.

    2011-01-01

    We report application of two-photon excitation of europium chelates to immunolabeling of epidermal growth factor receptor (EGFR) cell surface proteins on A431 cancer cells. The europium chelates are excited with two photons of infrared light and emit in the visible. Europium chelates are conjugated to antibodies for EGFR. A431 (human epidermoid carcinoma) cells are labeled with this conjugate and imaged using a multiphoton microscope. To minimize signal loss due to the relatively long-lived Eu3+ emission, the multiphoton microscope is used with scanning laser two-photon excitation and non-scanning detection with a CCD. The chelate labels show very little photobleaching (less than 1% during continuous illumination in the microscope for 20 minutes) and low levels of autofluorescence (less than 1% of the signal from labeled cells). The detection limit of the europium label in the cell assay is better than 100 zeptomoles. PMID:21833362

  13. Iron chelators ICL670 and 311 inhibit HIV-1 transcription

    SciTech Connect

    Debebe, Zufan; Ammosova, Tatyana; Jerebtsova, Marina; Kurantsin-Mills, Joseph; Niu, Xiaomei; Charles, Sharroya; Richardson, Des R.; Ray, Patricio E.; Gordeuk, Victor R.; Nekhai, Sergei

    2007-10-25

    HIV-1 replication is induced by an excess of iron and iron chelation by desferrioxamine (DFO) inhibits viral replication by reducing proliferation of infected cells. Treatment of cells with DFO and 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone (311) inhibit expression of proteins that regulate cell-cycle progression, including cycle-dependent kinase 2 (CDK2). Our recent studies showed that CDK2 participates in HIV-1 transcription and viral replication suggesting that inhibition of CDK2 by iron chelators might also affect HIV-1 transcription. Here we evaluated the effect of a clinically approved orally effective iron chelator, 4-[3,5-bis-(hydroxyphenyl)-1,2,4-triazol-1-yl]-benzoic acid (ICL670) and 311 on HIV-1 transcription. Both ICL670 and 311 inhibited Tat-induced HIV-1 transcription in CEM-T cells, 293T and HeLa cells. Neither ICL670 nor 311 induced cytotoxicity at concentrations that inhibited HIV-1 transcription. The chelators decreased cellular activity of CDK2 and reduced HIV-1 Tat phosphorylation by CDK2. Neither ICL670A or 311 decreased CDK9 protein level but significantly reduced association of CDK9 with cyclin T1 and reduced phosphorylation of Ser-2 residues of RNA polymerase II C-terminal domain. In conclusion, our findings add to the evidence that iron chelators can inhibit HIV-1 transcription by deregulating CDK2 and CDK9. Further consideration should be given to the development of iron chelators for future anti-retroviral therapeutics.

  14. Extraction of metals using supercritical fluid and chelate forming legand

    DOEpatents

    Wai, Chien M.; Laintz, Kenneth E.

    1998-01-01

    A method of extracting metalloid and metal species from a solid or liquid material by exposing the material to a supercritical fluid solvent containing a chelating agent is described. The chelating agent forms chelates that are soluble in the supercritical fluid to allow removal of the species from the material. In preferred embodiments, the extraction solvent is supercritical carbon dioxide and the chelating agent is a fluorinated .beta.-diketone. In especially preferred embodiments the extraction solvent is supercritical carbon dioxide, and the chelating agent comprises a fluorinated .beta.-diketone and a trialkyl phosphate, or a fluorinated .beta.-diketone and a trialkylphosphine oxide. Although a trialkyl phosphate can extract lanthanides and actinides from acidic solutions, a binary mixture comprising a fluorinated .beta.-diketone and a trialkyl phosphate or a trialkylphosphine oxide tends to enhance the extraction efficiencies for actinides and lanthanides. The method provides an environmentally benign process for removing contaminants from industrial waste without using acids or biologically harmful solvents. The method is particularly useful for extracting actinides and lanthanides from acidic solutions. The chelate and supercritical fluid can be regenerated, and the contaminant species recovered, to provide an economic, efficient process.

  15. Extraction of metals using supercritical fluid and chelate forming ligand

    DOEpatents

    Wai, C.M.; Laintz, K.E.

    1998-03-24

    A method of extracting metalloid and metal species from a solid or liquid material by exposing the material to a supercritical fluid solvent containing a chelating agent is described. The chelating agent forms chelates that are soluble in the supercritical fluid to allow removal of the species from the material. In preferred embodiments, the extraction solvent is supercritical carbon dioxide and the chelating agent is a fluorinated {beta}-diketone. In especially preferred embodiments the extraction solvent is supercritical carbon dioxide, and the chelating agent comprises a fluorinated {beta}-diketone and a trialkyl phosphate, or a fluorinated {beta}-diketone and a trialkylphosphine oxide. Although a trialkyl phosphate can extract lanthanides and actinides from acidic solutions, a binary mixture comprising a fluorinated {beta}-diketone and a trialkyl phosphate or a trialkylphosphine oxide tends to enhance the extraction efficiencies for actinides and lanthanides. The method provides an environmentally benign process for removing contaminants from industrial waste without using acids or biologically harmful solvents. The method is particularly useful for extracting actinides and lanthanides from acidic solutions. The chelate and supercritical fluid can be regenerated, and the contaminant species recovered, to provide an economic, efficient process. 7 figs.

  16. Iron Chelation Adherence to Deferoxamine and Deferasirox in Thalassemia

    PubMed Central

    Trachtenberg, Felicia; Vichinsky, Elliott; Haines, Dru; Pakbaz, Zahra; Mednick, Lauren; Sobota, Amy; Kwiatkowski, Janet; Thompson, Alexis A.; Porter, John; Coates, Thomas; Giardina, Patricia J.; Olivieri, Nancy; Yamashita, Robert; Neufeld, Ellis J.

    2015-01-01

    The Thalassemia Clinical Research Network collected adherence information from 79 patients on deferoxamine and 186 on deferasirox from 2007 to 2009. Chelation adherence was defined as percent of doses administered in the last 4 weeks (patient report) out of those prescribed (chart review). Chelation history since 2002 was available for 97 patients currently on deferoxamine and 217 on deferasirox, with crude estimates of adherence from chart review. Self-reported adherence to both deferoxamine and deferasirox were quite high, with slightly higher adherence to the oral chelator (97 vs. 92%). Ninety percent of patients on deferasirox reported at least 90% adherence, compared with 75% of patients on deferoxamine. Adherence to both chelators was highest in children, followed by adolescents and older adults. Predictors of lower deferoxamine adherence were smoking in the past year, problems sticking themselves (adults only), problems wearing their pump, and fewer transfusions in the past year. Predictors of lower deferasirox adherence were bodily pain and depression. Switching chelators resulted in increased adherence, regardless of the direction of the switch, although switching from deferoxamine to deferasirox was far more common. As adherence to deferoxamine is higher than previously reported, it appears beneficial for patients to have a choice in chelators. PMID:21523808

  17. IN SITU CR(VI) TREATMENT USING A FERROUS IRON-BASED REDUCTANT

    EPA Science Inventory

    Laboratory and field studies were conducted to evaluate the performance of a ferrous sulfate/ sodium hydrosulfite (dithionite) reductant blend in treating a hexavalent chromium (Cr(VI)) source area and Cr(VI) dissolved phase plume at a former industrial site in Charleston, South ...

  18. ELECTRODE MEASUREMENT OF REDOX POTENTIAL IN ANAEROBIC FERRIC/FERROUS CHLORIDE SYSTEMS

    EPA Science Inventory

    The behaviour of two inert redox electrodes (Pt and wax-impregnated graphite) was investigated in anaerobic ferrous and ferric chloride solutions in order to establish if these electrodes respond to the Fe3+/Fe2+ couple in a Nernstian manner. A new method fo...

  19. Effect of purification pretreatment on the recovery of magnetite from waste ferrous sulfate

    NASA Astrophysics Data System (ADS)

    Yu, Wang; Peng, Ying-lin; Zheng, Ya-jie

    2016-08-01

    The present study was conducted to elucidate the influence of impurities in waste ferrous sulfate on its recovery of magnetite. Ferrous sulfate solution was purified by the addition of NaOH solution to precipitate impurities, and magnetite was recovered from ferrous sulfate solution without and with purification pretreatment. Calcium hydroxide was added to the solution of ferrous sulfate as a precipitator. A mixed product of magnetite and gypsum was subsequently obtained by air oxidation and heating. Wet-milling was performed prior to magnetic separation to recover magnetite from the mixed products. The results show that with the purification pretreatment, the grade of iron in magnetite concentrate increased from 62.05% to 65.58% and the recovery rate of iron decreased from 85.35% to 80.35%. The purification pretreatment reduced the conglutination between magnetite and gypsum, which favors their subsequent magnetic separation. In summary, a higher-grade magnetite with a better crystallinity and a larger particle size of 2.35 μm was obtained with the purification pretreatment.

  20. Ceric and ferrous dosimeters show precision for 50-5000 rad range

    NASA Technical Reports Server (NTRS)

    Frigerio, N. A.; Henry, V. D.

    1968-01-01

    Ammonium thiocyanate, added to the usual ferrous sulfate dosimeter solution, yielded a very stable, precise and temperature-independent system eight times as sensitive as the classical Fricke system in the 50 to 5000 rad range. The ceric dosimeters, promising for use in mixed radiation fields, respond nearly independently of LET.

  1. Stabilization of Pb and As in soils by applying combined treatment with phosphates and ferrous iron.

    PubMed

    Xenidis, Anthimos; Stouraiti, Christina; Papassiopi, Nymphodora

    2010-05-15

    The chemical immobilization of Pb and As in contaminated soil from Lavrion, Greece, using monocalcium phosphate and ferrous sulfate as stabilizing agents was investigated. Monocalcium phosphate was added to contaminated soil at PO(4) to Pb molar ratios equal to 0, 0.5, 1, 1.5 and 2.5, whereas ferrous sulfate was added at Fe to As molar ratios equal to 0, 2.5, 5, 10 and 20. Phosphates addition to contaminated soil decreased Pb leachability, but resulted in significant mobilization of As. Simultaneous immobilization of Pb and As was obtained only when soil was treated with mixtures of phosphates and ferrous sulfate. Arsenic uptake by plants was also seen to increase when soil was treated only with phosphates, but co-addition of ferrous sulfate was efficient in maintaining As phytoaccumulation at low levels. The addition of at least 1.5M/M phosphates and 10M/M iron sulfate to soil reduced the dissolved levels of Pb and As in the water extracts to values in compliance with the EU drinking water standards. However, both additives contributed in the acidification of soil, decreasing pH from 7.8 to values as low as 5.6 and induced the mobilization of pH sensitive elements, such as Zn and Cd. PMID:20116921

  2. Non-heme iron as ferrous sulfate does not interact with heme iron absorption in humans.

    PubMed

    Gaitán, Diego; Olivares, Manuel; Lönnerdal, Bo; Brito, Alex; Pizarro, Fernando

    2012-12-01

    The absorption of heme iron has been described as distinctly different from that of non-heme iron. Moreover, whether heme and non-heme iron compete for absorption has not been well established. Our objective was to investigate the potential competition between heme and non-heme iron as ferrous sulfate for absorption, when both iron forms are ingested on an empty stomach. Twenty-six healthy nonpregnant women were selected to participate in two iron absorption studies using iron radioactive tracers. We obtained the dose-response curve for absorption of 0.5, 10, 20, and 50 mg heme iron doses, as concentrated red blood cells. Then, we evaluated the absorption of the same doses, but additionally we added non-heme iron, as ferrous sulfate, at constant heme/non-heme iron molar ratio (1:1). Finally, we compare the two curves by a two-way ANOVA. Iron sources were administered on an empty stomach. One factor analysis showed that heme iron absorption was diminished just by increasing total heme iron (P < 0.0001). The addition of non-heme iron as ferrous sulfate did not have any effect on heme iron absorption (P = NS). We reported evidence that heme and non-heme iron as ferrous sulfate does not compete for absorption. The mechanism behind the absorption of these iron sources is not clear. PMID:22935997

  3. ELECTRODE MEASUREMENT OF REDOX POTENTIAL IN ANAEROBIC FERRIC/FERROUS CHLORIDE SYSTEMS

    EPA Science Inventory

    The behavior of two inert redox electrodes (Pt and wax-impregnated graphite) was investigated in anaerobic ferrous and ferric chloride solutions in order to establish if these electrodes respond to the FE3/Fe2+ couple in a Nernstian nanner. ew method for determining dissolved fer...

  4. Energy conservation and efficiency in Giprokoks designs at Ukrainian ferrous-metallurgical enterprises

    SciTech Connect

    M.I. Fal'kov

    2009-07-15

    Energy conditions at Ukrainian ferrous-metallurgical enterprises are analyzed. Measures to boost energy conservation and energy efficiency are proposed: specifically, the introduction of systems for dry slaking of coke; and steam-gas turbines that employ coke-oven gas or a mixture of gases produced at metallurgical enterprises. Such turbines may be built from Ukrainian components.

  5. ANALYSIS OF FERRIC AND FERROUS IONS IN SOIL EXTRACTS BY ION CHROMATOGRAPHY

    EPA Science Inventory

    A method using ion chromatography (IC) for the analysis of ferrous (Fe 2+) and ferric (Fe 3+) ions in soil extracts has been developed. This method uses an ion exchange column with detection at 520 nm after post-column derivatization. Selectivity is achieved by using an anionic...

  6. 76 FR 31357 - Agency Information Collection Activities: Comment Request for the Ferrous Metals Surveys

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-05-31

    ... Comments On February 22, 2011, we published a Federal Register Notice (76 FR 9810) announcing that we would... Metals Surveys AGENCY: U.S. Geological Survey (USGS), Interior. ACTION: Notice of a revision of a... requirements for the Ferrous Metals Surveys. This collection consists of 17 forms. This notice provides...

  7. ORGANIC EMISSIONS FROM FERROUS METALLURGICAL INDUSTRIES: COMPILATION OF EMISSION FACTORS AND CONTROL TECHNOLOGIES

    EPA Science Inventory

    The report gives results of a review and analysis of the information and data available in the public domain on organic emissions from the ferrous metallurgy industry, specifically the iron and steel, iron foundry, and ferroalloy industries. Emission sources and information gaps ...

  8. Martian weathering/alteration scenarios from spectral studies of ferric and ferrous minerals

    NASA Technical Reports Server (NTRS)

    Bell, James F., III; Adams, John B.; Morris, Richard V.

    1992-01-01

    We review the major aspects of our current knowledge of martian ferric and ferrous mineralogy based on the available ground-based telescopic and spacecraft data. What we know and what we don't know are used to constrain various weathering/alteration models and to identify key future measurements and techniques that can distinguish between these models.

  9. The magnesium chelation step in chlorophyll biosynthesis

    SciTech Connect

    Weinstein, J.

    1990-11-01

    In photosynthetic organisms, the biogenesis of energy transducing membranes requires the coordinate synthesis of prosthetic groups, proteins, and various lipids. Two of the major prosthetic groups, chlorophyll and heme, share a common biosynthetic pathway that diverges at the point of metal insertion into protoporphyrin IX (Proto). Insertion of iron leads to the formation of hemes, while insertion of magnesium is the first step unique to chlorophyll formation. This project is directed toward identifying the enzyme(s) responsible for magnesium chelation and elucidating the mechanism which regulates the flux of precursors through the branch point enzymes in isolated chloroplasts. Using intact chloroplasts from greening cucumber cotyledons, we have confirmed the ATP requirement for Mg-Proto formation. Use of non-hydrolyzable ATP analogs, uncouplers and ionophores has led to the conclusions that ATP hydrolysis is necessary, but that this hydrolysis is not linked to the requirement for membrane intactness by transmembrane ion gradients or electrical potentials. The enzyme(s) are flexible with respect to the porphyrin substrate specificity, accepting porphyrins with -vinyl, -ethyl, or -H substituents at the 2 and 4 positions. The activity increases approximately four-fold during greening. Possible physiological feedback inhibitors such as heme, protochlorophyllide, and chlorophyllide had no specific effect on the activity. The activity has now been assayed in barely, corn and peas, with the system from peas almost ten-fold more active than the cucumber system. Work is continuing in pea chloroplasts with the development of a continuous assay and investigation of the feasibility of characterizing an active, organelle-free preparation. 6 figs.

  10. Bifunctional Chelates Optimized for Molecular MRI

    PubMed Central

    2015-01-01

    Important requirements for exogenous dyes or contrast agents in magnetic resonance imaging (MRI) include an effective concentration of paramagnetic or superparamagnetic ions at the target to be imaged. We report the concise synthesis and characterization of several new enantiopure bifunctional derivatives of (α1R,α4R,α7R,α10R)-α1,α4,α7,α10-tetramethyl-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTMA) (and their 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) analogues as controls) that can be covalently attached to a contrast agent delivery system using either click or peptide coupling chemistry. Gd complexes of these derivatives can be attached to delivery systems while maintaining optimal water residence time for increased molecular imaging sensitivity. Long chain biotin (LC-biotin) derivatives of the Eu(III) and Gd(III) chelates associated with avidin are used to demonstrate higher efficiencies. Variable-temperature relaxometry, 17O NMR, and nuclear magnetic resonance dispersion (NMRD) spectroscopy used on the complexes and biotin–avidin adducts measure the influence of water residence time and rotational correlation time on constrained and unconstrained systems. The Gd(III)-DOTMA derivative has a shorter water residence time than the Gd(III)-DOTA derivative. Compared to the constrained Gd(III)-DOTA derivatives, the rotationally constrained Gd(III)-DOTMA derivative has ∼40% higher relaxivity at 37 °C, which could increase its sensitivity as an MRI agent as well as reduce the dose of the targeting agent. PMID:24933389

  11. Method for preparing radionuclide-labeled chelating agent-ligand complexes

    DOEpatents

    Meares, Claude F.; Li, Min; DeNardo, Sally J.

    1999-01-01

    Radionuclide-labeled chelating agent-ligand complexes that are useful in medical diagnosis or therapy are prepared by reacting a radionuclide, such as .sup.90 Y or .sup.111 In, with a polyfunctional chelating agent to form a radionuclide chelate that is electrically neutral; purifying the chelate by anion exchange chromatography; and reacting the purified chelate with a targeting molecule, such as a monoclonal antibody, to form the complex.

  12. Effect of calcium oxide on the efficiency of ferrous ion oxidation and total iron precipitation during ferrous ion oxidation in simulated acid mine drainage treatment with inoculation of Acidithiobacillus ferrooxidans.

    PubMed

    Liu, Fenwu; Zhou, Jun; Jin, Tongjun; Zhang, Shasha; Liu, Lanlan

    2016-01-01

    Calcium oxide was added into ferrous ion oxidation system in the presence of Acidithiobacillus ferrooxidans at concentrations of 0-4.00 g/L. The pH, ferrous ion oxidation efficiency, total iron precipitation efficiency, and phase of the solid minerals harvested from different treatments were investigated during the ferrous ion oxidation process. In control check (CK) system, pH of the solution decreased from 2.81 to 2.25 when ferrous ions achieved complete oxidation after 72 h of Acidithiobacillus ferrooxidans incubation without the addition of calcium oxide, and total iron precipitation efficiency reached 20.2%. Efficiency of ferrous ion oxidation and total iron precipitation was significantly improved when the amount of calcium oxide added was ≤1.33 g/L, and the minerals harvested from systems were mainly a mixture of jarosite and schwertmannite. For example, the ferrous ion oxidation efficiency reached 100% at 60 h and total iron precipitation efficiency was increased to 32.1% at 72 h when 1.33 g/L of calcium oxide was added. However, ferrous ion oxidation and total iron precipitation for jarosite and schwertmannite formation were inhibited if the amount of calcium oxide added was above 2.67 g/L, and large amounts of calcium sulfate dihydrate were generated in systems. PMID:27003087

  13. Ferrous Carbonyl Dithiolates as Precursors to FeFe, FeCo, and FeMn Carbonyl Dithiolates

    PubMed Central

    2015-01-01

    Reported are complexes of the formula Fe(dithiolate)(CO)2(diphos) and their use to prepare homo- and heterobimetallic dithiolato derivatives. The starting iron dithiolates were prepared by a one-pot reaction of FeCl2 and CO with chelating diphosphines and dithiolates, where dithiolate = S2(CH2)22– (edt2–), S2(CH2)32– (pdt2–), S2(CH2)2(C(CH3)2)2– (Me2pdt2–) and diphos = cis-C2H2(PPh2)2 (dppv), C2H4(PPh2)2 (dppe), C6H4(PPh2)2 (dppbz), C2H4[P(C6H11)2]2 (dcpe). The incorporation of 57Fe into such building block complexes commenced with the conversion of 57Fe into 57Fe2I4(iPrOH)4, which then was treated with K2pdt, CO, and dppe to give 57Fe(pdt)(CO)2(dppe). NMR and IR analyses show that these complexes exist as mixtures of all-cis and trans-CO isomers, edt2– favoring the former and pdt2– the latter. Treatment of Fe(dithiolate)(CO)2(diphos) with the Fe(0) reagent (benzylideneacetone)Fe(CO)3 gave Fe2(dithiolate)(CO)4(diphos), thereby defining a route from simple ferrous salts to models for hydrogenase active sites. Extending the building block route to heterobimetallic complexes, treatment of Fe(pdt)(CO)2(dppe) with [(acenaphthene)Mn(CO)3]+ gave [(CO)3Mn(pdt)Fe(CO)2(dppe)]+ ([3d(CO)]+). Reduction of [3d(CO)]+ with BH4– gave the Cs-symmetric μ-hydride (CO)3Mn(pdt)(H)Fe(CO)(dppe) (H3d). Complex H3d is reversibly protonated by strong acids, the proposed site of protonation being sulfur. Treatment of Fe(dithiolate)(CO)2(diphos) with CpCoI2(CO) followed by reduction by Cp2Co affords CpCo(dithiolate)Fe(CO)(diphos) (4), which can also be prepared from Fe(dithiolate)(CO)2(diphos) and CpCo(CO)2. Like the electronically related (CO)3Fe(pdt)Fe(CO)(diphos), these complexes undergo protonation to afford the μ-hydrido complexes [CpCo(dithiolate)HFe(CO)(diphos)]+. Low-temperature NMR studies indicate that Co is the kinetic site of protonation. PMID:24803716

  14. Highly regioselective hydroformylation with hemispherical chelators.

    PubMed

    Sémeril, David; Matt, Dominique; Toupet, Loïc

    2008-01-01

    The hemispherical diphosphites (R,R)- or (S,S)-5,11,17,23-tetra-tert-butyl-25,27-di(OR)-26,28-bis(1,1'-binaphthyl-2,2'-dioxyphosphanyloxy)calix[4]arene (R=OPr, OCH(2)Ph, OCH(2)-naphtyl, O-fluorenyl; R=H, R'=OPr) (L(R)), all with C(2) symmetry, have been synthesised starting from the appropriate di-O-alkylated calix[4]arene precursor. In the presence of [Rh(acac)(CO)(2)], these ligands straightforwardly provide chelate complexes in which the metal centre sits in a molecular pocket defined by two naphthyl planes related by the C(2) axis and the two apically situated R groups. Hydroformylation of octene with the L(Pr)/Rh system turned out to be highly regioselective, the linear-to-branched (l:b) aldehyde ratio reaching 58:1. The l:b ratio significantly increased when the propyl groups were replaced by -CH(2)Ph (l:b=80) or -CH(2)naphthyl (l:b=100) groups, that is, with substituents able to sterically interact with the apical metal sites, but without inducing an opening of the cleft nesting the catalytic centre. The trend to preferentially form the aldehyde the shape of which fits with the shape of the catalytic pocket was further confirmed in the hydroformylation of styrene, for which, in contrast to catalysis with conventional diphosphanes, the linear aldehyde was the major product (up to ca. 75 % linear aldehyde). In the hydroformylation of trans-2-octene with the L(benzyl)/Rh system, combined isomerisation/hydroformylation led to a remarkably high l:b aldehyde ratios of 25, thus showing that isomerisation is more effective than hydroformylation. Unusually large amounts of linear products were also observed with all the above diphosphites in the tandem hydroformylation/amination of styrene (l:b of ca. 3:1) as well as in the hydroformylation of allyl benzyl ether (l:b ratio up to 20). PMID:18686280

  15. Oxidation-Induced Degradable Nanogels for Iron Chelation

    PubMed Central

    Liu, Zhi; Wang, Yan; Purro, Max; Xiong, May P.

    2016-01-01

    Iron overload can increase cellular oxidative stress levels due to formation of reactive oxygen species (ROS); untreated, it can be extremely destructive to organs and fatal to patients. Since elevated oxidative stress levels are inherent to the condition in such patients, oxidation-induced degradable nanogels for iron chelation were rationally designed by simultaneously polymerizing oxidation-sensitive host-guest crosslinkers between β-cyclodextrin (β-CD) and ferrocene (Fc) and iron chelating moieties composed of deferoxamine (DFO) into the final gel scaffold in reverse emulsion reaction chambers. UV-Vis absorption and atomic absorption spectroscopy (AAS) was used to verify iron chelating capability of nanogels. These materials can degrade into smaller chelating fragments at rates proportional to the level of oxidative stress present. Conjugating DFO reduces the cytotoxicity of the chelator in the macrophage cells. Importantly, the nanogel can effectively reduce cellular ferritin expression in iron overloaded cells and regulate intracellular iron levels at the same time, which is important for maintaining a homeostatic level of this critical metal in cells. PMID:26868174

  16. Ab Initio Coordination Chemistry for Nickel Chelation Motifs

    PubMed Central

    Jesu Jaya Sudan, R.; Lesitha Jeeva Kumari, J.; Sudandiradoss, C.

    2015-01-01

    Chelation therapy is one of the most appreciated methods in the treatment of metal induced disease predisposition. Coordination chemistry provides a way to understand metal association in biological structures. In this work we have implemented coordination chemistry to study nickel coordination due to its high impact in industrial usage and thereby health consequences. This paper reports the analysis of nickel coordination from a large dataset of nickel bound structures and sequences. Coordination patterns predicted from the structures are reported in terms of donors, chelate length, coordination number, chelate geometry, structural fold and architecture. The analysis revealed histidine as the most favored residue in nickel coordination. The most common chelates identified were histidine based namely HHH, HDH, HEH and HH spaced at specific intervals. Though a maximum coordination number of 8 was observed, the presence of a single protein donor was noted to be mandatory in nickel coordination. The coordination pattern did not reveal any specific fold, nevertheless we report preferable residue spacing for specific structural architecture. In contrast, the analysis of nickel binding proteins from bacterial and archeal species revealed no common coordination patterns. Nickel binding sequence motifs were noted to be organism specific and protein class specific. As a result we identified about 13 signatures derived from 13 classes of nickel binding proteins. The specifications on nickel coordination presented in this paper will prove beneficial for developing better chelation strategies. PMID:25985439

  17. Essential Metalloelement Chelates Facilitate Repair of Radiation Injury

    PubMed Central

    Soderberg, Lee S. F.; Chang, Louis W.; Walker, Richard B.

    2001-01-01

    Treatment with essential metalloelement (Cu, Fe, Mn, and Zn) chelates or combinations of them before and/or after radiation injury is a useful approach to overcoming radiation injury. No other agents are known to increase survival when they are used to treat after irradiation, in a radiorecovery treatment paradigm. These chelates may be useful in facilitating de novo syntheses of essential metalloelement-dependent enzymes required to repair radiation injury. Reports of radioprotection, which involves treatment before irradiation, with calcium-channel blockers, acyl Melatonin homologs, and substituted anilines, which may serve as chelating agents after biochemical modification in vivo, as well as Curcumin, which is a chelating agent, have been included in this review. These inclusions are intended to suggest additional approaches to combination treatments that may be useful in facilitating radiation recovery. These approaches to radioprotection and radiorecovery offer promise in facilitating recovery from radiation-induced injury experienced by patients undergoing radiotherapy for neoplastic disease and by individuals who experience environmental, occupational, or accidental exposure to ultraviolet, x-ray, or γ-ray radiation. Since there are no existing treatments of radiation-injury intended to facilitate tissue repair, studies of essential metalloelement chelates and combinations of them, as well as combinations of them with existing organic radioprotectants, seem worthwhile. PMID:18475999

  18. 3-hydroxy-2(1H)-pyridinone chelating agents

    DOEpatents

    Raymond, Kenneth N.; Xu, Jide

    1997-01-01

    Disclosed is a series of improved metal chelating agents, which are highly effective upon both injection and oral administration; several of the most effective are of low toxicity. These chelating agents incorporate within their structure 1-hydroxy-2-pyridinone (1,2-HOPO) and 3-hydroxy-2-pyridinone (3,2-HOPO) moieties with a substituted carbamoyl group ortho to the hydroxy or oxo groups of the hydroxypyridinone ring. The electron-withdrawing carbamoyl group increases the acidity of the hydroxypyridinones. In the metal complexes of said chelating agents, the amide protons form very strong hydrogen bonds with its adjacent HOPO oxygen donor, making these complexes very stable at physiological conditions. The terminal N-substituents provides a certain degree of lipophilicity to said 3,2-HOPO, increasing oral activity. Also disclosed is a method of making the chelating agents and a method of producing a known compound, 3-hydroxy-1-alkyl-2(1H)pyridinone, used as a precursor to the chelating agent, safely and in large quantities.

  19. 3-hydroxy-2(1H)-pyridinone chelating agents

    DOEpatents

    Raymond, K.N.; Xu, J.

    1997-04-29

    Disclosed is a series of improved metal chelating agents, which are highly effective upon both injection and oral administration; several of the most effective are of low toxicity. These chelating agents incorporate within their structure 1-hydroxy-2-pyridinone (1,2-HOPO) and 3-hydroxy-2-pyridinone (3,2-HOPO) moieties with a substituted carbamoyl group ortho to the hydroxy or oxo groups of the hydroxypyridinone ring. The electron-withdrawing carbamoyl group increases the acidity of the hydroxypyridinones. In the metal complexes of the chelating agents, the amide protons form very strong hydrogen bonds with its adjacent HOPO oxygen donor, making these complexes very stable at physiological conditions. The terminal N-substituents provides a certain degree of lipophilicity to the 3,2-HOPO, increasing oral activity. Also disclosed is a method of making the chelating agents and a method of producing a known compound, 3-hydroxy-1-alkyl-2(1H)pyridinone, used as a precursor to the chelating agent, safely and in large quantities. 2 figs.

  20. Removal of phosphorus from wastewaters using ferrous salts - a pilot scale membrane bioreactor study.

    PubMed

    Wang, Yuan; Tng, K Han; Wu, Hao; Leslie, Greg; Waite, T David

    2014-06-15

    A pilot scale membrane bioreactor (3.7 m(3)/day capacity), configured for alternate point ferrous sulphate addition, was evaluated in a fourteen month trial to comply with an effluent discharge requirement of less than 0.15 mg-P/L at the 50(th) percentile and less than 0.30 mg-P/L at the 90th percentile. Ferrous sulphate was added at a molar ratio (Fe(II):PO4) of 2.99 in the filtration chamber for 85 days and 2.60 in the primary anoxic zone for 111 days. Addition of ferrous salts to the anoxic zone achieved a final effluent phosphorous concentration (mg-P/L) of <0.05 (29%), <0.15 (77%) and <0.30 (95%), while addition of ferrous salts in the filtration zone achieved <0.05 (18%), <0.15 (63%) and <0.30 (95%). Analysis of the concentration of iron(II) in the supernatant indicated that phosphorus was mainly removed via adsorption to amorphous iron oxyhydroxides particles in both dosing scenarios. However, analysis of residence time distribution (RTD) data of the reactor indicated that severe short-circuiting from the dosing point to the membrane outlet could occur when the ferrous salts were added to the membrane zone while the reactor behaved close to a completely mixed reactor when dosing to the primary anoxic zone, resulting in improved phosphorus removal. The addition of ferrous salt was also found to delay the onset of severe increase in trans-membrane pressure as a result of the removal of macro-molecules. However, detailed analysis of the form and concentration of iron species in the supernatant and permeate indicated that the presence of fine iron particles resulted in a higher fouling rate when Fe(II) was added to the membrane zone rather than the primary anoxic zone and could cause more severe irreversible fouling in long-term operation. PMID:24709534

  1. Media composition: antioxidants/chelators and cellular function.

    PubMed

    Combelles, Catherine M H; Hennet, Margo L

    2012-01-01

    Protection of embryos against oxidative insults during culture is necessary to maintain viability. Generation of excessive levels of reactive oxygen species (ROS) is triggered by various components of the in vitro environment, most of which embryos do not normally encounter in vivo. To compensate for these deficiencies in the culture environment, antioxidants and chelators are often used to control or suppress ROS levels as embryos develop. However, there is no consensus regarding dosage, time of exposure, or appropriate combinations of antioxidants and chelators in embryo culture. In order to elucidate this aspect of an embryo's chemical surroundings in vitro, we present the current knowledge on the function and effect of each antioxidant or chelator that is often included in an embryo culture medium. PMID:22829373

  2. Iron chelation inhibits the development of pulmonary vascular remodeling.

    PubMed

    Wong, Chi-Ming; Preston, Ioana R; Hill, Nicholas S; Suzuki, Yuichiro J

    2012-11-01

    Reactive oxygen species (ROS) have been implicated in the pathogenesis of pulmonary hypertension. Because iron is an important regulator of ROS biology, this study examined the effects of iron chelation on the development of pulmonary vascular remodeling. The administration of an iron chelator, deferoxamine, to rats prevented chronic hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling. Various iron chelators inhibited the growth of cultured pulmonary artery smooth muscle cells. Protein carbonylation, an important iron-dependent biological event, was promoted in association with pulmonary vascular remodeling and cell growth. A proteomic approach identified that Rho GDP-dissociation inhibitor (a negative regulator of RhoA) is carbonylated. In human plasma, the protein carbonyl content was significantly higher in patients with idiopathic pulmonary arterial hypertension than in healthy controls. These results suggest that iron plays an important role in the ROS-dependent mechanism underlying the development of pulmonary hypertension. PMID:22974762

  3. The effect of iron overload and chelation on erythroid differentiation.

    PubMed

    Taoka, Kazuki; Kumano, Keiki; Nakamura, Fumihiko; Hosoi, Masataka; Goyama, Susumu; Imai, Yoichi; Hangaishi, Akira; Kurokawa, Mineo

    2012-02-01

    We investigated the mechanisms of hematopoietic disorders caused by iron overload and chelation, in particular, the inhibition of erythroblast differentiation. Murine c-kit(+) progenitor cells or human CD34(+) peripheral blood hematopoietic progenitors were differentiated in vitro to the erythroid lineage with free iron and/or an iron chelator. Under iron overload, formation of erythroid burst-forming unit colonies and differentiation to mature erythroblasts were significantly suppressed; these effects were canceled by iron chelation with deferoxamine (DFO). Moreover, excessive iron burden promoted apoptosis in immature erythroblasts by elevating intracellular reactive oxygen species (ROS). Interestingly, both DFO and a potent anti-oxidant agent reduced intracellular ROS levels and suppressed apoptosis, thus restoring differentiation to mature erythroblasts. Accordingly, intracellular ROS may represent a new therapeutic target in the treatment of iron overload. PMID:22193844

  4. Molecular nanotechnologies of gelatin-immobilization using macrocyclic metal chelates

    PubMed Central

    Mikhailov, Oleg V.

    2014-01-01

    This article is a review of recent developments in the self-assembled nanostructures based on chelate coordination compounds. Molecular nanotechnologies of self-assembly of 3d-element aza- and thiazametalmacrocyclic complexes that happen in nanoreactors on the basis of metal hexacyanoferrate(II) gelatin-immobilized matrix under their contact with water solutions containing various (N,O,S)-donor atomic ligands and organic compounds having one or two carbonyl groups have been considered in this review. It has been noted that the assortment of macrocyclic metal chelates obtained as a result of using molecular nanotechnologies in such specific conditions considerably differs from the assortment of metal chelates formed at the conditions traditional for chemical synthesis. PMID:24516711

  5. Polyvalent metal ion chelating agents for xanthan solutions

    SciTech Connect

    Miller, J.W.; Tate, B.E.

    1984-08-21

    A stable xanthan solution with superior filterability and subterranean injectivity characteristics comprises biopolymer and a chelating agent selected from aliphatic alpha-hydroxy acids having from about 2-7 carbon atoms; aliphatic and aromatic beta-keto compounds having from about 4-9 carbon atoms; or 2- and 4-pyrones having a hydroxyl group alpha to the carbonyl and having 5 or 6 carbon atoms; said chelating agent being present in an amount of at least about 1.0 ppm of the total solution. A method of enhancing oil recovery comprising employing as a mobility control solution in oil-bearing formations a mixture of xanthan biopolymer and a chelating agent is also disclosed.

  6. Dissociation of gadolinium chelates in mice: relationship to chemical characteristics.

    PubMed

    Wedeking, P; Kumar, K; Tweedle, M F

    1992-01-01

    Tissue distributions of seven 153Gd-labeled Gd chelates were determined at five residence intervals (5 min to 14 days) following intravenous administration of 0.4 mmol/kg to mice. Relationships were sought among physicochemical parameters: thermodynamic and conditional (pH 7.4) equilibrium stability constants (log K and log K'), acid dissociation rate constants (k(obs)), lipophilicity (log P), overall charge, and size (molecular weight). Size and lipophilicity did not correlate with tissue distributions. There were possible correlations between anionic charge and rapid, early renal excretion and between stability constants and long-term residual Gd deposition. Strong correlations (r greater than 0.99) were found between acid dissociation rates and long-term deposition of Gd in the whole body, liver, and femur. This is attributed to dissociation of Gd from the chelates in vivo. Acid dissociation rates may be useful in predicting dissociation of Gd from chelates in vivo. PMID:1501535

  7. Clinical monitoring and management of complications related to chelation therapy in patients with β-thalassemia.

    PubMed

    Saliba, Antoine N; El Rassi, Fuad; Taher, Ali T

    2016-01-01

    Iron chelating agents - deferoxamine (DFO), deferiprone (DFP), and deferasirox (DFX) - are used to treat chronic iron overload in patients with β-thalassemia in an attempt to reduce morbidity and mortality related to siderosis. Each of the approved iron chelating agents has its own advantages over the others and also has its own risks, whether related to over-chelation or not. In this review, we briefly discuss the methods to monitor the efficacy of iron chelation therapy (ICT) and the evidence behind the use of each iron chelating agent. We also portray the risks and complications associated with each iron chelating agent and recommend strategies to manage adverse events. PMID:26613264

  8. A modified ferrous oxidation-xylenol orange assay for lipoxygenase activity in rice grains.

    PubMed

    Timabud, Tarinee; Sanitchon, Jirawat; Pongdontri, Paweena

    2013-12-01

    Ferrous oxidation-xylenol orange assay reagent was reformulated by using spectral analysis of ferric-xylenol orange complex to detect low concentrations of lipoxygenase rice grain products. Reducing the levels of ferrous sulphate and xylenol orange in the FOX reagent enabled the detection of low concentrations of hydroperoxy fatty acid derived from lipoxygenase activity in the range of 0.1-1.5 μM. Protein, substrate and time courses of the modified FOX assay were studied to determine lipoxygenase activity in rice grain. The assay was also applicable as a high throughput technique for comparisons of lipoxygenase activity from various rice varieties. This has important implications for rapid screening for low-lipoxygenase containing rice cultivars in rice breeding program and grain quality during storage. PMID:23870974

  9. Ferrous arrowheads and their oil quench hardening: Some early Indian evidence

    NASA Astrophysics Data System (ADS)

    Dube, R. K.

    2008-05-01

    A wide variety of ferrous arrowheads were in use in ancient India. Several typical chemical analyses of arrowheads found from archaeological excavation carried out at Kaushambi are reported in this paper. The average carbon content of these arrowheads varied from as low as 0.1 wt.% to approximately 0.9 wt.%. Literary evidence for oil quench hardening of ferrous arrowheads, as reported in famous Sanskrit epics—the Rāmāyana and the Mahābhārata—have been discussed in this paper. This type of quench hardening was intentionally adopted as it helped in preventing distortion and formation of quench cracks in arrowheads. The oil quench-hardened arrowheads were rubbed on stones to sharpen them, which also brought about tempering of martensite due to frictional heat.

  10. Possible Association of Ferrous Phosphates and Ferric Sulfates in S-rich Soil on Mars

    NASA Astrophysics Data System (ADS)

    Mao, J.; Schroeder, C.; Haderlein, S.

    2012-12-01

    NASA Mars Exploration Rover (MER) Spirit explored Gusev Crater to look for signs of ancient aqueous activity, assess past environmental conditions and suitability for life. Spirit excavated light-toned, S-rich soils at several locations. These are likely of hydrothermal, possibly fumarolic origin. At a location dubbed Paso Robles the light-toned soil was also rich in P - a signature from surrounding rock. While S is mainly bound in ferric hydrated sulfates [1], the mineralogy of P is ill-constrained [2]. P is a key element for life and its mineralogy constrains its availability. Ferrous phases observed in Paso Robles Mössbauer spectra may represent olivine and pyroxene from surrounding basaltic soil [1] or ferrous phosphate minerals [3]. Phosphate is well-known to complex and stabilize Fe 2+ against oxidation to Fe 3+ . Schröder et al. [3] proposed a formation pathway of ferrous phosphate/ferric sulfate associations: sulfuric acid reacts with basalt containing apatite, forming CaSO4 and phosphoric acid. The phosphoric and/or excess sulfuric acid reacts with olivine, forming Fe2+-phosphate and sulfate. The phosphate is less soluble and precipitates. Ferrous sulfate remains in solution and is oxidized as pH increases. To verify this pathway, we dissolved Fe2+-chloride and Na-phosphate salts in sulfuric acid inside an anoxic glovebox. The solution was titrated to pH 6 by adding NaOH when a first precipitate formed, which was ferrous phosphate according to Mössbauer spectroscopy (MB). At that point the solution was removed from the glovebox and allowed to evaporate in the presence of atmospheric oxygen, leading to the oxidation of Fe2+. The evaporation rate was controlled by keeping the suspensions at different temperatures; pH was monitored during the evaporation process. The final precipitates were analyzed by MB and X-Ray Fluorescence (XRF), comparable to MER MB and Alpha Particle X-ray Spectrometer instrument datasets, and complementary techniques such as X

  11. Pilot-plant study of wastewater sludge decontamination using a ferrous sulfate bioleaching process.

    PubMed

    Mercier, Guy; Drogui, Patrick; Blais, Jean-François; Chartier, Myriam

    2006-08-01

    The objective of this research was to investigate the performance of the ferrous sulfate bioleaching (FSBL) process in a pilot plant for decontamination and stabilization of wastewater sludge. Batch and continuous experiments, conducted with two 4-m3 bioreactors using indigenous iron-oxidizing bacteria (20% v/v of inoculum) with addition of 4.0 g ferrous sulfate heptahydrate per liter of sludge initially acidified to pH 4.0, were sufficient for effective heavy metal (cadmium, copper, manganese, zinc, and lead) removal yields. The average metal removal yields during the FSBL process were as follows: cadmium (69 to 75%), copper (68 to 70%), manganese (72 to 73%), zinc (65 to 66%), and lead (16%). The FSBL process was also found to be effective in removing both fecal and total coliforms (abatement > 5 to 6 log units). The nutrients content (nitrogen, phosphorus, and magnesium) were also preserved in decontaminated sludge. PMID:17059142

  12. Iron chelators ICL670 and 311 inhibit HIV-1 transcription.

    PubMed

    Debebe, Zufan; Ammosova, Tatyana; Jerebtsova, Marina; Kurantsin-Mills, Joseph; Niu, Xiaomei; Charles, Sharroya; Richardson, Des R; Ray, Patricio E; Gordeuk, Victor R; Nekhai, Sergei

    2007-10-25

    HIV-1 replication is induced by an excess of iron and iron chelation by desferrioxamine (DFO) inhibits viral replication by reducing proliferation of infected cells. Treatment of cells with DFO and 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone (311) inhibit expression of proteins that regulate cell-cycle progression, including cycle-dependent kinase 2 (CDK2). Our recent studies showed that CDK2 participates in HIV-1 transcription and viral replication suggesting that inhibition of CDK2 by iron chelators might also affect HIV-1 transcription. Here we evaluated the effect of a clinically approved orally effective iron chelator, 4-[3,5-bis-(hydroxyphenyl)-1,2,4-triazol-1-yl]-benzoic acid (ICL670) and 311 on HIV-1 transcription. Both ICL670 and 311 inhibited Tat-induced HIV-1 transcription in CEM-T cells, 293T and HeLa cells. Neither ICL670 nor 311 induced cytotoxicity at concentrations that inhibited HIV-1 transcription. The chelators decreased cellular activity of CDK2 and reduced HIV-1 Tat phosphorylation by CDK2. Neither ICL670A or 311 decreased CDK9 protein level but significantly reduced association of CDK9 with cyclin T1 and reduced phosphorylation of Ser-2 residues of RNA polymerase II C-terminal domain. In conclusion, our findings add to the evidence that iron chelators can inhibit HIV-1 transcription by deregulating CDK2 and CDK9. Further consideration should be given to the development of iron chelators for future anti-retroviral therapeutics. PMID:17631934

  13. Heavy metal displacement in chelate-irrigated soil during phytoremediation

    NASA Astrophysics Data System (ADS)

    Madrid, F.; Liphadzi, M. S.; Kirkham, M. B.

    2003-03-01

    Heavy metals in wastewater sewage sludge (biosolids), applied to land, contaminate soils. Phytoremediation, the use of plants to clean up toxic heavy metals, might remove them. Chelating agents are added to soil to solubilize the metals for enhanced phytoextraction. Yet no studies follow the displacement and leaching of heavy metals in soil with and without roots following solubilization with chelates. The objective of this work was to determine the mobility of heavy metals in biosolids applied to the surface of soil columns (76 cm long; 17 cm diam.) with or without plants (barley; Hordeum vulgare L.). Three weeks after barley was planted, all columns were irrigated with the disodium salt of the chelating agent, EDTA (ethylenediamine tetraacetic acid) (0.5 g/kg soil). Drainage water, soil, and plants were analyzed for heavy metals (Cd, Cu, Fe, Mn, Ni, Pb, Zn). Total concentrations of the heavy metals in all columns at the end of the experiment generally were lower in the top 30 cm of soil with EDTA than without EDTA. The chelate increased concentrations of heavy metals in shoots. With or without plants, the EDTA mobilized Cd, Fe, Mn, Ni, Pb, and Zn, which leached to drainage water. Drainage water from columns without EDTA had concentrations of these heavy metals below detection limits. Only Cu did not leach in the presence of EDTA. Even though roots retarded the movement of Cd, Fe, Mn, Ni, Pb, and Zn through the EDTA-treated soil from 1 d (Cd) to 5 d (Fe), the drainage water from columns with EDTA had concentrations of Cd, Fe, Mn, and Pb that exceeded drinking water standards by 1.3, 500, 620, and 8.6 times, respectively. Because the chelate rendered Cd, Fe, Mn, Ni, Pb, and Zn mobile, it is suggested that the theory for leaching of soluble salts, put forward by Nielsen and associates in 1965, could be applied to control movement of the heavy metals for maximum uptake during chelate-assisted phytoremediation.

  14. Lauriston S. Taylor Lecture: the quest for therapeutic actinide chelators.

    PubMed

    Durbin, Patricia W

    2008-11-01

    All of the actinides are radioactive. Taken into the body, they damage and induce cancer in bone and liver, and in the lungs if inhaled, and U(VI) is a chemical kidney poison. Containment of radionuclides is fundamental to radiation protection, but if it is breached accidentally or deliberately, decontamination of exposed persons is needed to reduce the consequences of radionuclide intake. The only known way to reduce the health risks of internally deposited actinides is to accelerate their excretion with chelating agents. Ethylendiaminetetraacetic acid (EDTA) and diethylenetriaminepentaacetic acid (DTPA) were introduced in the 1950's. DTPA is now clinically accepted, but its oral activity is low, it must be injected as a Ca(II) or Zn(II) chelate to avoid toxicity, and it is structurally unsuitable for chelating U(VI) or Np(V). Actinide penetration into the mammalian iron transport and storage systems suggested that actinide ions would form stable complexes with the Fe(III)-binding units found in potent selective natural iron chelators (siderophores). Testing of that biomimetic approach began in the late 1970's with the design, production, and assessment for in vivo Pu(IV) chelation of synthetic multidentate ligands based on the backbone structures and Fe(III)-binding groups of siderophores. New efficacious actinide chelators have emerged from that program, in particular, octadentate 3,4,3-LI(1,2-HOPO) and tetradentate 5-LIO(Me-3,2-HOPO) have potential for clinical acceptance. Both are much more effective than CaNa3-DTPA for decorporation of Pu(IV), Am(III), U(VI), and Np(IV,V), they are orally active, and toxicity is acceptably low at effective dosage. PMID:18849679

  15. Combinational chelation therapy abrogates lead-induced neurodegeneration in rats.

    PubMed

    Pachauri, Vidhu; Saxena, Geetu; Mehta, Ashish; Mishra, Deepshikha; Flora, Swaran J S

    2009-10-15

    Lead, a ubiquitous and potent neurotoxicant causes oxidative stress which leads to numerous neurobehavioral and physiological alterations. The ability of lead to bind sulfhydryl groups or compete with calcium could be one of the reasons for its debilitating effects. In the present study, we addressed: i) if chelation therapy could circumvent the altered oxidative stress and prevent neuronal apoptosis in chronic lead-intoxicated rats, ii) whether chelation therapy could reverse biochemical and behavioral changes, and iii) if mono or combinational therapy with captopril (an antioxidant) and thiol chelating agents (DMSA/MiADMSA) is more effective than individual thiol chelator in lead-exposed rats. Results indicated that lead caused a significant increase in reactive oxygen species, nitric oxide, and intracellular free calcium levels along with altered behavioral abnormalities in locomotor activity, exploratory behavior, learning, and memory that were supported by changes in neurotransmitter levels. A fall in membrane potential, release of cytochrome c, and DNA damage indicated mitochondrial-dependent apoptosis. Most of these alterations showed significant recovery following combined therapy with captopril with MiADMSA and to a smaller extend with captopril+DMSA over monotherapy with these chelators. It could be concluded from our present results that co-administration of a potent antioxidant (like captopril) might be a better treatment protocol than monotherapy to counter lead-induced oxidative stress. The major highlight of the work is an interesting experimental evidence of the efficacy of combinational therapy using an antioxidant with a thiol chelator in reversing neurological dystrophy caused due to chronic lead exposure in rats. PMID:19595699

  16. Combinational chelation therapy abrogates lead-induced neurodegeneration in rats

    SciTech Connect

    Pachauri, Vidhu; Saxena, Geetu; Mehta, Ashish; Mishra, Deepshikha; Flora, Swaran J.S.

    2009-10-15

    Lead, a ubiquitous and potent neurotoxicant causes oxidative stress which leads to numerous neurobehavioral and physiological alterations. The ability of lead to bind sulfhydryl groups or compete with calcium could be one of the reasons for its debilitating effects. In the present study, we addressed: i) if chelation therapy could circumvent the altered oxidative stress and prevent neuronal apoptosis in chronic lead-intoxicated rats, ii) whether chelation therapy could reverse biochemical and behavioral changes, and iii) if mono or combinational therapy with captopril (an antioxidant) and thiol chelating agents (DMSA/MiADMSA) is more effective than individual thiol chelator in lead-exposed rats. Results indicated that lead caused a significant increase in reactive oxygen species, nitric oxide, and intracellular free calcium levels along with altered behavioral abnormalities in locomotor activity, exploratory behavior, learning, and memory that were supported by changes in neurotransmitter levels. A fall in membrane potential, release of cytochrome c, and DNA damage indicated mitochondrial-dependent apoptosis. Most of these alterations showed significant recovery following combined therapy with captopril with MiADMSA and to a smaller extend with captopril + DMSA over monotherapy with these chelators. It could be concluded from our present results that co-administration of a potent antioxidant (like captopril) might be a better treatment protocol than monotherapy to counter lead-induced oxidative stress. The major highlight of the work is an interesting experimental evidence of the efficacy of combinational therapy using an antioxidant with a thiol chelator in reversing neurological dystrophy caused due to chronic lead exposure in rats.

  17. Laser beam welding non-ferrous metals. (Latest citations from METADEX). Published Search

    SciTech Connect

    Not Available

    1994-09-01

    The bibliography contains citations concerning techniques and the evaluation of laser beam welding of non-ferrous metals. Welding parameters, such as incident laser power and welding speed, are reviewed in relation to their characterization of weld microstructure. Weld examination techniques are cited, including macrophotography, light and electron microscopy, and microhardness profiling. (Contains a minimum of 170 citations and includes a subject term index and title list.)

  18. Separation of non-ferrous metals from ASR by corona electrostatic separation

    NASA Astrophysics Data System (ADS)

    Kim, Yang-soo; Choi, Jin-Young; Jeon, Ho-Seok; Han, Oh-Hyung; Park, Chul-Hyun

    2016-04-01

    Automotive shredder residue (ASR), the residual fraction of approximate 25% obtained after dismantling and shredding from waste car, consists of polymers (plastics and rubber), metals (ferrous and non-ferrous), wood, glass and fluff (textile and fiber). ASR cannot be effectively separated due to its heterogeneous materials and coated or laminated complexes and then largely deposited in land-fill sites as waste. Thus reducing a pollutant release before disposal, techniques that can improve the liberation of coated (or laminated) complexes and the recovery of valuable metals from the shredder residue are needed. ASR may be separated by a series of physical processing operations such as comminution, air, magnetic and electrostatic separations. The work deals with the characterization of the shredder residue coming from an industrial plant in korea and focuses on estimating the optimal conditions of corona electrostatic separation for improving the separation efficiency of valuable non-ferrous metals such as aluminum, copper and etc. From the results of test, the maximum separation achievable for non-ferrous metals using a corona electrostatic separation has been shown to be recovery of 92.5% at a grade of 75.8%. The recommended values of the process variables, particle size, electrode potential, drum speed, splitter position and relative humidity are -6mm, 50 kV, 35rpm, 20° and less 40%, respectively. Acknowledgments This study was supported by the R&D Center for Valuable Recycling (Global-Top R&BD Program) of the Ministry of Environment. (Project No. GT-11-C-01-170-0)

  19. Stress corrosion cracking of several high strength ferrous and nickel alloys

    NASA Technical Reports Server (NTRS)

    Nelson, E. E.

    1971-01-01

    The stress corrosion cracking resistance of several high strength ferrous and nickel base alloys has been determined in a sodium chloride solution. Results indicate that under these test conditions Multiphase MP35N, Unitemp L605, Inconel 718, Carpenter 20Cb and 20Cb-3 are highly resistant to stress corrosion cracking. AISI 410 and 431 stainless steels, 18 Ni maraging steel (250 grade) and AISI 4130 steel are susceptible to stress corrosion cracking under some conditions.

  20. Study of electropolishing of ferrous alloys using rotating-disk electrodes

    NASA Astrophysics Data System (ADS)

    Hryniewich, T.; Muller, R. H.; Tobias, C. W.

    1981-06-01

    Studies were performed on the rotating disk electrode system under controlled electrochemical and hydrodynamic conditions to establish conditions at which the best surface finish, after electropolishing of different types of ferrous alloys, may be achieved. The investigations were made over a wide range of applied current density, mass loss, and current efficiency using pure iron, armco iron, steels 1018, 1028, 1040, 1060, 1080, 4141 and H13 and 01 toolsteels. Characteristics of the finished surfaces are described.

  1. A Method for Imaging Steel Bars Behind a Ferrous Steel Boundary

    SciTech Connect

    Fernandes, B.; Miller, G.; Zaid, M.; Gaydecki, P.

    2006-03-06

    A system for detecting steel objects behind ferrous steel boundaries is described. It may be used to image steel reinforcing bars in concrete, where a steel sheet exists between the bars and the surface. The sensor comprises a transmitter, receiver and a dummy coil, which cancels cross-talk and enhances the signal from the bars. It is possible to penetrate a 2mm thick sheet at 125 Hz and image 16 mm diameter bars placed underneath.

  2. A Method for Imaging Steel Bars Behind a Ferrous Steel Boundary

    NASA Astrophysics Data System (ADS)

    Fernandes, B.; Miller, G.; Zaid, M.; Gaydecki, P.

    2006-03-01

    A system for detecting steel objects behind ferrous steel boundaries is described. It may be used to image steel reinforcing bars in concrete, where a steel sheet exists between the bars and the surface. The sensor comprises a transmitter, receiver and a dummy coil, which cancels cross-talk and enhances the signal from the bars. It is possible to penetrate a 2mm thick sheet at 125 Hz and image 16 mm diameter bars placed underneath.

  3. SEPARATION OF PLUTONIUM FROM LANTHANUM BY CHELATION-EXTRACTION

    DOEpatents

    James, R.A.; Thompson, S.G.

    1958-12-01

    Plutonium can be separated from a mixture of plutonlum and lanthanum in which the lanthanum to plutonium molal ratio ls at least five by adding the ammonium salt of N-nitrosoarylhydroxylamine to an aqueous solution having a pH between about 3 and 0.2 and containing the plutonium in a valence state of at least +3, to form a plutonium chelate compound of N-nitrosoarylhydroxylamine. The plutonium chelate compound may be recovered from the solution by extracting with an immiscible organic solvent such as chloroform.

  4. LITERATURE REVIEW: REDUCTION OF NP(V) TO NP (IV)-ALTERNATIVES TO FERROUS SULFAMATE

    SciTech Connect

    Kessinger, G.; Kyser, E.; Almond, P.

    2009-09-28

    The baseline approach to control of Np oxidation in UREX and PUREX separation processes is the reduction of Np(V) and Np(VI) to Np(IV) using ferrous sulfamate. Use of this reagent results in increased sulfur and iron concentrations in the liquid waste streams from the process. Presence of these two elements, especially sulfur, increases the complexity of the development of wasteforms for immobilizing these effluents. Investigations are underway to identify reductants that eliminate sulfur and iron from the Np reduction process. While there are a variety of chemical reductants that will reduce Np to Np(IV) in nitric acid media, the reaction rates for most are so slow that the reductants are not be feasible for use in an operating plant process. In an attempt to identify additional alternatives to ferrous sulfamate, a literature search and review was performed. Based on the results of the literature review, it is concluded that photochemical and catalytic processes should also be investigated to test the utility of these two approaches. The catalytic process could be investigated for use in conjunction with chemical oxidants to speed the reaction rates for reductants that react slowly, but would otherwise be appropriate replacements for ferrous sulfamate. The photochemical approach, which has received little attention during the past few decades, also shows promise, especially the photocatalytic approach that includes a catalyst, such as Pt supported on SiC, which can be used in tandem with an oxidant, for Np reduction.

  5. Dissolution of nickel ferrite in aqueous solutions containing oxalic acid and ferrous salts

    SciTech Connect

    Figueroa, C.A.; Sileo, E.E.; Morando, P.J.; Blesa, M.A.

    2000-05-15

    The dissolution of nickel ferrite in oxalic acid and in ferrous oxalate-oxalic acid aqueous solution was studied. Nickel ferrite was synthesized by thermal decomposition of a mixed tartrate; the particles were shown to be coated with a thin ferric oxide layer. Dissolution takes place in two stages, the first one corresponding to the dissolution of the ferric oxide outer layer and the second one being the dissolution of Ni{sub 1.06}Fe{sub 1.96}O{sub 4}. The kinetics of dissolution during this first stage is typical of ferric oxides: in oxalic acid, both a ligand-assisted and a redox mechanism operates, whereas in the presence of ferrous ions, redox catalysis leads to a faster dissolution. The rate dependence on both oxalic acid and on ferrous ion is described by the Langmuir-Hinshelwood equation. In the second stage, Langmuir-Hinshelwood kinetics also describes the dissolution of iron and nickel from nickel ferrite. It may be concluded that oxalic acid operates to dissolve iron, and the ensuing disruption of the solid framework accelerates the release of nickel.

  6. Ferrous iron-dependent drug delivery enables controlled and selective release of therapeutic agents in vivo

    PubMed Central

    Deu, Edgar; Chen, Ingrid T.; Lauterwasser, Erica M. W.; Valderramos, Juan; Li, Hao; Edgington, Laura E.; Renslo, Adam R.; Bogyo, Matthew

    2013-01-01

    The precise targeting of cytotoxic agents to specific cell types or cellular compartments is of significant interest in medicine, with particular relevance for infectious diseases and cancer. Here, we describe a method to exploit aberrant levels of mobile ferrous iron (FeII) for selective drug delivery in vivo. This approach makes use of a 1,2,4-trioxolane moiety, which serves as an FeII-sensitive “trigger,” making drug release contingent on FeII-promoted trioxolane fragmentation. We demonstrate in vivo validation of this approach with the Plasmodium berghei model of murine malaria. Malaria parasites produce high concentrations of mobile ferrous iron as a consequence of their catabolism of host hemoglobin in the infected erythrocyte. Using activity-based probes, we successfully demonstrate the FeII-dependent and parasite-selective delivery of a potent dipeptidyl aminopeptidase inhibitor. We find that delivery of the compound in its FeII-targeted form leads to more sustained target inhibition with greatly reduced off-target inhibition of mammalian cathepsins. This selective drug delivery translates into improved efficacy and tolerability. These findings demonstrate the utility of a purely chemical means to achieve selective drug targeting in vivo. This approach may find useful application in parasitic infections and more broadly in any disease state characterized by aberrant production of reactive ferrous iron. PMID:24145449

  7. Ferrous iron-dependent drug delivery enables controlled and selective release of therapeutic agents in vivo.

    PubMed

    Deu, Edgar; Chen, Ingrid T; Lauterwasser, Erica M W; Valderramos, Juan; Li, Hao; Edgington, Laura E; Renslo, Adam R; Bogyo, Matthew

    2013-11-01

    The precise targeting of cytotoxic agents to specific cell types or cellular compartments is of significant interest in medicine, with particular relevance for infectious diseases and cancer. Here, we describe a method to exploit aberrant levels of mobile ferrous iron (Fe(II)) for selective drug delivery in vivo. This approach makes use of a 1,2,4-trioxolane moiety, which serves as an Fe(II)-sensitive "trigger," making drug release contingent on Fe(II)-promoted trioxolane fragmentation. We demonstrate in vivo validation of this approach with the Plasmodium berghei model of murine malaria. Malaria parasites produce high concentrations of mobile ferrous iron as a consequence of their catabolism of host hemoglobin in the infected erythrocyte. Using activity-based probes, we successfully demonstrate the Fe(II)-dependent and parasite-selective delivery of a potent dipeptidyl aminopeptidase inhibitor. We find that delivery of the compound in its Fe(II)-targeted form leads to more sustained target inhibition with greatly reduced off-target inhibition of mammalian cathepsins. This selective drug delivery translates into improved efficacy and tolerability. These findings demonstrate the utility of a purely chemical means to achieve selective drug targeting in vivo. This approach may find useful application in parasitic infections and more broadly in any disease state characterized by aberrant production of reactive ferrous iron. PMID:24145449

  8. New developments in the processing of the non ferrous metal fraction of car scrap

    SciTech Connect

    Dalmijn, W.L.; Houwelingen, J.A. van

    1995-12-31

    The processing of scrap and scrap cars starts with size reduction by a hammermill, or shredder. After the liberation the magnetic fraction is removed. The remaining nonmagnetic fraction mixed with other materials is screened and each fraction is processed separately. The increased use of plastic has a negative effect on the recovery of metals and waste production. At Huron Valley, Belleville Michigan, USA, the non-ferrous fraction from 5 million obsolete cars per year, containing 200,000 tons of non-ferrous metal, is processed. Aluminium is recovered with a heavy medium separation process and concentrated with eddy current separators. The remaining heavy non-ferrous fraction is concentrated by a new combination of eddy current separation and image processing. After this separation process the zinc fraction is melted and refined and the copper, brass, stainless steel and other high-quality concentrates are sold to the secondary industries. The recycling of car scrap has become an important source of metals and materials for the secondary materials processing industry.

  9. Stable intermediate-spin ferrous iron in lower-mantle perovskite

    SciTech Connect

    McCammon, C.; Kantor, I.; Narygina, O.; Rouquette, J.; Ponkratz, U.; Sergueev, I.; Mezouar, M.; Prakapenka, V.; Dubrovinsky, L.

    2008-11-10

    The lower mantle is dominated by a magnesium- and iron-bearing mineral with the perovskite structure. Iron has the ability to adopt different electronic configurations, and transitions in its spin state in the lower mantle can significantly influence mantle properties and dynamics. However, previous studies aimed at understanding these transitions have provided conflicting results. Here we report the results of high-pressure (up to 110 GPa) and high-temperature (up to 1,000 K) experiments aimed at understanding spin transitions of iron in perovskite at lower-mantle conditions. Our Moessbauer and nuclear forward scattering data for two lower-mantle perovskite compositions demonstrate that the transition of ferrous iron from the high-spin to the intermediate-spin state occurs at approximately 30 GPa, and that high temperatures favour the stability of the intermediate-spin state. We therefore infer that ferrous iron adopts the intermediate-spin state throughout the bulk of the lower mantle. Our X-ray data show significant anisotropic compression of lower-mantle perovskite containing intermediate-spin ferrous iron, which correlates strongly with the spin transition. We predict spin-state heterogeneities in the uppermost part of the lower mantle associated with sinking slabs and regions of upwelling. These may affect local properties, including thermal and electrical conductivity, deformation (viscosity) and chemical behaviour, and thereby affect mantle dynamics.

  10. Gastrointestinal Complications of Ferrous Sulfate in Pregnant Women: A Randomized Double-Blind Placebo-Controlled Trial

    PubMed Central

    Jafarbegloo, Esmat; Ahmari Tehran, Hoda; Dadkhah Tehrani, Tahmineh

    2015-01-01

    Background: Some pregnant women discontinue iron supplements consumption due to Gastrointestinal (GI) complications, whereas pregnancy induces the same complications physiologically. Objectives: The aim of the present study was to assess GI complications of ferrous sulfate in pregnant women. Patients and Methods: This randomized, double-blind, placebo-controlled clinical trial was performed on 176 pregnant women referred to prenatal care clinic of Maryam Hospital from April 2011 to February 2012. Pregnant women with Hb ≥ 13.2 gr/dL at 13th - 18th weeks of gestation were selected based on the inclusion criteria and were randomly assigned to the ferrous sulfate and placebo groups. The ferrous sulfate group (n = 90) received a 50-mg ferrous sulfate tablet daily from the 20th week to the end of pregnancy and the placebo group (n = 89) received one placebo tablet in the same way. All participants were visited twice at 24th - 28th and 32nd - 36th weeks to assess the GI complications as well as Hb level to determine the Hb changes in two groups. Chi-square test, t-test and Kolmogorov-Smirnov test were used to analyze the data. P value of < 0.05 and confidence level of 95% were considered as statistically significant. Results: None of the GI complications were significantly different between the ferrous sulfate and placebo groups at 24th - 28th and 32nd - 36th weeks. Hemoglobin drop lower than 10.5 gr/dL at 24th - 28th weeks or lower than 11 g/dL at 32nd - 36th weeks was not observed in any cases. Conclusions: It can be concluded that GI complications in pregnant women using ferrous sulfate are mostly caused by physiologic changes of pregnancy rather than ferrous sulfate; therefore, it is not reasonable to stop using ferrous sulfate due to GI complications. PMID:26430520